---
description: NHGRI-EBI GWAS Catalog
---

# references

  


| STUDY.ACCESSION | Phenotype0 | PubmedID | Author | Year |
| :--- | :--- | :--- | :--- | :--- |
| GCST004600 | Eosinophil percentage of white cells | 27863252 | Astle WJ | 2016 |
| GCST004606 | Eosinophil counts | 27863252 | Astle WJ | 2016 |
| GCST007930 | Medication use \(agents acting on the renin-angiotensin system\) | 31015401 | Wu Y | 2019 |
| GCST007462 | Age of smoking initiation \(MTAG\) | 30643251 | Liu M | 2019 |
| GCST007468 | Smoking initiation \(ever regular vs never regular\) \(MTAG\) | 30643251 | Liu M | 2019 |
| GCST007461 | Alcohol consumption \(drinks per week\) | 30643251 | Liu M | 2019 |
| GCST002014 | Helicobacter pylori serologic status | 23652523 | Mayerle J | 2013 |
| GCST005346 | Total body bone mineral density \(age 30-45\) | 29304378 | Medina-Gomez C | 2018 |
| GCST006478 | Worry | 29942085 | Nagel M | 2018 |
| GCST006940 | Neurociticism | 29500382 | Nagel M | 2018 |
| GCST006571 | Educational attainment \(MTAG\) | 30038396 | Lee JJ | 2018 |
| GCST006442 | Educational attainment \(years of education\) | 30038396 | Lee JJ | 2018 |
| GCST006568 | Highest math class taken \(MTAG\) | 30038396 | Lee JJ | 2018 |
| GCST006414 | Atrial fibrillation | 30061737 | Nielsen JB | 2018 |
| GCST001496 | Non-albumin protein levels | 22558069 | Osman W | 2012 |
| GCST000493 | Sphingolipid levels | 19798445 | Hicks AA | 2009 |
| GCST006101 | Cardiometabolic and hematological traits | 27668658 | Iotchkova V | 2016 |
| GCST006574 | Highest math class taken | 30038396 | Lee JJ | 2018 |
| GCST005951 | Body mass index | 26426971 | Winkler TW | 2015 |
| GCST002783 | Body mass index | 25673413 | Locke AE | 2015 |
| GCST006085 | Prostate cancer | 29892016 | Schumacher FR | 2018 |
| GCST002606 | Prostate cancer | 25217961 | Al Olama AA | 2014 |
| GCST005316 | Intelligence \(MTAG\) | 29326435 | Hill WD | 2018 |
| GCST000817 | Height | 20881960 | Lango Allen H | 2010 |
| GCST006250 | Intelligence | 29942086 | Savage JE | 2018 |
| GCST005806 | Blood protein levels | 29875488 | Sun BB | 2018 |
| GCST006290 | Myopia \(age of diagnosis\) | 29808027 | Tedja MS | 2018 |
| GCST007847 | Type 2 diabetes | 30718926 | Suzuki K | 2019 |
| GCST003854 | Gut microbiota \(functional units\) | 27694959 | Bonder MJ | 2016 |
| GCST006979 | Heel bone mineral density | 30598549 | Morris JA | 2018 |
| GCST006288 | Heel bone mineral density | 28869591 | Kemp JP | 2017 |
| GCST004599 | Mean platelet volume | 27863252 | Astle WJ | 2016 |
| GCST007929 | Medication use \(calcium channel blockers\) | 31015401 | Wu Y | 2019 |
| GCST007020 | Male-pattern baldness | 30573740 | Yap CX | 2018 |
| GCST006368 | Body mass index | 30108127 | Hoffmann TJ | 2018 |
| GCST006475 | Depressed affect | 29942085 | Nagel M | 2018 |
| GCST007327 | Smoking status \(ever vs never smokers\) | 30643258 | Karlsson Linner R | 2019 |
| GCST004076 | Optic disc area | 28073927 | Springelkamp H | 2017 |
| GCST002443 | Blood metabolite levels | 24816252 | Shin SY | 2014 |
| GCST004988 | Breast cancer | 29059683 | Michailidou K | 2017 |
| GCST004093 | Prostate-specific antigen levels | 28139693 | Hoffmann TJ | 2017 |
| GCST006436 | Triglyceride levels | 30108155 | Hebbar P | 2018 |
| GCST006573 | Self-reported math ability | 30038396 | Lee JJ | 2018 |
| GCST005323 | Depressive symptoms \(MTAG\) | 29292387 | Turley P | 2018 |
| GCST006476 | Neuroticism | 29942085 | Nagel M | 2018 |
| GCST007342 | Depression | 30718901 | Howard DM | 2019 |
| GCST007709 | General factor of neuroticism | 30867560 | Hill WD | 2019 |
| GCST007062 | Hodgkin's lymphoma | 30194254 | Sud A | 2018 |
| GCST007323 | Risk-taking tendency \(4-domain principal component model\) | 30643258 | Karlsson Linner R | 2019 |
| GCST006061 | Atrial fibrillation | 29892015 | Roselli C | 2018 |
| GCST007710 | Anxiety/tension \(special factor of neuroticism\) | 30867560 | Hill WD | 2019 |
| GCST006946 | Worry too long after an embarrassing experience | 29500382 | Nagel M | 2018 |
| GCST004612 | High light scatter reticulocyte percentage of red cells | 27863252 | Astle WJ | 2016 |
| GCST004619 | Reticulocyte fraction of red cells | 27863252 | Astle WJ | 2016 |
| GCST004622 | Reticulocyte count | 27863252 | Astle WJ | 2016 |
| GCST001487 | Thyroid function | 22494929 | Rawal R | 2012 |
| GCST003155 | Systemic lupus erythematosus | 26502338 | Bentham J | 2015 |
| GCST006614 | Total cholesterol levels | 30275531 | Klarin D | 2018 |
| GCST006585 | Blood protein levels | 30072576 | Emilsson V | 2018 |
| GCST006921 | Regular attendance at a pub or social club | 29970889 | Day FR | 2018 |
| GCST006269 | General cognitive ability | 29844566 | Davies G | 2018 |
| GCST001856 | Thyroid hormone levels | 23408906 | Porcu E | 2013 |
| GCST001923 | Glomerular filtration rate | 23535967 | Tin A | 2013 |
| GCST005038 | Allergic disease \(asthma, hay fever or eczema\) | 29083406 | Ferreira MA | 2017 |
| GCST007707 | Hypertension | 30487518 | Takeuchi F | 2018 |
| GCST000051 | Atrial fibrillation/atrial flutter | 17603472 | Gudbjartsson DF | 2007 |
| GCST001579 | Age-related macular degeneration \(choroidal neovascularisation\) | 22705344 | Sobrin L | 2012 |
| GCST006950 | Feeling worry | 29500382 | Nagel M | 2018 |
| GCST002667 | Mammographic density \(dense area\) | 25342443 | Lindstrom S | 2014 |
| GCST003124 | Mild influenza \(H1N1\) infection | 26379185 | Garcia-Etxebarria K | 2015 |
| GCST008103 | Bipolar disorder | 31043756 | Stahl EA | 2019 |
| GCST007932 | Medication use \(thyroid preparations\) | 31015401 | Wu Y | 2019 |
| GCST004365 | Blood protein levels | 28240269 | Suhre K | 2017 |
| GCST006622 | Neonatal cytokine/chemokine levels \(fetal genetic effect\) | 30134952 | Traglia M | 2018 |
| GCST000507 | Systemic lupus erythematosus | 19838193 | Han JW | 2009 |
| GCST005752 | Systemic lupus erythematosus | 28714469 | Langefeld CD | 2017 |
| GCST005580 | Intraocular pressure | 29617998 | Gao XR | 2018 |
| GCST006412 | Intraocular pressure | 29785010 | Khawaja AP | 2018 |
| GCST000685 | Eye color traits | 20463881 | Liu F | 2010 |
| GCST007692 | Chronic obstructive pulmonary disease | 30804561 | Sakornsakolpat P | 2019 |
| GCST005350 | Total body bone mineral density \(age 45-60\) | 29304378 | Medina-Gomez C | 2018 |
| GCST002702 | Height | 25429064 | He M | 2014 |
| GCST007141 | Low density lipoprotein cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST007143 | Total cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST002896 | Cholesterol, total | 25961943 | Surakka I | 2015 |
| GCST006569 | Self-reported math ability \(MTAG\) | 30038396 | Lee JJ | 2018 |
| GCST002500 | QT interval | 24952745 | Arking DE | 2014 |
| GCST004063 | Waist circumference adjusted for body mass index | 25673412 | Shungin D | 2015 |
| GCST007325 | General risk tolerance \(MTAG\) | 30643258 | Karlsson Linner R | 2019 |
| GCST007474 | Smoking initiation \(ever regular vs never regular\) | 30643251 | Liu M | 2019 |
| GCST000054 | Type 1 diabetes | 17632545 | Hakonarson H | 2007 |
| GCST006947 | Feeling fed-up | 29500382 | Nagel M | 2018 |
| GCST007095 | Systolic blood pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST006231 | Mean arterial pressure | 27618448 | Liu C | 2016 |
| GCST007339 | Neuroticism | 30643256 | Baselmans BML | 2019 |
| GCST007705 | Pulse pressure | 30487518 | Takeuchi F | 2018 |
| GCST007340 | Depressive symptoms | 30643256 | Baselmans BML | 2019 |
| GCST007094 | Diastolic blood pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST007097 | Pulse pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST007703 | Systolic blood pressure | 30487518 | Takeuchi F | 2018 |
| GCST000393 | Systolic blood pressure | 19430479 | Levy D | 2009 |
| GCST007099 | Systolic blood pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST007096 | Pulse pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST002321 | Lipid traits | 24386095 | Zhou L | 2013 |
| GCST004617 | Eosinophil percentage of granulocytes | 27863252 | Astle WJ | 2016 |
| GCST004623 | Neutrophil percentage of granulocytes | 27863252 | Astle WJ | 2016 |
| GCST005324 | Depressive symptoms | 29292387 | Turley P | 2018 |
| GCST000913 | Iron status biomarkers | 21149283 | Oexle K | 2010 |
| GCST007464 | Smoking cessation \(MTAG\) | 30643251 | Liu M | 2019 |
| GCST007472 | Alcohol consumption \(drinks per week\) \(MTAG\) | 30643251 | Liu M | 2019 |
| GCST008295 | Number of decayed, missing and filled tooth surfaces or use of dentures | 31235808 | Shungin D | 2019 |
| GCST008306 | Dentures | 31235808 | Shungin D | 2019 |
| GCST000494 | Bone mineral density \(spine\) | 19801982 | Rivadeneira F | 2009 |
| GCST007691 | Femoral neck bone mineral density | 22504420 | Estrada K | 2012 |
| GCST006624 | Systolic blood pressure | 30224653 | Evangelou E | 2018 |
| GCST004603 | Platelet count | 27863252 | Astle WJ | 2016 |
| GCST004607 | Plateletcrit | 27863252 | Astle WJ | 2016 |
| GCST005348 | Total body bone mineral density | 29304378 | Medina-Gomez C | 2018 |
| GCST005796 | Lumbar spine bone mineral density | 29499414 | Pei YF | 2018 |
| GCST007856 | Colorectal cancer or advanced adenoma | 30510241 | Huyghe JR | 2018 |
| GCST005863 | Menopause \(age at onset\) | 29773799 | Horikoshi M | 2018 |
| GCST003044 | Crohn's disease | 26192919 | Liu JZ | 2015 |
| GCST003335 | Waist circumference | 26785701 | Wen W | 2016 |
| GCST007983 | Morningness | 30804565 | Jansen PR | 2019 |
| GCST001089 | Esophageal cancer | 21642993 | Wu C | 2011 |
| GCST005288 | Extrinsic epigenetic age acceleration | 29374233 | Lu AT | 2018 |
| GCST002442 | Blood metabolite ratios | 24816252 | Shin SY | 2014 |
| GCST007512 | Benign prostatic hyperplasia and lower urinary tract symptoms \(prostate cancer excluded\) | 30410027 | Gudmundsson J | 2018 |
| GCST007507 | Benign prostatic hyperplasia and lower urinary tract symptoms | 30410027 | Gudmundsson J | 2018 |
| GCST007943 | Medication use \(antihistamines for systemic use\) | 31015401 | Wu Y | 2019 |
| GCST005656 | IgG glycosylation patterns | 29535710 | Wahl A | 2018 |
| GCST003795 | Age at first birth | 27798627 | Barban N | 2016 |
| GCST002084 | Allergic sensitization | 23817571 | Bonnelykke K | 2013 |
| GCST004278 | Pulse pressure | 28135244 | Warren HR | 2017 |
| GCST006661 | Male-pattern baldness | 28196072 | Hagenaars SP | 2017 |
| GCST006570 | Cognitive performance \(MTAG\) | 30038396 | Lee JJ | 2018 |
| GCST007431 | Lung function \(FEV1/FVC\) | 30804560 | Shrine N | 2019 |
| GCST004279 | Systolic blood pressure | 28135244 | Warren HR | 2017 |
| GCST007432 | FEV1 | 30804560 | Shrine N | 2019 |
| GCST007268 | Diastolic blood pressure | 30578418 | Giri A | 2018 |
| GCST007341 | Well-being spectrum \(multivariate analysis\) | 30643256 | Baselmans BML | 2019 |
| GCST007324 | Adventurousness | 30643258 | Karlsson Linner R | 2019 |
| GCST007985 | Snoring | 30804565 | Jansen PR | 2019 |
| GCST006630 | Diastolic blood pressure | 30224653 | Evangelou E | 2018 |
| GCST007267 | Systolic blood pressure | 30578418 | Giri A | 2018 |
| GCST007877 | Creatinine levels | 31015462 | Graham SE | 2019 |
| GCST004904 | Body mass index | 28892062 | Akiyama M | 2017 |
| GCST006366 | Central corneal thickness | 29760442 | Iglesias AI | 2018 |
| GCST005897 | Low tan response | 29739929 | Visconti A | 2018 |
| GCST001729 | Crohn's disease | 23128233 | Jostins L | 2012 |
| GCST007928 | Medication use \(diuretics\) | 31015401 | Wu Y | 2019 |
| GCST007344 | Estimated glomerular filtration rate | 30604766 | Morris AP | 2019 |
| GCST002149 | Schizophrenia | 23974872 | Ripke S | 2013 |
| GCST004611 | High light scatter reticulocyte count | 27863252 | Astle WJ | 2016 |
| GCST006952 | Feeling tense | 29500382 | Nagel M | 2018 |
| GCST005076 | Breast cancer \(estrogen-receptor negative\) | 29058716 | Milne RL | 2017 |
| GCST006462 | Uterine fibroids | 30194396 | Rafnar T | 2018 |
| GCST006480 | Glioblastoma \(age-stratified\) | 30152087 | Ostrom QT | 2018 |
| GCST003228 | Glioma | 26424050 | Kinnersley B | 2015 |
| GCST005931 | Glioma | 29743610 | Ostrom QT | 2018 |
| GCST004478 | Serous invasive ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST005932 | Glioblastoma | 29743610 | Ostrom QT | 2018 |
| GCST004481 | Low-grade serous and serous borderline ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST004349 | Glioblastoma | 28346443 | Melin BS | 2017 |
| GCST004348 | Non-glioblastoma glioma | 28346443 | Melin BS | 2017 |
| GCST004950 | Breast cancer | 25751625 | Michailidou K | 2015 |
| GCST001298 | Breast cancer | 22037553 | Haiman CA | 2011 |
| GCST004479 | Serous borderline ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST004480 | High-grade serous ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST001930 | Breast cancer | 23535733 | Garcia-Closas M | 2013 |
| GCST007236 | Breast cancer | 25751625 | Michailidou K | 2015 |
| GCST005075 | Breast Cancer in BRCA1 mutation carriers | 29058716 | Milne RL | 2017 |
| GCST001937 | Breast cancer | 23535729 | Michailidou K | 2013 |
| GCST002748 | Epithelial ovarian cancer | 25581431 | Kuchenbaecker KB | 2015 |
| GCST004415 | Invasive epithelial ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST003780 | Breast cancer \(estrogen-receptor negative\) | 28171663 | Huo D | 2016 |
| GCST004347 | Glioma | 28346443 | Melin BS | 2017 |
| GCST001806 | Corneal structure | 23291589 | Lu Y | 2013 |
| GCST006941 | Irritable mood | 29500382 | Nagel M | 2018 |
| GCST007576 | Chronotype | 30696823 | Jones SE | 2019 |
| GCST002647 | Height | 25282103 | Wood AR | 2014 |
| GCST002602 | Vitamin D levels | 25208829 | Anderson D | 2014 |
| GCST003010 | Gastric cancer | 26129866 | Hu N | 2015 |
| GCST003009 | Cardia gastric cancer | 26129866 | Hu N | 2015 |
| GCST003007 | Non-cardia gastric cancer | 26129866 | Hu N | 2015 |
| GCST004620 | Sum basophil neutrophil counts | 27863252 | Astle WJ | 2016 |
| GCST004626 | Myeloid white cell count | 27863252 | Astle WJ | 2016 |
| GCST004613 | Sum neutrophil eosinophil counts | 27863252 | Astle WJ | 2016 |
| GCST004610 | White blood cell count | 27863252 | Astle WJ | 2016 |
| GCST004614 | Granulocyte count | 27863252 | Astle WJ | 2016 |
| GCST004629 | Neutrophil count | 27863252 | Astle WJ | 2016 |
| GCST005905 | Global electrical heterogeneity phenotypes | 29622589 | Tereshchenko LG | 2018 |
| GCST007227 | QRS duration | 30679814 | van Setten J | 2019 |
| GCST001335 | Mean platelet volume | 22139419 | Gieger C | 2011 |
| GCST006258 | Diastolic blood pressure | 27618452 | Ehret GB | 2016 |
| GCST006259 | Systolic blood pressure | 27618452 | Ehret GB | 2016 |
| GCST004280 | Diastolic blood pressure | 28135244 | Warren HR | 2017 |
| GCST005232 | Neuroticism | 29255261 | Luciano M | 2017 |
| GCST006021 | Systolic blood pressure | 27618447 | Surendran P | 2016 |
| GCST003676 | Educational attainment \(years of education\) | 27225129 | Okbay A | 2016 |
| GCST001765 | Red blood cell traits | 23222517 | van der Harst P | 2012 |
| GCST003666 | Metabolite levels \(small molecules and protein measures\) | 27005778 | Kettunen J | 2016 |
| GCST004628 | Immature fraction of reticulocytes | 27863252 | Astle WJ | 2016 |
| GCST006421 | Cannabis use | 30150663 | Pasman JA | 2018 |
| GCST006922 | Regular attendance at a religious group | 29970889 | Day FR | 2018 |
| GCST007269 | Pulse pressure | 30578418 | Giri A | 2018 |
| GCST004618 | White blood cell count \(basophil\) | 27863252 | Astle WJ | 2016 |
| GCST008059 | Estimated glomerular filtration rate | 31152163 | Wuttke M | 2019 |
| GCST002944 | Prostate cancer | 26034056 | Hoffmann TJ | 2015 |
| GCST004627 | Lymphocyte counts | 27863252 | Astle WJ | 2016 |
| GCST006867 | Type 2 diabetes | 30054458 | Xue A | 2018 |
| GCST007132 | High density lipoprotein cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST000802 | Ovarian cancer | 20852632 | Goode EL | 2010 |
| GCST001941 | Ovarian cancer | 23535730 | Pharoah PD | 2013 |
| GCST007430 | Peak expiratory flow | 30804560 | Shrine N | 2019 |
| GCST007429 | Lung function \(FVC\) | 30804560 | Shrine N | 2019 |
| GCST006289 | Spherical equivalent | 29808027 | Tedja MS | 2018 |
| GCST001776 | Cardiac Troponin-T levels | 23247143 | Yu B | 2012 |
| GCST005195 | Coronary artery disease | 29212778 | van der Harst P | 2017 |
| GCST007142 | Triglycerides | 29507422 | Hoffmann TJ | 2018 |
| GCST005827 | Estrone levels | 29325096 | Eriksson AL | 2018 |
| GCST008316 | Corneal endothelial cell size variation coefficient | 30894546 | Ivarsdottir EV | 2019 |
| GCST005434 | Pancreatic cancer | 29422604 | Klein AP | 2018 |
| GCST003758 | Pancreatic cancer | 27579533 | Zhang M | 2016 |
| GCST006655 | Breast size | 29855537 | Hirata T | 2018 |
| GCST003875 | Gut microbiota \(bacterial taxa\) | 27723756 | Wang J | 2016 |
| GCST004635 | Testicular germ cell tumor | 28604728 | Litchfield K | 2017 |
| GCST007701 | High density lipoprotein cholesterol levels | 30911093 | Bandesh K | 2019 |
| GCST007702 | Triglyceride levels | 30911093 | Bandesh K | 2019 |
| GCST000584 | Triglycerides | 20139978 | Kamatani Y | 2010 |
| GCST000289 | Triglycerides | 19060911 | Aulchenko YS | 2008 |
| GCST000974 | HDL cholesterol | 21347282 | Lettre G | 2011 |
| GCST001137 | White blood cell count | 21738480 | Nalls MA | 2011 |
| GCST008058 | Estimated glomerular filtration rate | 31152163 | Wuttke M | 2019 |
| GCST005896 | Non-melanoma skin cancer | 29739929 | Visconti A | 2018 |
| GCST006572 | Cognitive performance | 30038396 | Lee JJ | 2018 |
| GCST004633 | Neutrophil percentage of white cells | 27863252 | Astle WJ | 2016 |
| GCST004634 | Basophil percentage of granulocytes | 27863252 | Astle WJ | 2016 |
| GCST004631 | Basophil percentage of white cells | 27863252 | Astle WJ | 2016 |
| GCST004576 | Waist-to-hip ratio adjusted for body mass index | 28448500 | Graff M | 2017 |
| GCST004578 | Waist-to-hip ratio adjusted for BMI in active individuals | 28448500 | Graff M | 2017 |
| GCST007445 | Factor VIII levels | 30586737 | Sabater-Lleal M | 2018 |
| GCST002222 | LDL cholesterol | 24097068 | Willer CJ | 2013 |
| GCST004235 | Total cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST004233 | LDL cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST002221 | Cholesterol, total | 24097068 | Willer CJ | 2013 |
| GCST004615 | Hemoglobin concentration | 27863252 | Astle WJ | 2016 |
| GCST007228 | Pulmonary arterial hypertension | 30527956 | Rhodes CJ | 2018 |
| GCST006291 | Spherical equivalent or myopia \(age of diagnosis\) | 29808027 | Tedja MS | 2018 |
| GCST004604 | Hematocrit | 27863252 | Astle WJ | 2016 |
| GCST000809 | Triglycerides | 20864672 | Waterworth DM | 2010 |
| GCST007140 | High density lipoprotein cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST005194 | Coronary artery disease | 29212778 | van der Harst P | 2017 |
| GCST004776 | Systolic blood pressure | 28739976 | Wain LV | 2017 |
| GCST004630 | Mean corpuscular hemoglobin | 27863252 | Astle WJ | 2016 |
| GCST004601 | Red blood cell count | 27863252 | Astle WJ | 2016 |
| GCST004602 | Mean corpuscular volume | 27863252 | Astle WJ | 2016 |
| GCST003740 | Barrett's esophagus  or Esophageal adenocarcinoma | 27527254 | Gharahkhani P | 2016 |
| GCST007733 | Serum uric acid levels | 30993211 | Nakatochi M | 2019 |
| GCST003401 | Glomerular filtration rate in non diabetics \(creatinine\) | 26831199 | Pattaro C | 2016 |
| GCST007463 | Cigarettes smoked per day \(MTAG\) | 30643251 | Liu M | 2019 |
| GCST007941 | Medication use \(adrenergics, inhalants\) | 31015401 | Wu Y | 2019 |
| GCST007942 | Medication use \(glucocorticoids\) | 31015401 | Wu Y | 2019 |
| GCST005337 | Headache | 29397368 | Meng W | 2018 |
| GCST007326 | Number of sexual partners | 30643258 | Karlsson Linner R | 2019 |
| GCST005571 | Osteoarthritis of the hip or knee \(with total joint replacement\) | 29436472 | Casalone E | 2018 |
| GCST005573 | Osteoarthritis of the hip or knee | 29436472 | Casalone E | 2018 |
| GCST006951 | Feeling hurt | 29500382 | Nagel M | 2018 |
| GCST000829 | Waist-hip ratio | 20935629 | Heid IM | 2010 |
| GCST004064 | Waist-hip ratio | 25673412 | Shungin D | 2015 |
| GCST006904 | Cerebral amyloid deposition \(PET imaging\) | 30361487 | Yan Q | 2018 |
| GCST006896 | Free thyroxine concentration | 30367059 | Teumer A | 2018 |
| GCST005146 | Birth weight | 27680694 | Horikoshi M | 2016 |
| GCST005865 | Early age at menarche | 29773799 | Horikoshi M | 2018 |
| GCST000678 | Breast cancer | 20453838 | Turnbull C | 2010 |
| GCST006945 | Feeling guilty | 29500382 | Nagel M | 2018 |
| GCST006479 | Diverticular disease | 30177863 | Maguire LH | 2018 |
| GCST000033 | Bipolar disorder | 17486107 | Baum AE | 2007 |
| GCST001139 | Chronic hepatitis C infection | 21725309 | Miki D | 2011 |
| GCST006628 | Systolic blood pressure | 30224653 | Evangelou E | 2018 |
| GCST002831 | Lead levels in blood | 25820613 | Warrington NM | 2015 |
| GCST002873 | Thyroid cancer | 25855579 | Mancikova V | 2015 |
| GCST004067 | Hip circumference adjusted for BMI | 25673412 | Shungin D | 2015 |
| GCST004608 | Granulocyte percentage of myeloid white cells | 27863252 | Astle WJ | 2016 |
| GCST004609 | Monocyte percentage of white cells | 27863252 | Astle WJ | 2016 |
| GCST005902 | Depression \(broad\) | 29662059 | Howard DM | 2018 |
| GCST008070 | HDL cholesterol levels | 30698716 | de Vries PS | 2019 |
| GCST008076 | Triglyceride levels | 30698716 | de Vries PS | 2019 |
| GCST008087 | Triglyceride levels in current drinkers | 30698716 | de Vries PS | 2019 |
| GCST008085 | HDL cholesterol levels in current drinkers | 30698716 | de Vries PS | 2019 |
| GCST004292 | Glomerular filtration rate \(creatinine\) | 28452372 | Gorski M | 2017 |
| GCST000760 | Cholesterol, total | 20686565 | Teslovich TM | 2010 |
| GCST004873 | Endometriosis | 28881265 | Sobalska-Kwapis M | 2017 |
| GCST002764 | Optic cup area | 25631615 | Springelkamp H | 2015 |
| GCST004066 | Hip circumference | 25673412 | Shungin D | 2015 |
| GCST004557 | Body mass index | 28448500 | Graff M | 2017 |
| GCST004065 | Waist circumference | 25673412 | Shungin D | 2015 |
| GCST006395 | Glaucoma | 30054594 | MacGregor S | 2018 |
| GCST001671 | IgG levels | 23225573 | Buck D | 2012 |
| GCST003116 | Coronary artery disease | 26343387 | Nikpay M | 2015 |
| GCST004787 | Coronary artery disease \(myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease\) | 28714975 | Nelson CP | 2017 |
| GCST006612 | LDL cholesterol | 30275531 | Klarin D | 2018 |
| GCST002166 | Serum protein levels \(sST2\) | 23999434 | Ho JE | 2013 |
| GCST003925 | Gout | 27899376 | Nakayama A | 2016 |
| GCST003926 | Renal underexcretion gout | 27899376 | Nakayama A | 2016 |
| GCST002541 | Menarche \(age at onset\) | 25231870 | Perry JR | 2014 |
| GCST004773 | Type 2 diabetes | 28566273 | Scott RA | 2017 |
| GCST001134 | White blood cell types | 21738478 | Okada Y | 2011 |
| GCST004946 | Schizophrenia | 28991256 | Li Z | 2017 |
| GCST007044 | Extremely high intelligence | 29520040 | Coleman JRI | 2018 |
| GCST005839 | Depression | 29700475 | Wray NR | 2018 |
| GCST007553 | Autism and major depressive disorder \(MTAG\) | 30804558 | Grove J | 2019 |
| GCST002240 | Bladder cancer | 24163127 | Figueroa JD | 2013 |
| GCST000830 | Body mass index | 20935630 | Speliotes EK | 2010 |
| GCST007992 | Colorectal cancer | 31089142 | Law PJ | 2019 |
| GCST007988 | Insomnia | 30804565 | Jansen PR | 2019 |
| GCST001969 | Heart rate | 23583979 | den Hoed M | 2013 |
| GCST003720 | Migraine | 27322543 | Gormley P | 2016 |
| GCST006943 | Feeling miserable | 29500382 | Nagel M | 2018 |
| GCST007387 | Insomnia symptoms \(never/rarely vs. sometimes/usually\) | 30804566 | Lane JM | 2019 |
| GCST007388 | Insomnia symptoms \(never/rarely vs. usually\) | 30804566 | Lane JM | 2019 |
| GCST003837 | Chronotype | 27494321 | Jones SE | 2016 |
| GCST003454 | Morning vs. evening chronotype | 26955885 | Lane JM | 2016 |
| GCST003453 | Chronotype | 26955885 | Lane JM | 2016 |
| GCST003194 | Fibrinogen levels | 26561523 | de Vries PS | 2015 |
| GCST002147 | Fibrinogen | 23969696 | Sabater-Lleal M | 2013 |
| GCST006463 | Urinary albumin excretion \(no hypertensive medication\) | 30220432 | Haas ME | 2018 |
| GCST006586 | Urinary albumin excretion | 30220432 | Haas ME | 2018 |
| GCST007718 | Urinary albumin-to-creatinine ratio | 30910378 | Zanetti D | 2019 |
| GCST007798 | Asthma | 30929738 | Ferreira MAR | 2019 |
| GCST004605 | Mean corpuscular hemoglobin concentration | 27863252 | Astle WJ | 2016 |
| GCST001147 | Prostate cancer | 21743057 | Schumacher FR | 2011 |
| GCST006627 | Diastolic blood pressure | 30224653 | Evangelou E | 2018 |
| GCST007822 | Facial attractiveness \(male raters\) | 30946739 | Hu B | 2019 |
| GCST001105 | Migraine | 21666692 | Chasman DI | 2011 |
| GCST006636 | Menstruation quality of life impact \(dysmenorrhea\) | 29855537 | Hirata T | 2018 |
| GCST004549 | Endometriosis | 28537267 | Sapkota Y | 2017 |
| GCST004302 | Primary biliary cholangitis | 28425483 | Qiu F | 2017 |
| GCST002217 | Sj?gren's syndrome | 24097066 | Li Y | 2013 |
| GCST000502 | Hematocrit | 19862010 | Ganesh SK | 2009 |
| GCST005145 | Glycated hemoglobin levels | 29170429 | Hachiya T | 2017 |
| GCST007338 | Positive affect | 30643256 | Baselmans BML | 2019 |
| GCST004625 | Monocyte count | 27863252 | Astle WJ | 2016 |
| GCST001728 | Ulcerative colitis | 23128233 | Jostins L | 2012 |
| GCST006075 | Hair color | 29662168 | Hysi PG | 2018 |
| GCST000368 | Fibrinogen | 20031577 | Danik JS | 2009 |
| GCST007986 | Ease of getting up in the morning | 30804565 | Jansen PR | 2019 |
| GCST007382 | Plasma free amino acid levels \(adjusted for twenty other PFAAs\) | 30659259 | Imaizumi A | 2019 |
| GCST002346 | Breast cancer \(early onset\) | 24493630 | Ahsan H | 2014 |
| GCST004236 | LDL cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST004231 | Total cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST005528 | Juvenile idiopathic arthritis \(oligoarticular or rheumatoid factor-negative polyarticular\) | 23603761 | Hinks A | 2013 |
| GCST007995 | Asthma \(childhood onset\) | 31036433 | Pividori M | 2019 |
| GCST002318 | Rheumatoid arthritis | 24390342 | Okada Y | 2013 |
| GCST006959 | Rheumatoid arthritis | 30423114 | Laufer VA | 2018 |
| GCST003117 | Myocardial infarction | 26343387 | Nikpay M | 2015 |
| GCST005651 | Urinary metabolite concentrations in chronic kidney disease | 29545352 | Li Y | 2018 |
| GCST003119 | Urinary metabolites | 26352407 | Raffler J | 2015 |
| GCST005649 | Urinary metabolite ratios in chronic kidney disease | 29545352 | Li Y | 2018 |
| GCST000879 | Crohn's disease | 21102463 | Franke A | 2010 |
| GCST004495 | BMI \(adjusted for smoking behaviour\) | 28443625 | Justice AE | 2017 |
| GCST004499 | BMI in non-smokers | 28443625 | Justice AE | 2017 |
| GCST006802 | Body mass index | 26961502 | Wood AR | 2016 |
| GCST004398 | Lipoprotein \(a\) levels | 28512139 | Mack S | 2017 |
| GCST001381 | Menopause \(age at onset\) | 22267201 | Stolk L | 2012 |
| GCST007923 | Medication use \(drugs used in diabetes\) | 31015401 | Wu Y | 2019 |
| GCST007638 | Glycine levels | 30837465 | Wittemans LBL | 2019 |
| GCST006613 | Triglycerides | 30275531 | Klarin D | 2018 |
| GCST007706 | Mean arterial pressure | 30487518 | Takeuchi F | 2018 |
| GCST007704 | Diastolic blood pressure | 30487518 | Takeuchi F | 2018 |
| GCST003045 | Ulcerative colitis | 26192919 | Liu JZ | 2015 |
| GCST005235 | Hand grip strength | 29313844 | Willems SM | 2017 |
| GCST007994 | Asthma \(age of onset\) | 31036433 | Pividori M | 2019 |
| GCST007797 | Asthma onset \(childhood vs adult\) | 30929738 | Ferreira MAR | 2019 |
| GCST001148 | Prostate cancer | 21743467 | Kote-Jarai Z | 2011 |
| GCST006944 | Experiencing mood swings | 29500382 | Nagel M | 2018 |
| GCST007725 | Serum uric acid levels | 30993211 | Nakatochi M | 2019 |
| GCST002083 | Self-reported allergy | 23817569 | Hinds DA | 2013 |
| GCST005097 | Fractures \(vertebral\) | 29170203 | Alonso N | 2017 |
| GCST004364 | Intelligence | 28530673 | Sniekers S | 2017 |
| GCST008163 | Height | 28552196 | Tachmazidou I | 2017 |
| GCST004505 | Waist-to-hip ratio adjusted for BMI \(adjusted for smoking behaviour\) | 28443625 | Justice AE | 2017 |
| GCST004504 | Waist circumference adjusted for BMI in non-smokers | 28443625 | Justice AE | 2017 |
| GCST002782 | Waist-to-hip ratio adjusted for body mass index | 25673412 | Shungin D | 2015 |
| GCST005956 | Waist-to-hip ratio adjusted for BMI | 26426971 | Winkler TW | 2015 |
| GCST004562 | Waist circumference adjusted for body mass index | 28448500 | Graff M | 2017 |
| GCST004500 | Waist circumference adjusted for BMI \(adjusted for smoking behaviour\) | 28443625 | Justice AE | 2017 |
| GCST000758 | Triglycerides | 20686565 | Teslovich TM | 2010 |
| GCST004564 | Waist circumference adjusted for BMI in active individuals | 28448500 | Graff M | 2017 |
| GCST002322 | Asthma and hay fever | 24388013 | Ferreira MA | 2013 |
| GCST004983 | Parental lifespan | 29030599 | Joshi PK | 2017 |
| GCST006543 | Pericardial adipose tissue adjusted for height and weight | 27918534 | Chu AY | 2016 |
| GCST006544 | Pericardial adipose tissue adjusted for height and weight | 27918534 | Chu AY | 2016 |
| GCST003968 | Pericardial adipose tissue adjusted for height and weight | 27918534 | Chu AY | 2016 |
| GCST001247 | Cardiovascular disease risk factors | 21943158 | Middelberg RP | 2011 |
| GCST004785 | Vitiligo | 27723757 | Jin Y | 2016 |
| GCST005648 | Serum metabolite concentrations in chronic kidney disease | 29545352 | Li Y | 2018 |
| GCST001198 | Multiple sclerosis | 21833088 | Sawcer S | 2011 |
| GCST005047 | Type 2 diabetes | 22885922 | Morris AP | 2012 |
| GCST005830 | Hand grip strength | 29691431 | Tikkanen E | 2018 |
| GCST005829 | Hand grip strength | 29691431 | Tikkanen E | 2018 |
| GCST007201 | Schizophrenia | 30285260 | Ikeda M | 2018 |
| GCST007459 | Smoking behaviour \(cigarettes smoked per day\) | 30643251 | Liu M | 2019 |
| GCST007205 | Schizophrenia | 30285260 | Ikeda M | 2018 |
| GCST000651 | Creatinine levels | 20383145 | Chambers JC | 2010 |
| GCST005042 | Restless legs syndrome | 29029846 | Schormair B | 2017 |
| GCST000042 | Crohn's disease | 17554300 | Wellcome Trust Case Control Consortium | 2007 |
| GCST006804 | Red cell distribution width | 28957414 | Pilling LC | 2017 |
| GCST003264 | Post bronchodilator FEV1/FVC ratio | 26634245 | Lutz SM | 2015 |
| GCST004632 | Lymphocyte percentage of white cells | 27863252 | Astle WJ | 2016 |
| GCST001870 | Bone mineral density | 23437003 | Paternoster L | 2013 |
| GCST000877 | Bone mineral density | 21124946 | Paternoster L | 2010 |
| GCST002999 | Lobe size | 26105758 | Adhikari K | 2015 |
| GCST007093 | Osteoarthritis | 30664745 | Tachmazidou I | 2019 |
| GCST004621 | Red cell distribution width | 27863252 | Astle WJ | 2016 |
| GCST005891 | Glomerular filtration rate in diabetes | 29703844 | van Zuydam NR | 2018 |
| GCST000499 | Hemoglobin | 19862010 | Ganesh SK | 2009 |
| GCST004215 | Urea levels | 28270201 | Nagy R | 2017 |
| GCST001482 | Lumbar spine bone mineral density | 22504420 | Estrada K | 2012 |
| GCST006923 | Loneliness | 29970889 | Day FR | 2018 |
| GCST006924 | Loneliness \(MTAG\) | 29970889 | Day FR | 2018 |
| GCST005650 | Serum metabolite ratios in chronic kidney disease | 29545352 | Li Y | 2018 |
| GCST002449 | Plasma omega-6 polyunsaturated fatty acid levels \(arachidonic acid\) | 24823311 | Guan W | 2014 |
| GCST001179 | Plasma omega-3 polyunsaturated fatty acid levels \(docosapentaenoic acid\) | 21829377 | Lemaitre RN | 2011 |
| GCST001834 | Oleic acid \(18:1n-9\) levels | 23362303 | Wu JH | 2013 |
| GCST002965 | Glycerophospholipid levels | 26068415 | Draisma HHM | 2015 |
| GCST002721 | Trans fatty acid levels | 25646338 | Mozaffarian D | 2014 |
| GCST004338 | Oleic acid \(18:1n-9\) levels | 28298293 | Hu Y | 2017 |
| GCST001180 | Plasma omega-3 polyunsaturated fatty acid levels \(alphalinolenic acid\) | 21829377 | Lemaitre RN | 2011 |
| GCST004339 | Palmitoleic acid \(16:1n-7\) levels | 28298293 | Hu Y | 2017 |
| GCST001840 | Stearic acid \(18:0\) levels | 23362303 | Wu JH | 2013 |
| GCST001841 | Palmitoleic acid \(16:1n-7\) levels | 23362303 | Wu JH | 2013 |
| GCST001919 | Type 2 diabetes | 23532257 | Ma RC | 2013 |
| GCST002633 | Intracranial aneurysm | 25256182 | Foroud T | 2014 |
| GCST000957 | Natriuretic peptide levels | 21273288 | Del Greco M F | 2011 |
| GCST001199 | Iris characteristics | 21835309 | Larsson M | 2011 |
| GCST005196 | Coronary artery disease | 29212778 | van der Harst P | 2017 |
| GCST007434 | Metastasis in stage I-III microsatellite instability low/stable colorectal cancer \(time to event\) | 30738427 | Penney ME | 2019 |
| GCST000719 | Alopecia areata | 20596022 | Petukhova L | 2010 |
| GCST001200 | Graves' disease | 21841780 | Chu X | 2011 |
| GCST005326 | Neuroticism \(MTAG\) | 29292387 | Turley P | 2018 |
| GCST006626 | Pulse pressure | 30224653 | Evangelou E | 2018 |
| GCST004521 | Autism spectrum disorder or schizophrenia | 28540026 | Anney RJL | 2017 |
| GCST007400 | Systemic lupus erythematosus | 28714469 | Langefeld CD | 2017 |
| GCST004185 | Lung function \(FEV1/FVC\) | 28166213 | Wain LV | 2017 |
| GCST005186 | Fasting blood glucose | 22581228 | Manning AK | 2012 |
| GCST003721 | Migraine without aura | 27322543 | Gormley P | 2016 |
| GCST007581 | Carpal tunnel syndrome | 30833571 | Wiberg A | 2019 |
| GCST006857 | Leisure-time exercise behaviour | 30102679 | Hara M | 2018 |
| GCST007337 | Life satisfaction | 30643256 | Baselmans BML | 2019 |
| GCST001605 | C-reactive protein and white blood cell count | 22788528 | Kong M | 2012 |
| GCST007603 | Smoking initiation | 30617275 | Erzurumluoglu AM | 2019 |
| GCST002580 | Intraocular pressure | 25173106 | Hysi PG | 2014 |
| GCST004389 | Circulating chemerin levels | 25521368 | Tonjes A | 2014 |
| GCST004775 | Pulse pressure | 28739976 | Wain LV | 2017 |
| GCST003274 | Pulse pressure | 26390057 | Kato N | 2015 |
| GCST001967 | Body mass index | 23583978 | Monda KL | 2013 |
| GCST004861 | Itch intensity from mosquito bite | 28199695 | Jones AV | 2017 |
| GCST001745 | Sagittal craniosynostosis | 23160099 | Justice CM | 2012 |
| GCST003790 | Glomerular filtration rate | 27588450 | Mahajan A | 2016 |
| GCST004624 | Sum eosinophil basophil counts | 27863252 | Astle WJ | 2016 |
| GCST007839 | Mouth ulcers | 30837455 | Dudding T | 2019 |
| GCST007876 | Estimated glomerular filtration rate | 31015462 | Graham SE | 2019 |
| GCST005570 | Hepatitis B virus-related hepatocellular carcinoma | 29246937 | Li Y | 2018 |
| GCST001741 | Pancreatitis | 23143602 | Whitcomb DC | 2012 |
| GCST008167 | Mean platelet volume | 31194788 | Read RW | 2019 |
| GCST006477 | Depression | 29942085 | Nagel M | 2018 |
| GCST004075 | Vertical cup-disc ratio | 28073927 | Springelkamp H | 2017 |
| GCST001610 | Renal function-related traits \(BUN\) | 22797727 | Okada Y | 2012 |
| GCST003851 | Caffeine metabolism \(plasma 1,7-dimethylxanthine \(paraxanthine\) to 1,3,7-trimethylxanthine \(caffeine\) ratio\) | 27702941 | Cornelis MC | 2016 |
| GCST003846 | Caffeine metabolism \(plasma 1,3,7-trimethylxanthine \(caffeine\) level\) | 27702941 | Cornelis MC | 2016 |
| GCST004858 | Dupuytren's disease | 28886342 | Ng M | 2017 |
| GCST001500 | Wilms tumor | 22544364 | Turnbull C | 2012 |
| GCST006980 | Fractures | 30598549 | Morris JA | 2018 |
| GCST003372 | Glomerular filtration rate \(creatinine\) | 26831199 | Pattaro C | 2016 |
| GCST001607 | Renal function-related traits \(eGRFcrea\) | 22797727 | Okada Y | 2012 |
| GCST001606 | Renal function-related traits \(sCR\) | 22797727 | Okada Y | 2012 |
| GCST007517 | Type 2 diabetes | 29632382 | Mahajan A | 2018 |
| GCST004384 | Hypertension | 28498854 | Liang J | 2017 |
| GCST004074 | Intraocular pressure | 28073927 | Springelkamp H | 2017 |
| GCST004863 | Mosquito bite size | 28199695 | Jones AV | 2017 |
| GCST007931 | Medication use \(HMG CoA reductase inhibitors\) | 31015401 | Wu Y | 2019 |
| GCST007899 | Fasting blood glucose | 25631608 | Wessel J | 2015 |
| GCST003262 | Post bronchodilator FEV1 | 26634245 | Lutz SM | 2015 |
| GCST007687 | Photic sneeze reflex | 30899065 | Wang M | 2019 |
| GCST004232 | HDL cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST006984 | Takayasu arteritis | 30498034 | Terao C | 2018 |
| GCST001702 | Prostate cancer | 23023329 | Xu J | 2012 |
| GCST002762 | Optic cup area | 25631615 | Springelkamp H | 2015 |
| GCST002681 | Post-traumatic stress disorder | 25456346 | Nievergelt CM | 2014 |
| GCST000775 | Central corneal thickness | 20719862 | Vitart V | 2010 |
| GCST001337 | Platelet count | 22139419 | Gieger C | 2011 |
| GCST006131 | Colorectal cancer | 29917119 | Schmit SL | 2018 |
| GCST002411 | Colorectal cancer | 24737748 | Whiffin N | 2014 |
| GCST001248 | Pulmonary function | 21946350 | Soler Artigas M | 2011 |
| GCST004146 | Chronic lymphocytic leukemia | 28165464 | Law PJ | 2017 |
| GCST004237 | Triglyceride levels | 28334899 | Spracklen CN | 2017 |
| GCST000180 | Bone mineral density \(spine\) | 18445777 | Styrkarsdottir U | 2008 |
| GCST000297 | Bone mineral density \(hip\) | 19079262 | Styrkarsdottir U | 2008 |
| GCST000181 | Bone mineral density \(hip\) | 18445777 | Styrkarsdottir U | 2008 |
| GCST003125 | Influenza A \(H1N1\) infection | 26379185 | Garcia-Etxebarria K | 2015 |
| GCST007335 | Age at first sexual intercourse | 27089180 | Day FR | 2016 |
| GCST002216 | Triglycerides | 24097068 | Willer CJ | 2013 |
| GCST000759 | LDL cholesterol | 20686565 | Teslovich TM | 2010 |
| GCST000807 | LDL cholesterol | 20864672 | Waterworth DM | 2010 |
| GCST000287 | LDL cholesterol | 19060906 | Kathiresan S | 2008 |
| GCST003153 | Cirrhosis \(alcohol related\) | 26482880 | Buch S | 2015 |
| GCST007294 | Body fat distribution \(trunk fat ratio\) | 30664634 | Rask-Andersen M | 2019 |
| GCST007295 | Body fat distribution \(leg fat ratio\) | 30664634 | Rask-Andersen M | 2019 |
| GCST006022 | Pulse pressure | 27618447 | Surendran P | 2016 |
| GCST007320 | Alzheimer's disease or family history of Alzheimer's disease | 30617256 | Jansen IE | 2019 |
| GCST000270 | Colorectal cancer | 19011631 | Houlston RS | 2008 |
| GCST002326 | Pulmonary emphysema | 24383474 | Manichaikul A | 2014 |
| GCST004209 | Cholesterol, total | 28270201 | Nagy R | 2017 |
| GCST002601 | Plasma plasminogen levels | 25208887 | Ma Q | 2014 |
| GCST002333 | Bone properties \(heel\) | 24430505 | Moayyeri A | 2014 |
| GCST002335 | Bone properties \(heel\) | 24430505 | Moayyeri A | 2014 |
| GCST002231 | Digestive system disease \(Barrett's esophagus and esophageal adenocarcinoma combined\) | 24121790 | Levine DM | 2013 |
| GCST000755 | HDL cholesterol | 20686565 | Teslovich TM | 2010 |
| GCST001725 | Inflammatory bowel disease | 23128233 | Jostins L | 2012 |
| GCST007561 | Sleep duration | 30846698 | Dashti HS | 2019 |
| GCST000880 | Menarche \(age at onset\) | 21102462 | Elks CE | 2010 |
| GCST000569 | Two-hour glucose challenge | 20081857 | Saxena R | 2010 |
| GCST007394 | Mitochondrial DNA copy number | 30704525 | Guyatt AL | 2019 |
| GCST001946 | PCA3 expression level | 23555189 | Chen Z | 2013 |
| GCST003629 | nicotine metabolite ratio in current smokers | 27488534 | Patel YM | 2016 |
| GCST000114 | Skin pigmentation | 17999355 | Stokowski RP | 2007 |
| GCST000119 | Freckles | 17952075 | Sulem P | 2007 |
| GCST007098 | Diastolic blood pressure | 27841878 | Hoffmann TJ | 2016 |
| GCST007492 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST000068 | Height | 17767157 | Weedon MN | 2007 |
| GCST000174 | Height | 18391952 | Weedon MN | 2008 |
| GCST000176 | Height | 18391950 | Lettre G | 2008 |
| GCST001484 | Head circumference \(infant\) | 22504419 | Taal HR | 2012 |
| GCST001758 | Birth weight | 23202124 | Horikoshi M | 2012 |
| GCST002098 | Brugada syndrome | 23872634 | Bezzina CR | 2013 |
| GCST005667 | Central corneal thickness | 29760442 | Iglesias AI | 2018 |
| GCST004147 | Chronic obstructive pulmonary disease | 28166215 | Hobbs BD | 2017 |
| GCST005328 | Subjective well-being | 29292387 | Turley P | 2018 |
| GCST006097 | Moderate to vigorous physical activity levels | 29899525 | Klimentidis YC | 2018 |
| GCST007385 | Plasma free amino acid levels | 30659259 | Imaizumi A | 2019 |
| GCST002899 | HDL cholesterol | 25961943 | Surakka I | 2015 |
| GCST000712 | Type 2 diabetes | 20581827 | Voight BF | 2010 |
| GCST001973 | Menarche \(age at onset\) | 23599027 | Demerath EW | 2013 |
| GCST007353 | Generalized epilepsy | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST006091 | Freckles | 29895819 | Endo C | 2018 |
| GCST007133 | Triglycerides | 29507422 | Hoffmann TJ | 2018 |
| GCST006611 | HDL cholesterol | 30275531 | Klarin D | 2018 |
| GCST005867 | Menarche \(age at onset\) | 29773799 | Horikoshi M | 2018 |
| GCST002834 | Corneal curvature | 25823570 | Miyake M | 2015 |
| GCST006050 | Central corneal thickness | 29847655 | Fan BJ | 2018 |
| GCST006899 | Thyroid stimulating hormone levels | 30367059 | Teumer A | 2018 |
| GCST005212 | Asthma | 29273806 | Demenais F | 2017 |
| GCST006862 | Asthma | 29273806 | Demenais F | 2017 |
| GCST001865 | Aortic-valve calcification | 23388002 | Thanassoulis G | 2013 |
| GCST004963 | Lipoprotein phospholipase A2 activity in cardiovascular disease | 28753643 | Yeo A | 2017 |
| GCST006698 | Parental longevity \(both parents in top 10%\) | 29227965 | Pilling LC | 2017 |
| GCST003665 | Metabolite levels \(lipoprotein measures\) | 27005778 | Kettunen J | 2016 |
| GCST001218 | Lp \(a\) levels | 21900290 | Qi Q | 2011 |
| GCST001425 | Response to statin therapy | 22368281 | Deshmukh HA | 2012 |
| GCST005561 | Aortic valve stenosis | 29511194 | Helgadottir A | 2018 |
| GCST001726 | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy | 23118302 | Chu AY | 2012 |
| GCST002675 | Response to statins \(LDL cholesterol change\) | 25350695 | Postmus I | 2014 |
| GCST002881 | ADAMTS13 activity | 25934476 | de Vries PS | 2015 |
| GCST008129 | Body mass index | 29273807 | Turcot V | 2017 |
| GCST003818 | Resting heart rate | 27798624 | Eppinga RN | 2016 |
| GCST006423 | Fractures | 30158200 | Trajanoska K | 2018 |
| GCST004412 | Craniofacial microsomia | 26853712 | Zhang YB | 2016 |
| GCST001810 | Menopause \(age at onset\) | 23307926 | Perry JR | 2013 |
| GCST007401 | Factor VII activity | 30642921 | de Vries PS | 2019 |
| GCST007347 | Juvenile myoclonic epilepsy | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST002118 | Metabolite levels \(Pyroglutamine\) | 23934736 | Yu B | 2013 |
| GCST007329 | Automobile speeding propensity | 30643258 | Karlsson Linner R | 2019 |
| GCST000653 | Age-related macular degeneration | 20385826 | Neale BM | 2010 |
| GCST000290 | HDL cholesterol | 19060906 | Kathiresan S | 2008 |
| GCST002390 | Glycated hemoglobin levels | 24647736 | Chen P | 2014 |
| GCST000803 | Glycated hemoglobin levels | 20858683 | Soranzo N | 2010 |
| GCST007953 | Glycated hemoglobin levels | 28898252 | Wheeler E | 2017 |
| GCST007954 | Glycated hemoglobin levels | 28898252 | Wheeler E | 2017 |
| GCST003853 | Hip minimal joint space width | 27701424 | Castano-Betancourt MC | 2016 |
| GCST007328 | Alcohol consumption \(drinks per week\) | 30643258 | Karlsson Linner R | 2019 |
| GCST002537 | Breast cancer | 25038754 | Cai Q | 2014 |
| GCST006870 | Hippocampal tail volume | 30279459 | van der Meer D | 2018 |
| GCST006881 | Hippocampal tail volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST006981 | Facial wrinkles | 29555444 | Hamer MA | 2018 |
| GCST001808 | Tumor biomarkers | 23300138 | He M | 2013 |
| GCST002738 | Psoriasis | 25574825 | Baurecht H | 2015 |
| GCST008064 | Chronic kidney disease | 31152163 | Wuttke M | 2019 |
| GCST007778 | Urinary sodium to creatinine ratio | 30910378 | Zanetti D | 2019 |
| GCST008062 | Blood urea nitrogen levels | 31152163 | Wuttke M | 2019 |
| GCST007838 | Glycine levels | 31070104 | Jia Q | 2019 |
| GCST007836 | Glycine levels | 31070104 | Jia Q | 2019 |
| GCST007721 | Urinary potassium to creatinine ratio | 30910378 | Zanetti D | 2019 |
| GCST008060 | Estimated glomerular filtration rate | 31152163 | Wuttke M | 2019 |
| GCST007837 | Glycine levels | 31070104 | Jia Q | 2019 |
| GCST002391 | Plasma homocysteine levels \(post-methionine load test\) | 24651765 | Williams SR | 2014 |
| GCST002223 | HDL cholesterol | 24097068 | Willer CJ | 2013 |
| GCST007878 | Urea levels | 31015462 | Graham SE | 2019 |
| GCST001791 | Urate levels | 23263486 | Kottgen A | 2012 |
| GCST003659 | Modified Stumvoll Insulin Sensitivity Index \(BMI interaction\) | 27416945 | Walford GA | 2016 |
| GCST002582 | Glaucoma \(primary open-angle\) | 25173105 | Gharahkhani P | 2014 |
| GCST001493 | Glaucoma \(primary open-angle\) | 22570617 | Wiggs JL | 2012 |
| GCST000700 | Vertical cup-disc ratio | 20548946 | Ramdas WD | 2010 |
| GCST005046 | N-glycan levels | 21908519 | Huffman JE | 2011 |
| GCST000925 | N-glycan levels | 21203500 | Lauc G | 2010 |
| GCST000173 | Psoriasis | 18369459 | Liu Y | 2008 |
| GCST000734 | Follicular lymphoma | 20639881 | Conde L | 2010 |
| GCST008226 | Renal cell carcinoma | 31231134 | Laskar RS | 2019 |
| GCST003368 | circulating leptin levels adjusted for BMI | 26833098 | Kilpelainen TO | 2016 |
| GCST002463 | Systemic lupus erythematosus | 24871463 | Armstrong DL | 2014 |
| GCST000996 | Systemic lupus erythematosus | 21408207 | Chung SA | 2011 |
| GCST000650 | Systemic sclerosis | 20383147 | Radstake TR | 2010 |
| GCST001033 | Type 2 diabetes | 21490949 | Sim X | 2011 |
| GCST001301 | Schizophrenia | 22037555 | Shi Y | 2011 |
| GCST000805 | HDL cholesterol | 20864672 | Waterworth DM | 2010 |
| GCST001986 | Age-related macular degeneration | 23577725 | Naj AC | 2013 |
| GCST001578 | Age-related macular degeneration \(geographic atrophy\) | 22705344 | Sobrin L | 2012 |
| GCST001884 | Age-related macular degeneration | 23455636 | Fritsche LG | 2013 |
| GCST001571 | Age-related macular degeneration | 22694956 | Cipriani V | 2012 |
| GCST004737 | Neovascular age-related macular degeneration | 28703135 | Ruamviboonsuk P | 2017 |
| GCST002201 | Calcium levels | 24068962 | O'Seaghdha CM | 2013 |
| GCST001848 | IgG glycosylation | 23382691 | Lauc G | 2013 |
| GCST002724 | Airway responsiveness in chronic obstructive pulmonary disease | 25514360 | Hansel NN | 2014 |
| GCST007092 | Osteoarthritis of the hip or knee | 30664745 | Tachmazidou I | 2019 |
| GCST007091 | Osteoarthritis \(hip\) | 30664745 | Tachmazidou I | 2019 |
| GCST004508 | Waist-to-hip ratio adjusted for BMI in non-smokers | 28443625 | Justice AE | 2017 |
| GCST004132 | Crohn's disease | 28067908 | de Lange KM | 2017 |
| GCST001103 | Alcohol consumption \(transferrin glycosylation\) | 21665994 | Kutalik Z | 2011 |
| GCST000263 | Multiple sclerosis | 18997785 | Aulchenko YS | 2008 |
| GCST004373 | Atrial fibrillation | 28416822 | Low SK | 2017 |
| GCST003429 | Morning vs. evening chronotype | 26835600 | Hu Y | 2016 |
| GCST001086 | Paget's disease | 21623375 | Albagha OM | 2011 |
| GCST007483 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST007487 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST002961 | Acylcarnitine levels | 26068415 | Draisma HHM | 2015 |
| GCST000561 | Electrocardiographic traits | 20062063 | Holm H | 2010 |
| GCST000588 | Red blood cell count | 20139978 | Kamatani Y | 2010 |
| GCST001662 | Generalized epilepsy | 22949513 | EPICURE Consortium | 2012 |
| GCST002148 | Otitis media \(chronic/recurrent\) | 23974705 | Allen EK | 2013 |
| GCST005787 | Heart rate response to exercise | 29769521 | Ramirez J | 2018 |
| GCST004208 | Body mass index | 28270201 | Nagy R | 2017 |
| GCST002245 | Alzheimer's disease \(late onset\) | 24162737 | Lambert JC | 2013 |
| GCST005325 | Subjective well-being \(MTAG\) | 29292387 | Turley P | 2018 |
| GCST000122 | Rheumatoid arthritis | 17982456 | Plenge RM | 2007 |
| GCST000531 | Inflammatory bowel disease \(early onset\) | 19915574 | Imielinski M | 2009 |
| GCST006948 | Feeling nervous | 29500382 | Nagel M | 2018 |
| GCST006949 | Suffering from nerves | 29500382 | Nagel M | 2018 |
| GCST007443 | Nasal polyps | 30643255 | Kristjansson RP | 2019 |
| GCST001548 | Male-pattern baldness | 22693459 | Li R | 2012 |
| GCST001242 | Schizophrenia | 21926974 | Ripke S | 2011 |
| GCST002539 | Schizophrenia | 25056061 | Ripke S | 2014 |
| GCST004238 | Triglyceride levels | 28334899 | Spracklen CN | 2017 |
| GCST000135 | HDL cholesterol | 18193043 | Willer CJ | 2008 |
| GCST001237 | HDL cholesterol | 21909109 | Kim YJ | 2011 |
| GCST001230 | Triglycerides | 21909109 | Kim YJ | 2011 |
| GCST000139 | Triglycerides | 18193043 | Willer CJ | 2008 |
| GCST002078 | Migraine without aura | 23793025 | Anttila V | 2013 |
| GCST004895 | Colorectal cancer | 28960316 | Tanskanen T | 2017 |
| GCST003799 | Colorectal cancer | 26965516 | Zeng C | 2016 |
| GCST000052 | Colorectal cancer | 17618283 | Zanke BW | 2007 |
| GCST002413 | Prostate cancer \(early onset\) | 24740154 | Lange EM | 2014 |
| GCST002010 | Esophageal squamous cell cancer \(length of survival\) | 23644492 | Wu C | 2013 |
| GCST002184 | Mean platelet volume | 24026423 | Shameer K | 2013 |
| GCST004894 | Type 2 diabetes | 28869590 | Zhao W | 2017 |
| GCST004809 | Immunoglobulin light chain \(AL\) amyloidosis \(serum Ig lambda profile\) | 28679651 | Meziane I | 2017 |
| GCST004334 | Mean corpuscular hemoglobin | 28453575 | Hodonsky CJ | 2017 |
| GCST002027 | Red blood cell traits | 23696099 | Ding K | 2013 |
| GCST001873 | Red blood cell traits | 23446634 | Chen Z | 2013 |
| GCST007952 | Glycated hemoglobin levels | 28898252 | Wheeler E | 2017 |
| GCST004333 | Red cell distribution width | 28453575 | Hodonsky CJ | 2017 |
| GCST004332 | Red blood cell count | 28453575 | Hodonsky CJ | 2017 |
| GCST004335 | Mean corpuscular volume | 28453575 | Hodonsky CJ | 2017 |
| GCST001183 | Asthma | 21804548 | Hirota T | 2011 |
| GCST001357 | Response to tamoxifen in breast cancer | 22180457 | Kiyotani K | 2011 |
| GCST000392 | Type 1 diabetes | 19430480 | Barrett JC | 2009 |
| GCST003835 | Depressive symptoms \(stressful life events interaction\) | 27529621 | Otowa T | 2016 |
| GCST008109 | Fasting blood proinsulin levels | 23263489 | Huyghe JR | 2012 |
| GCST004713 | Testicular germ cell tumor | 28604732 | Wang Z | 2017 |
| GCST002022 | Testicular germ cell tumor | 23666240 | Ruark E | 2013 |
| GCST006304 | Irritable bowel syndrome | 29626450 | Bonfiglio F | 2018 |
| GCST007614 | C-reactive protein levels | 30388399 | Ligthart S | 2018 |
| GCST000380 | Height | 19396169 | Cho YS | 2009 |
| GCST001277 | Liver enzyme levels \(gamma-glutamyl transferase\) | 22001757 | Chambers JC | 2011 |
| GCST001126 | Parkinson's disease | 21738487 | Do CB | 2011 |
| GCST002759 | Motion sickness | 25628336 | Hromatka BS | 2015 |
| GCST006041 | Major depressive disorder | 27479909 | Hyde CL | 2016 |
| GCST004795 | Brain volume in infants \(white matter\) | 28763065 | Xia K | 2017 |
| GCST002755 | Depressive symptoms \(SSRI exposure interaction\) | 25649181 | Noordam R | 2015 |
| GCST000143 | Systemic lupus erythematosus | 18204447 | Kozyrev SV | 2008 |
| GCST000544 | Pulmonary function | 20010834 | Repapi E | 2009 |
| GCST004183 | Lung function \(FEV1\) | 28166213 | Wain LV | 2017 |
| GCST000667 | Smoking behavior | 20418888 | Thorgeirsson TE | 2010 |
| GCST000666 | Smoking behavior | 20418890 | Tobacco and Genetics Consortium | 2010 |
| GCST000171 | Nicotine dependence | 18385739 | Thorgeirsson TE | 2008 |
| GCST000506 | Lung adenocarcinoma | 19836008 | Landi MT | 2009 |
| GCST000668 | Smoking behavior | 20418889 | Liu JZ | 2010 |
| GCST004512 | Smoking status \(heavy vs light\) | 28520984 | Saccone NL | 2017 |
| GCST007602 | Smoking behaviour \(cigarettes smoked per day\) | 30617275 | Erzurumluoglu AM | 2019 |
| GCST000256 | Lung cancer | 18978790 | McKay JD | 2008 |
| GCST001217 | Metabolic traits | 21886157 | Suhre K | 2011 |
| GCST000583 | Hematological and biochemical traits | 20139978 | Kamatani Y | 2010 |
| GCST006911 | Asthma \(moderate or severe\) | 30552067 | Shrine N | 2018 |
| GCST000965 | C-reactive protein levels | 21300955 | Dehghan A | 2011 |
| GCST005014 | Tonsillectomy | 28928442 | Tian C | 2017 |
| GCST007354 | Intracranial aneurysm | 30823506 | Hong EP | 2019 |
| GCST001331 | Multiple myeloma | 22120009 | Broderick P | 2011 |
| GCST001679 | Complement C3 and C4 levels | 23028341 | Yang X | 2012 |
| GCST003724 | Bipolar disorder | 27329760 | Hou L | 2016 |
| GCST006519 | Growth differentiation factor-15 levels | 22997280 | Ho JE | 2012 |
| GCST005312 | Menopause \(age at onset\) | 26414677 | Day FR | 2015 |
| GCST004878 | Sj?gren's syndrome | 24097067 | Lessard CJ | 2013 |
| GCST005007 | Strep throat | 28928442 | Tian C | 2017 |
| GCST004616 | Platelet distribution width | 27863252 | Astle WJ | 2016 |
| GCST007998 | Intraocular pressure | 30591961 | Huang L | 2018 |
| GCST004744 | Lung adenocarcinoma | 28604730 | McKay JD | 2017 |
| GCST002047 | Educational attainment | 23722424 | Rietveld CA | 2013 |
| GCST005716 | Type 2 diabetes | 27362418 | Zhang H | 2016 |
| GCST005712 | Growth differentiation factor-15 levels \(conditioned on rs888663\) | 29628937 | Jiang J | 2018 |
| GCST001316 | IgE levels | 22075330 | Granada M | 2011 |
| GCST006408 | Allergic sensitization | 30013184 | Waage J | 2018 |
| GCST006020 | Diastolic blood pressure | 27618447 | Surendran P | 2016 |
| GCST006925 | Knee osteoarthritis | 30374069 | Styrkarsdottir U | 2018 |
| GCST001814 | Age-related macular degeneration | 23326517 | Holliday EG | 2013 |
| GCST007225 | Varicose veins | 30566020 | Fukaya E | 2018 |
| GCST001451 | Glaucoma \(primary open-angle\) | 22419738 | Osman W | 2012 |
| GCST006252 | Childhood steroid-sensitive nephrotic syndrome | 29903748 | Debiec H | 2018 |
| GCST001793 | Coagulation factor levels | 23267103 | Desch KC | 2012 |
| GCST007442 | Low density lipoprotein cholesterol levels | 30718733 | Moon S | 2019 |
| GCST007441 | Total cholesterol levels | 30718733 | Moon S | 2019 |
| GCST001798 | End-stage coagulation | 23381943 | Williams FM | 2013 |
| GCST003369 | Anxiety disorder \(factor score\) | 26754954 | Otowa T | 2016 |
| GCST001438 | Crohn's disease | 22412388 | Kenny EE | 2012 |
| GCST002843 | Sitting height ratio | 25865494 | Chan Y | 2015 |
| GCST005345 | Total body bone mineral density \(age 0-15\) | 29304378 | Medina-Gomez C | 2018 |
| GCST000652 | Age-related macular degeneration | 20385819 | Chen W | 2010 |
| GCST007089 | Polycystic ovary syndrome | 30566500 | Day F | 2018 |
| GCST003061 | Cutaneous malignant melanoma | 26237428 | Law MH | 2015 |
| GCST002446 | Plasma omega-6 polyunsaturated fatty acid levels \(linoleic acid\) | 24823311 | Guan W | 2014 |
| GCST002031 | Primary tooth development \(number of teeth\) | 23704328 | Fatemifar G | 2013 |
| GCST005367 | Vitamin D levels | 29343764 | Jiang X | 2018 |
| GCST003855 | Gut microbiota \(bacterial taxa\) | 27694959 | Bonder MJ | 2016 |
| GCST005958 | Waist-to-hip ratio adjusted for BMI \(age &gt;50\) | 26426971 | Winkler TW | 2015 |
| GCST006903 | Hip shape \(DXA scan\) | 30320955 | Baird DA | 2018 |
| GCST004137 | Optic cup area | 28073927 | Springelkamp H | 2017 |
| GCST003260 | Ischemic stroke \(small artery occlusion\) | 26708676 | Pulit SL | 2015 |
| GCST003258 | Ischemic stroke | 26708676 | Pulit SL | 2015 |
| GCST002630 | Systolic blood pressure | 25249183 | Lu X | 2014 |
| GCST005848 | Heart rate response to recovery post exercise \(50 sec\) | 29497042 | Verweij N | 2018 |
| GCST005846 | Heart rate response to recovery post exercise \(10 sec\) | 29497042 | Verweij N | 2018 |
| GCST005847 | Heart rate response to recovery post exercise \(20 sec\) | 29497042 | Verweij N | 2018 |
| GCST003838 | Morning vs. evening chronotype | 27494321 | Jones SE | 2016 |
| GCST004696 | Chronotype | 28604731 | Hammerschlag AR | 2017 |
| GCST001361 | Ankle-brachial index | 22199011 | Murabito JM | 2011 |
| GCST003877 | Abdominal aortic aneurysm | 27899403 | Jones GT | 2016 |
| GCST001587 | Coronary heart disease | 22751097 | Lu X | 2012 |
| GCST000030 | Myocardial infarction | 17478679 | Helgadottir A | 2007 |
| GCST004006 | Mean corpuscular hemoglobin | 28017375 | van Rooij FJA | 2016 |
| GCST004004 | Mean corpuscular volume | 28017375 | van Rooij FJA | 2016 |
| GCST000503 | Mean corpuscular volume | 19862010 | Ganesh SK | 2009 |
| GCST000504 | Mean corpuscular hemoglobin | 19862010 | Ganesh SK | 2009 |
| GCST000964 | Ulcerative colitis | 21297633 | Anderson CA | 2011 |
| GCST006048 | Rheumatoid arthritis \(ACPA-positive\) | 24532676 | Kim K | 2014 |
| GCST006926 | Osteoarthritis \(hip\) | 30374069 | Styrkarsdottir U | 2018 |
| GCST004422 | Vascular endothelial growth factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004439 | Interleukin-12p70 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003403 | Vascular endothelial growth factor levels | 26910538 | Choi SH | 2016 |
| GCST000248 | Liver enzyme levels | 18940312 | Yuan X | 2008 |
| GCST007402 | Factor VII activity or levels | 30642921 | de Vries PS | 2019 |
| GCST002940 | Sporadic pituitary adenoma | 26029870 | Ye Z | 2015 |
| GCST003586 | Prostate cancer | 27262462 | Teerlink CC | 2016 |
| GCST001099 | Sudden cardiac arrest | 21658281 | Aouizerat BE | 2011 |
| GCST007708 | Worry/vulnerability \(special factor of neuroticism\) | 30867560 | Hill WD | 2019 |
| GCST008158 | Body mass index | 28552196 | Tachmazidou I | 2017 |
| GCST008151 | Waist circumference | 28552196 | Tachmazidou I | 2017 |
| GCST008160 | Waist circumference | 28552196 | Tachmazidou I | 2017 |
| GCST007293 | Body fat distribution \(arm fat ratio\) | 30664634 | Rask-Andersen M | 2019 |
| GCST000442 | Aortic root size | 19584346 | Vasan RS | 2009 |
| GCST003845 | Breast cancer | 27117709 | Couch FJ | 2016 |
| GCST003842 | Breast cancer \(estrogen-receptor negative\) | 27117709 | Couch FJ | 2016 |
| GCST002305 | Breast cancer \(estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative\) | 24325915 | Purrington KS | 2013 |
| GCST004234 | HDL cholesterol levels | 28334899 | Spracklen CN | 2017 |
| GCST000649 | Chronic kidney disease | 20383146 | Kottgen A | 2010 |
| GCST001792 | Colorectal cancer | 23263487 | Jia WH | 2012 |
| GCST007552 | Colorectal cancer | 30529582 | Lu Y | 2018 |
| GCST002454 | Colorectal cancer | 24836286 | Zhang B | 2014 |
| GCST000994 | Drinking behavior | 21372407 | Takeuchi F | 2011 |
| GCST000847 | Retinal vascular caliber | 21060863 | Ikram MK | 2010 |
| GCST004655 | Left ventricle diastolic internal dimension | 28394258 | Wild PS | 2017 |
| GCST002890 | Prostate cancer | 25939597 | Berndt SI | 2015 |
| GCST007002 | Cerebrospinal fluid t-tau levels in normal cognition | 29274321 | Chung J | 2017 |
| GCST007927 | Medication use \(beta blocking agents\) | 31015401 | Wu Y | 2019 |
| GCST000178 | C-reactive protein | 18439548 | Ridker PM | 2008 |
| GCST001904 | HDL cholesterol | 23505323 | Weissglas-Volkov D | 2013 |
| GCST002897 | Triglycerides | 25961943 | Surakka I | 2015 |
| GCST006483 | Lung function \(FVC\) | 30061609 | Wyss AB | 2018 |
| GCST006481 | Lung function \(FEV1\) | 30061609 | Wyss AB | 2018 |
| GCST007090 | Knee osteoarthritis | 30664745 | Tachmazidou I | 2019 |
| GCST006402 | Energy intake | 30071075 | Jiang L | 2018 |
| GCST008279 | Trochanter size | 31053729 | Styrkarsdottir U | 2019 |
| GCST001481 | Brain structure | 22504417 | Stein JL | 2012 |
| GCST000919 | Serum prostate-specific antigen levels | 21160077 | Gudmundsson J | 2010 |
| GCST002388 | Serum metabolite levels | 24625756 | Yu B | 2014 |
| GCST001003 | Metabolic syndrome | 21386085 | Kraja AT | 2011 |
| GCST001005 | HDL Cholesterol - Triglycerides \(HDLC-TG\) | 21386085 | Kraja AT | 2011 |
| GCST001006 | Waist Circumference - Triglycerides \(WC-TG\) | 21386085 | Kraja AT | 2011 |
| GCST005750 | Digit length ratio | 29659830 | Warrington NM | 2018 |
| GCST005749 | Digit length ratio \(left hand\) | 29659830 | Warrington NM | 2018 |
| GCST005748 | Digit length ratio \(right hand\) | 29659830 | Warrington NM | 2018 |
| GCST003184 | Atopic dermatitis | 26482879 | Paternoster L | 2015 |
| GCST007321 | Family history of Alzheimer's disease | 30617256 | Jansen IE | 2019 |
| GCST007319 | Alzheimer's disease \(late onset\) | 30617256 | Jansen IE | 2019 |
| GCST003253 | Microalbuminuria | 26631737 | Teumer A | 2015 |
| GCST003255 | Urinary albumin-to-creatinine ratio | 26631737 | Teumer A | 2015 |
| GCST000169 | Colorectal cancer | 18372905 | Tomlinson IP | 2008 |
| GCST002483 | Lung function \(forced vital capacity\) | 24929828 | Loth DW | 2014 |
| GCST002544 | Parkinson's disease | 25064009 | Nalls MA | 2014 |
| GCST004902 | Parkinson's disease | 28892059 | Chang D | 2017 |
| GCST003614 | Opioid dependence | 26239289 | Nelson EC | 2015 |
| GCST004297 | Atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST000039 | Crohn's disease | 17554261 | Parkes M | 2007 |
| GCST002828 | Urate levels in obese individuals | 25811787 | Huffman JE | 2015 |
| GCST002829 | Urate levels in overweight individuals | 25811787 | Huffman JE | 2015 |
| GCST000612 | Celiac disease | 20190752 | Dubois PC | 2010 |
| GCST003769 | Depression | 27089181 | Okbay A | 2016 |
| GCST001144 | Dupuytren's disease | 21732829 | Dolmans GH | 2011 |
| GCST006066 | Glaucoma \(primary open-angle\) | 29891935 | Choquet H | 2018 |
| GCST006405 | Coronary artery disease in diabetes | 30003307 | Fall T | 2018 |
| GCST002352 | Type 2 diabetes | 24509480 | Mahajan A | 2014 |
| GCST002128 | Type 2 diabetes | 23945395 | Hara K | 2013 |
| GCST003619 | Type 2 diabetes | 27189021 | Cook JP | 2016 |
| GCST000024 | Type 2 diabetes | 17463248 | Scott LJ | 2007 |
| GCST006801 | Type 2 diabetes | 26961502 | Wood AR | 2016 |
| GCST000028 | Type 2 diabetes | 17463246 | Saxena R | 2007 |
| GCST001666 | Type 2 diabetes | 22961080 | Li H | 2012 |
| GCST000914 | Polycystic ovary syndrome | 21151128 | Chen ZJ | 2010 |
| GCST001276 | Liver enzyme levels \(alkaline phosphatase\) | 22001757 | Chambers JC | 2011 |
| GCST001499 | Atrial fibrillation | 22544366 | Ellinor PT | 2012 |
| GCST007460 | Smoking cessation | 30643251 | Liu M | 2019 |
| GCST001912 | Acute lymphoblastic leukemia \(childhood\) | 23512250 | Xu H | 2013 |
| GCST001320 | Acute lymphoblastic leukemia \(childhood\) | 22076464 | Ellinghaus E | 2011 |
| GCST000464 | Acute lymphoblastic leukemia \(childhood\) | 19684603 | Trevino LR | 2009 |
| GCST007727 | Acute lymphoblastic leukemia \(childhood\) | 28817678 | Archer NP | 2017 |
| GCST001454 | Rheumatoid arthritis | 22446963 | Okada Y | 2012 |
| GCST001224 | Breast cancer | 21908515 | Cai Q | 2011 |
| GCST001653 | Androgen levels | 22936694 | Jin G | 2012 |
| GCST006914 | Sleep duration | 30531941 | Doherty A | 2018 |
| GCST006810 | Self-reported risk-taking behaviour | 30271922 | Clifton EAD | 2018 |
| GCST005349 | Total body bone mineral density \(age over 60\) | 29304378 | Medina-Gomez C | 2018 |
| GCST002307 | Systolic blood pressure \(alcohol consumption interaction\) | 24376456 | Simino J | 2013 |
| GCST001604 | Insulin-related traits | 22791750 | Chen G | 2012 |
| GCST001007 | Metabolic syndrome \(bivariate traits\) | 21386085 | Kraja AT | 2011 |
| GCST001965 | Glycemic traits | 23575436 | Go MJ | 2013 |
| GCST001233 | Metabolite levels | 21909109 | Kim YJ | 2011 |
| GCST001375 | Diabetes \(gestational\) | 22233651 | Kwak SH | 2012 |
| GCST001436 | Metabolic syndrome | 22399527 | Kristiansson K | 2012 |
| GCST001486 | Fasting plasma glucose | 22508271 | Rasmussen-Torvik LJ | 2012 |
| GCST005215 | Corrected insulin response | 24699409 | Prokopenko I | 2014 |
| GCST005222 | Insulin disposition index | 24699409 | Prokopenko I | 2014 |
| GCST001762 | Obesity-related traits | 23251661 | Comuzzie AG | 2012 |
| GCST005219 | Incremental insulin | 24699409 | Prokopenko I | 2014 |
| GCST005180 | Homeostasis model assessment of beta-cell function | 20081858 | Dupuis J | 2010 |
| GCST004575 | Acute insulin response | 28490609 | Wood AR | 2017 |
| GCST001527 | Fasting blood glucose \(BMI interaction\) | 22581228 | Manning AK | 2012 |
| GCST000276 | Fasting plasma glucose | 19060907 | Prokopenko I | 2008 |
| GCST006629 | Pulse pressure | 30224653 | Evangelou E | 2018 |
| GCST005216 | Corrected insulin response adjusted for insulin sensitivity index | 24699409 | Prokopenko I | 2014 |
| GCST005314 | Offspring birth weight | 29309628 | Beaumont RN | 2018 |
| GCST004489 | Insulin disposition index | 28490609 | Wood AR | 2017 |
| GCST000568 | Fasting blood glucose | 20081858 | Dupuis J | 2010 |
| GCST005217 | Insulin levels adjusted for BMI | 24699409 | Prokopenko I | 2014 |
| GCST004487 | Peak insulin response | 28490609 | Wood AR | 2017 |
| GCST000371 | Tanning | 19340012 | Nan H | 2009 |
| GCST007615 | C-reactive protein levels | 30388399 | Ligthart S | 2018 |
| GCST004824 | P wave terminal force | 28794112 | Christophersen IE | 2017 |
| GCST002493 | Bone mineral density \(paediatric, skull\) | 24945404 | Kemp JP | 2014 |
| GCST006464 | Endometrial cancer | 30093612 | O'Mara TA | 2018 |
| GCST003391 | Low high density lipoprotein cholesterol levels | 26879886 | Wakil SM | 2016 |
| GCST006065 | Glaucoma \(primary open-angle\) | 29891935 | Choquet H | 2018 |
| GCST000298 | Body mass index | 19079261 | Willer CJ | 2008 |
| GCST005953 | Body mass index \(age &lt;50\) | 26426971 | Winkler TW | 2015 |
| GCST007990 | Coronary artery disease | 28714974 | Klarin D | 2017 |
| GCST004360 | Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer | 28429243 | Dudenkov TM | 2017 |
| GCST004733 | Heart rate variability traits \(RMSSD\) | 28613276 | Nolte IM | 2017 |
| GCST004734 | Heart rate variability traits \(SDNN\) | 28613276 | Nolte IM | 2017 |
| GCST004732 | Heart rate variability traits \(pvRSA/HF\) | 28613276 | Nolte IM | 2017 |
| GCST007226 | PR interval | 30679814 | van Setten J | 2019 |
| GCST007842 | Glioma | 30714141 | Chen H | 2019 |
| GCST005572 | Osteoarthritis of the hip \(with total joint replacement\) | 29436472 | Casalone E | 2018 |
| GCST007815 | Male-pattern baldness | 28272467 | Heilmann-Heimbach S | 2017 |
| GCST007940 | Medication use \(antidepressants\) | 31015401 | Wu Y | 2019 |
| GCST000671 | Lipoprotein-associated phospholipase A2 activity and mass | 20442857 | Suchindran S | 2010 |
| GCST007939 | Medication use \(antimigraine preparations\) | 31015401 | Wu Y | 2019 |
| GCST006915 | Physical activity \(moderate intensity activity duration\) | 30531941 | Doherty A | 2018 |
| GCST000954 | Alcohol consumption | 21270382 | Baik I | 2011 |
| GCST002456 | PR segment | 24850809 | Verweij N | 2014 |
| GCST004184 | Lung function \(FVC\) | 28166213 | Wain LV | 2017 |
| GCST001720 | Endometriosis | 23104006 | Nyholt DR | 2012 |
| GCST002626 | Vertical cup-disc ratio | 25241763 | Springelkamp H | 2014 |
| GCST000673 | Cleft lip | 20436469 | Beaty TH | 2010 |
| GCST000563 | Ankylosing spondylitis | 20062062 | Reveille JD | 2010 |
| GCST000971 | PR interval | 21347284 | Smith JG | 2011 |
| GCST005412 | Thrombin-activatable fibrinolysis inhibitor levels | 29378355 | Stanne TM | 2018 |
| GCST001670 | Vitiligo | 22951725 | Tang XF | 2012 |
| GCST004862 | Itch intensity from mosquito bite adjusted by bite size | 28199695 | Jones AV | 2017 |
| GCST005788 | Heart rate response to recovery post exercise | 29769521 | Ramirez J | 2018 |
| GCST001858 | Refractive error | 23396134 | Verhoeven VJ | 2013 |
| GCST001216 | Retinol levels | 21878437 | Mondul AM | 2011 |
| GCST001275 | Liver enzyme levels \(alanine transaminase\) | 22001757 | Chambers JC | 2011 |
| GCST005763 | Blood glucose levels | 29615537 | Kulminski AM | 2018 |
| GCST004180 | Pediatric bone mineral content \(hip\) | 28181694 | Chesi A | 2017 |
| GCST005116 | Male-pattern baldness | 29146897 | Pirastu N | 2017 |
| GCST002898 | LDL cholesterol | 25961943 | Surakka I | 2015 |
| GCST000285 | Cholesterol, total | 19060911 | Aulchenko YS | 2008 |
| GCST002086 | C-reactive protein | 23844046 | Dorajoo R | 2013 |
| GCST004883 | Neuroblastoma \(11q deletion\) | 28924153 | Chang X | 2017 |
| GCST000154 | Prostate cancer | 18264096 | Thomas G | 2008 |
| GCST000796 | Type 2 diabetes | 20862305 | Shu XO | 2010 |
| GCST003400 | Type 2 diabetes | 26818947 | Imamura M | 2016 |
| GCST003796 | Number of children ever born | 27798627 | Barban N | 2016 |
| GCST004460 | Eotaxin levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST002153 | Cardiovascular heart disease in diabetics | 23982368 | Qi L | 2013 |
| GCST007234 | Acne \(severe\) | 30542056 | Petridis C | 2018 |
| GCST000299 | Weight | 19079260 | Thorleifsson G | 2008 |
| GCST000497 | Mean platelet volume | 19820697 | Soranzo N | 2009 |
| GCST008282 | Spine bone size | 31053729 | Styrkarsdottir U | 2019 |
| GCST001069 | Thyroid volume | 21565293 | Teumer A | 2011 |
| GCST000364 | QT interval | 19305409 | Pfeufer A | 2009 |
| GCST004210 | Body fat percentage | 28270201 | Nagy R | 2017 |
| GCST003598 | QRS duration | 27577874 | Evans DS | 2016 |
| GCST000167 | Type 2 diabetes | 18372903 | Zeggini E | 2008 |
| GCST005904 | Major depressive disorder \(probable\) | 29662059 | Howard DM | 2018 |
| GCST002252 | Blood pressure measurement \(high sodium and potassium intervention\) | 24165912 | He J | 2013 |
| GCST002250 | Blood pressure measurement \(low sodium intervention\) | 24165912 | He J | 2013 |
| GCST001010 | Primary biliary cholangitis | 21399635 | Mells GF | 2011 |
| GCST000489 | Prostate cancer | 19767754 | Gudmundsson J | 2009 |
| GCST002299 | Chronic lymphocytic leukemia | 24292274 | Speedy HE | 2013 |
| GCST002243 | Bladder cancer | 24163127 | Figueroa JD | 2013 |
| GCST001936 | Telomere length | 23535734 | Codd V | 2013 |
| GCST000843 | Colorectal cancer | 20972440 | Houlston RS | 2010 |
| GCST002140 | Multiple myeloma | 23955597 | Chubb D | 2013 |
| GCST004483 | Multiple myeloma | 27363682 | Mitchell JS | 2016 |
| GCST002233 | Adiponectin levels | 24105470 | Wu Y | 2013 |
| GCST000810 | Lung adenocarcinoma | 20871597 | Miki D | 2010 |
| GCST001609 | Lung adenocarcinoma | 22797724 | Shiraishi K | 2012 |
| GCST004559 | Body mass index in physically active individuals | 28448500 | Graff M | 2017 |
| GCST004519 | Body mass index \(adult\) | 28430825 | Ng MCY | 2017 |
| GCST004560 | Body mass index in physically inactive individuals | 28448500 | Graff M | 2017 |
| GCST006227 | Diastolic blood pressure | 27618448 | Liu C | 2016 |
| GCST002378 | Thyroid peroxidase antibody positivity | 24586183 | Medici M | 2014 |
| GCST004029 | Angiotensin-converting enzyme inhibitor intolerance | 28030426 | Mahmoudpour SH | 2017 |
| GCST000025 | Type 2 diabetes | 17463249 | Zeggini E | 2007 |
| GCST005795 | Femoral neck bone mineral density | 29499414 | Pei YF | 2018 |
| GCST007158 | Refractive astigmatism | 30306274 | Shah RL | 2018 |
| GCST000175 | Height | 18391951 | Gudbjartsson DF | 2008 |
| GCST002094 | Crohn's disease | 23850713 | Yang SK | 2013 |
| GCST000629 | Knee osteoarthritis | 20305777 | Nakajima M | 2010 |
| GCST005934 | Neuropathic pain in head and neck cancer | 29884837 | Reyes-Gibby CC | 2018 |
| GCST000999 | Coronary heart disease | 21378988 | Coronary Artery Disease \(C4D\) Genetics Consortium | 2011 |
| GCST006045 | Age at first birth | 27798627 | Barban N | 2016 |
| GCST007278 | Systemic seropositive rheumatic diseases \(Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies\) | 30573655 | Acosta-Herrera M | 2018 |
| GCST008077 | LDL cholesterol levels | 30698716 | de Vries PS | 2019 |
| GCST008086 | LDL cholesterol levels in current drinkers | 30698716 | de Vries PS | 2019 |
| GCST000262 | Intracranial aneurysm | 18997786 | Bilguvar K | 2008 |
| GCST005238 | Mood instability | 29187730 | Ward J | 2017 |
| GCST003770 | Neuroticism | 27089181 | Okbay A | 2016 |
| GCST004416 | Ovarian cancer in BRCA2 mutation carriers | 28346442 | Phelan CM | 2017 |
| GCST004462 | Epithelial ovarian cancer | 28346442 | Phelan CM | 2017 |
| GCST004414 | Ovarian cancer in BRCA1 mutation carriers | 28346442 | Phelan CM | 2017 |
| GCST000721 | Endometriosis | 20601957 | Uno S | 2010 |
| GCST006482 | Lung function \(FEV1/FVC\) | 30061609 | Wyss AB | 2018 |
| GCST007982 | Sleep duration | 30804565 | Jansen PR | 2019 |
| GCST002555 | Monocyte count | 25096241 | Keller MF | 2014 |
| GCST007446 | vWF levels | 30586737 | Sabater-Lleal M | 2018 |
| GCST000483 | Folate pathway vitamin levels | 19744961 | Hazra A | 2009 |
| GCST007191 | Hypersomnia \(HLA-DQB1\*06:02 negative\) | 30266950 | Miyagawa T | 2018 |
| GCST006919 | Ability to confide in someone | 29970889 | Day FR | 2018 |
| GCST005273 | Polycystic ovary syndrome | 26284813 | Hayes MG | 2015 |
| GCST000152 | Prostate cancer | 18264097 | Eeles RA | 2008 |
| GCST008231 | Prostate cancer | 31226226 | Du Z | 2019 |
| GCST002421 | Prostate cancer | 24753544 | Knipe DW | 2014 |
| GCST001796 | Prostate-specific antigen levels | 23269536 | Sun J | 2012 |
| GCST001877 | Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia \(combined\) | 23453885 | Smoller JW | 2013 |
| GCST000958 | Percent mammographic density | 21278746 | Lindstrom S | 2011 |
| GCST002260 | Narcolepsy | 24204295 | Han F | 2013 |
| GCST001709 | Atopic dermatitis | 23042114 | Hirota T | 2012 |
| GCST001251 | Pulmonary function | 21946350 | Soler Artigas M | 2011 |
| GCST003043 | Inflammatory bowel disease | 26192919 | Liu JZ | 2015 |
| GCST001184 | Meningioma | 21804547 | Dobbins SE | 2011 |
| GCST000396 | Diastolic blood pressure | 19430479 | Levy D | 2009 |
| GCST006424 | Severe diabetic retinopathy in type 2 diabetes | 30178632 | Meng W | 2018 |
| GCST001885 | Height | 23456168 | Hao Y | 2013 |
| GCST001915 | Alzheimer's disease \(cognitive decline\) | 23535033 | Sherva R | 2013 |
| GCST005545 | Lumbar spine bone mineral density | 26367794 | Zheng HF | 2015 |
| GCST005544 | Femoral neck bone mineral density | 26367794 | Zheng HF | 2015 |
| GCST002417 | Plasma thyroid-stimulating hormone levels | 24722205 | Kwak SH | 2014 |
| GCST008152 | Weight | 28552196 | Tachmazidou I | 2017 |
| GCST002461 | Body mass index | 24861553 | Wen W | 2014 |
| GCST004498 | BMI in smokers | 28443625 | Justice AE | 2017 |
| GCST002925 | Sex hormone levels | 26014426 | Ruth KS | 2015 |
| GCST003144 | Polycystic ovary syndrome | 26416764 | Day FR | 2015 |
| GCST006958 | Length of menstrual cycle | 30202859 | Laisk T | 2018 |
| GCST005269 | Luteinizing hormone levels in polycystic ovary syndrome | 26284813 | Hayes MG | 2015 |
| GCST004413 | Spontaneous dizygotic twinning | 27132594 | Mbarek H | 2016 |
| GCST002763 | Optic disc area | 25631615 | Springelkamp H | 2015 |
| GCST000410 | Malaria | 19465909 | Jallow M | 2009 |
| GCST006897 | Hyperthyroidism | 30367059 | Teumer A | 2018 |
| GCST006718 | Alcohol use disorder \(consumption score\) | 30336701 | Sanchez-Roige S | 2018 |
| GCST006942 | Feeling lonely | 29500382 | Nagel M | 2018 |
| GCST000901 | Neuroblastoma | 21124317 | Wang K | 2010 |
| GCST002545 | Ossification of the posterior longitudinal ligament of the spine | 25064007 | Nakajima M | 2014 |
| GCST000523 | Methotrexate phramacokinetics \(acute lymphoblastic leukemia\) | 19901119 | Trevino LR | 2009 |
| GCST000562 | PR interval | 20062060 | Pfeufer A | 2010 |
| GCST007500 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST007502 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST001142 | Vitamin E levels | 21729881 | Major JM | 2011 |
| GCST001727 | Lipoprotein-associated phospholipase A2 activity and mass | 23118302 | Chu AY | 2012 |
| GCST002337 | Amyotrophic lateral sclerosis \(sporadic\) | 24529757 | Xie T | 2014 |
| GCST005581 | Primary biliary cirrhosis | 22961000 | Liu JZ | 2012 |
| GCST007238 | Diastolic blood pressure | 27736895 | Franceschini N | 2016 |
| GCST006697 | Parental longevity \(combined parental attained age, Martingale residuals\) | 29227965 | Pilling LC | 2017 |
| GCST001807 | Tetralogy of Fallot | 23297363 | Cordell HJ | 2013 |
| GCST007918 | Serum uric acid levels | 29124443 | Yasukochi Y | 2017 |
| GCST001845 | Coronary heart disease | 23364394 | Lee JY | 2013 |
| GCST001072 | Blood pressure | 21572416 | Kato N | 2011 |
| GCST001074 | Blood pressure | 21572416 | Kato N | 2011 |
| GCST003272 | Systolic blood pressure | 26390057 | Kato N | 2015 |
| GCST002631 | Diastolic blood pressure | 25249183 | Lu X | 2014 |
| GCST003273 | Diastolic blood pressure | 26390057 | Kato N | 2015 |
| GCST003217 | Triglycerides | 26582766 | Lu X | 2015 |
| GCST001842 | Drinking behavior | 23364009 | Yang X | 2013 |
| GCST003197 | Thoracic-to-hip circumference ratio | 26675016 | Cha S | 2015 |
| GCST000498 | Hematological parameters | 19820697 | Soranzo N | 2009 |
| GCST001234 | Gamma glutamyl transpeptidase | 21909109 | Kim YJ | 2011 |
| GCST000818 | Urate levels | 20884846 | Yang Q | 2010 |
| GCST007045 | PR interval | 30046033 | van Setten J | 2018 |
| GCST002836 | Axial length | 25823570 | Miyake M | 2015 |
| GCST002115 | Axial length | 24144296 | Cheng CY | 2013 |
| GCST002701 | Verbal declarative memory | 25648963 | Debette S | 2014 |
| GCST008259 | Alcohol use disorder | 30940813 | Kranzler HR | 2019 |
| GCST005077 | Breast cancer | 29058716 | Milne RL | 2017 |
| GCST001699 | Serum albumin level | 23022100 | Franceschini N | 2012 |
| GCST000224 | Chronic lymphocytic leukemia | 18758461 | Di Bernardo MC | 2008 |
| GCST007513 | Prostate-specific antigen levels | 30410027 | Gudmundsson J | 2018 |
| GCST001465 | Adiponectin levels | 22479202 | Dastani Z | 2012 |
| GCST004318 | Facial morphology \(factor 14, intercanthal width\) | 28441456 | Lee MK | 2017 |
| GCST003642 | Eye morphology | 27560520 | Shaffer JR | 2016 |
| GCST007557 | Birth weight | 27680694 | Horikoshi M | 2016 |
| GCST001178 | Plasma omega-3 polyunsaturated fatty acid level \(eicosapentaenoic acid\) | 21829377 | Lemaitre RN | 2011 |
| GCST002277 | Schizophrenia | 24253340 | Lencz T | 2013 |
| GCST002497 | Blood pressure | 24954895 | Simino J | 2014 |
| GCST006431 | Plasma parathyroid hormone levels | 30134803 | Matana A | 2018 |
| GCST008164 | Free thyroxine concentration | 25743335 | Taylor PN | 2015 |
| GCST003940 | Trans-epidermal water loss | 28011148 | Zhang M | 2016 |
| GCST005208 | B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio | 29237677 | Salo PP | 2017 |
| GCST003298 | NT-proBNP levels in acute coronary syndrome | 26908625 | Johansson A | 2016 |
| GCST004258 | Diastolic blood pressure \(long-term average\) | 28348047 | Li C | 2017 |
| GCST002672 | Febrile seizures | 25344690 | Feenstra B | 2014 |
| GCST002657 | Acute lymphoblastic leukemia \(childhood\) | 25310577 | Evans TJ | 2014 |
| GCST001957 | Obesity \(early onset extreme\) | 23563609 | Wheeler E | 2013 |
| GCST007182 | Two-hour glucose in pregnancy \(gestational week 30-32\) | 30324795 | Moen GH | 2018 |
| GCST007184 | General glucose level in pregnancy \(gestational week 30-32\) | 30324795 | Moen GH | 2018 |
| GCST000383 | Type 2 diabetes | 19401414 | Takeuchi F | 2009 |
| GCST007218 | QT interval | 30679814 | van Setten J | 2019 |
| GCST008057 | Varicose veins | 30998689 | Shadrina AS | 2019 |
| GCST006637 | Pain medicine use during menstruation | 29855537 | Hirata T | 2018 |
| GCST004441 | Interleukin-18 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST007485 | Anthropometric traits | 30166351 | Galvan-Femenia I | 2018 |
| GCST004886 | Alcohol consumption | 28937693 | Clarke TK | 2017 |
| GCST001942 | Prostate cancer | 23535732 | Eeles RA | 2013 |
| GCST006409 | Allergic rhinitis | 30013184 | Waage J | 2018 |
| GCST001416 | Body mass index \(SNP x SNP interaction\) | 22344221 | Okada Y | 2012 |
| GCST003447 | Neuroticism | 27067015 | Smith DJ | 2016 |
| GCST000756 | Magnesium levels | 20700443 | Meyer TE | 2010 |
| GCST004131 | Inflammatory bowel disease | 28067908 | de Lange KM | 2017 |
| GCST002652 | Cotinine glucuronidation | 25293881 | Patel YM | 2014 |
| GCST007104 | QRS duration | 30012220 | Prins BP | 2018 |
| GCST007103 | QRS duration | 30012220 | Prins BP | 2018 |
| GCST000444 | QT interval | 19587794 | Nolte IM | 2009 |
| GCST006089 | Prostate cancer \(early onset\) | 29892016 | Schumacher FR | 2018 |
| GCST001642 | Vaspin levels | 22907691 | Breitfeld J | 2012 |
| GCST005003 | Mumps | 28928442 | Tian C | 2017 |
| GCST004976 | nicotine metabolite ratio in current smokers | 28921760 | Chenoweth MJ | 2017 |
| GCST004433 | Macrophage inflammatory protein 1b levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004246 | Alzheimer's disease | 28183528 | Jun GR | 2017 |
| GCST000542 | Pulmonary function | 20010835 | Hancock DB | 2009 |
| GCST006670 | Primary sclerosing cholangitis | 23603763 | Liu JZ | 2013 |
| GCST003227 | Non-glioblastoma glioma | 26424050 | Kinnersley B | 2015 |
| GCST007433 | Fulminant type 1 diabetes | 30552108 | Kawabata Y | 2018 |
| GCST005191 | Hair shape | 29220522 | Liu F | 2017 |
| GCST007922 | Medication use \(drugs for peptic ulcer and gastro-oesophageal reflux disease\) | 31015401 | Wu Y | 2019 |
| GCST000043 | Type 1 diabetes | 17554300 | Wellcome Trust Case Control Consortium | 2007 |
| GCST007938 | Medication use \(anilides\) | 31015401 | Wu Y | 2019 |
| GCST004572 | Iron status biomarkers \(transferrin saturation\) | 28334935 | Raffield LM | 2017 |
| GCST004570 | Iron status biomarkers \(iron levels\) | 28334935 | Raffield LM | 2017 |
| GCST001592 | Osteoarthritis | 22763110 | Zeggini E | 2012 |
| GCST008356 | Geographic atrophy lesion growth rate in age-related macular degeneration | 31120506 | Grassmann F | 2019 |
| GCST006360 | IgA levels | 30053915 | Scepanovic P | 2018 |
| GCST007944 | Medication use \(antiglaucoma preparations and miotics\) | 31015401 | Wu Y | 2019 |
| GCST007000 | Logical memory \(delayed recall\) in mild cognitive impairment | 29274321 | Chung J | 2017 |
| GCST003017 | Colorectal cancer | 26151821 | Schumacher FR | 2015 |
| GCST003052 | Adolescent idiopathic scoliosis | 26211971 | Ogura Y | 2015 |
| GCST000395 | Systolic blood pressure | 19430483 | Newton-Cheh C | 2009 |
| GCST001227 | Systolic blood pressure | 21909115 | Ehret GB | 2011 |
| GCST004777 | Diastolic blood pressure | 28739976 | Wain LV | 2017 |
| GCST001235 | Blood pressure | 21909110 | Wain LV | 2011 |
| GCST004257 | Systolic blood pressure \(long-term average\) | 28348047 | Li C | 2017 |
| GCST001236 | Blood pressure | 21909110 | Wain LV | 2011 |
| GCST007589 | Intracranial volume | 30818988 | Klein M | 2019 |
| GCST001968 | Interstitial lung disease | 23583980 | Fingerlin TE | 2013 |
| GCST003251 | Late-onset myasthenia gravis | 26562150 | Seldin MF | 2015 |
| GCST007436 | Carotid intima media thickness | 30510157 | Franceschini N | 2018 |
| GCST005591 | Colorectal cancer | 29471430 | Tanikawa C | 2018 |
| GCST003324 | Ischemic stroke | 26732560 | Cheng YC | 2016 |
| GCST008156 | Hip circumference adjusted for BMI | 28552196 | Tachmazidou I | 2017 |
| GCST008196 | Soluble VCAM-1 levels | 31217265 | Sliz E | 2019 |
| GCST000006 | Age-related macular degeneration \(wet\) | 17053108 | Dewan A | 2006 |
| GCST000662 | Vitiligo | 20410501 | Jin Y | 2010 |
| GCST004554 | Weight | 28548082 | Southam L | 2017 |
| GCST002502 | Corneal curvature | 24963161 | Chen P | 2014 |
| GCST000585 | Mean corpuscular volume | 20139978 | Kamatani Y | 2010 |
| GCST002737 | Atopic dermatitis | 25574825 | Baurecht H | 2015 |
| GCST002646 | Infant length | 25281659 | van der Valk RJ | 2014 |
| GCST000132 | LDL cholesterol | 18193043 | Willer CJ | 2008 |
| GCST000340 | Myocardial infarction \(early onset\) | 19198609 | Kathiresan S | 2009 |
| GCST004419 | Mucinous ovarian carcinoma | 28346442 | Phelan CM | 2017 |
| GCST004651 | Aortic root size | 28394258 | Wild PS | 2017 |
| GCST000225 | Inflammatory bowel disease | 18758464 | Kugathasan S | 2008 |
| GCST007241 | Obesity \(extreme\) | 30677029 | Riveros-McKay F | 2019 |
| GCST006983 | Attention deficit hyperactivity disorder or cannabis use | 30610198 | Soler Artigas M | 2019 |
| GCST000927 | Response to metformin in type 2 diabetes \(glycemic\) | 21186350 | Zhou K | 2010 |
| GCST007128 | Blood protein levels | 30111768 | Yao C | 2018 |
| GCST002469 | HDL cholesterol | 24886709 | Ko A | 2014 |
| GCST002767 | Intraocular pressure | 25637523 | Springelkamp H | 2015 |
| GCST008202 | Soluble E-selectin levels | 31217265 | Sliz E | 2019 |
| GCST008302 | Number of decayed, missing and filled tooth surfaces | 31235808 | Shungin D | 2019 |
| GCST000450 | Matrix metalloproteinase levels | 20031604 | Cheng YC | 2009 |
| GCST006102 | Interleukin-10 levels | 22205395 | Tekola Ayele F | 2011 |
| GCST000998 | Coronary heart disease | 21378990 | Schunkert H | 2011 |
| GCST007935 | Medication use \(drugs affecting bone structure and mineralization\) | 31015401 | Wu Y | 2019 |
| GCST003583 | Response to radiotherapy in prostate cancer \(overall toxicity\) | 27515689 | Kerns SL | 2016 |
| GCST004424 | TRAIL levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003815 | Late-onset Alzheimer's disease | 27770636 | Mez J | 2016 |
| GCST004865 | Itch intensity from mosquito bite adjusted by bite size | 28199695 | Jones AV | 2017 |
| GCST000772 | Parkinson's disease | 20711177 | Hamza TH | 2010 |
| GCST001445 | Parkinson's disease | 22438815 | Lill CM | 2012 |
| GCST000365 | Breast cancer | 19330030 | Thomas G | 2009 |
| GCST007799 | Asthma \(adult onset\) | 30929738 | Ferreira MAR | 2019 |
| GCST004249 | Alzheimer's disease in APOE e4- carriers | 28183528 | Jun GR | 2017 |
| GCST002835 | Renal cell carcinoma | 25826619 | Henrion MY | 2015 |
| GCST006465 | Endometrial cancer \(endometrioid histology\) | 30093612 | O'Mara TA | 2018 |
| GCST003524 | Endometrial cancer | 27135401 | Cheng TH | 2016 |
| GCST003525 | Endometrial endometrioid carcinoma | 27135401 | Cheng TH | 2016 |
| GCST004300 | Incident atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST004296 | Atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST004438 | Monocyte chemoattractant protein-1 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003327 | Squamous cell carcinoma | 26829030 | Asgari MM | 2016 |
| GCST001939 | Tanning | 23548203 | Zhang M | 2013 |
| GCST001933 | Sunburns | 23548203 | Zhang M | 2013 |
| GCST007516 | Type 2 diabetes \(adjusted for BMI\) | 29632382 | Mahajan A | 2018 |
| GCST007515 | Type 2 diabetes | 29632382 | Mahajan A | 2018 |
| GCST007518 | Type 2 diabetes \(adjusted for BMI\) | 29632382 | Mahajan A | 2018 |
| GCST004179 | Pediatric bone mineral content \(femoral neck\) | 28181694 | Chesi A | 2017 |
| GCST008165 | Thyroid stimulating hormone levels | 25743335 | Taylor PN | 2015 |
| GCST000592 | Systemic lupus erythematosus | 20169177 | Yang W | 2010 |
| GCST004399 | Lipoprotein\(a\) levels adjusted for apolipoprotein\(a\) isoforms | 28512139 | Mack S | 2017 |
| GCST007637 | Diffusing capacity of carbon monoxide | 30694715 | Sakornsakolpat P | 2019 |
| GCST005790 | Rosacea symptom severity | 29771307 | Aponte JL | 2018 |
| GCST007159 | Corneal astigmatism | 30306274 | Shah RL | 2018 |
| GCST007160 | Refractive astigmatism | 30306274 | Shah RL | 2018 |
| GCST004432 | Platelet-derived growth factor BB levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST008339 | Corneal endothelial cell density | 30894546 | Ivarsdottir EV | 2019 |
| GCST004325 | Facial morphology \(factor 21, depth of nasal alae\) | 28441456 | Lee MK | 2017 |
| GCST003427 | Alzheimer disease and age of onset | 26830138 | Herold C | 2016 |
| GCST008162 | Hip circumference | 28552196 | Tachmazidou I | 2017 |
| GCST004708 | Fear of minor pain | 28701861 | Randall CL | 2017 |
| GCST006677 | Acute insulin response \(insulin secretion adjusted\) | 28490609 | Wood AR | 2017 |
| GCST002883 | AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor | 25935875 | Varenhorst C | 2015 |
| GCST007509 | Cleft palate | 30452639 | Butali A | 2018 |
| GCST003123 | Severe influenza A \(H1N1\) infection | 26379185 | Garcia-Etxebarria K | 2015 |
| GCST006143 | Bone mineral density \(total hip\) | 29883787 | Gregson CL | 2018 |
| GCST004440 | Interferon gamma-induced protein 10 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST005668 | Delta-5 desaturase activity response to n3-polyunsaturated fat supplement | 29246731 | de Toro-Martin J | 2017 |
| GCST005171 | QT interval | 29213071 | Mendez-Giraldez R | 2017 |
| GCST006487 | Insomnia complaints | 28604731 | Hammerschlag AR | 2017 |
| GCST004695 | Insomnia complaints | 28604731 | Hammerschlag AR | 2017 |
| GCST003981 | Insomnia | 27992416 | Lane JM | 2016 |
| GCST004750 | Squamous cell lung carcinoma | 28604730 | McKay JD | 2017 |
| GCST004387 | Pulse pressure | 28498854 | Liang J | 2017 |
| GCST004133 | Ulcerative colitis | 28067908 | de Lange KM | 2017 |
| GCST003830 | Response to bronchodilator in chronic obstructive pulmonary disease \(change in FEV1\) | 26503814 | Hardin M | 2016 |
| GCST007435 | Carotid plaque | 30510157 | Franceschini N | 2018 |
| GCST007849 | Triglycerides | 24507774 | Peloso GM | 2014 |
| GCST003390 | Thrombosis | 26908601 | Hinds DA | 2016 |
| GCST003252 | Systemic lupus erythematosus | 26606652 | Alarcon-Riquelme ME | 2015 |
| GCST002674 | Febrile seizures \(MMR vaccine-related\) | 25344690 | Feenstra B | 2014 |
| GCST002673 | Febrile seizures \(MMR vaccine-unrelated\) | 25344690 | Feenstra B | 2014 |
| GCST004697 | Ease of getting up in the morning | 28604731 | Hammerschlag AR | 2017 |
| GCST008061 | Estimated glomerular filtration rate | 31152163 | Wuttke M | 2019 |
| GCST004693 | Daytime nap | 28604731 | Hammerschlag AR | 2017 |
| GCST004797 | Brain volume in infants \(grey matter\) | 28763065 | Xia K | 2017 |
| GCST004207 | HDL cholesterol | 28270201 | Nagy R | 2017 |
| GCST004526 | Subclinical trait of interstitial lung disease \(basilar percentage of high attenuation areas on CT scan\) | 28521775 | Manichaikul A | 2017 |
| GCST004086 | Drug-induced liver injury | 28043905 | Nicoletti P | 2016 |
| GCST008097 | Bisphosphonate-associated atypical femoral fracture | 31006051 | Kharazmi M | 2019 |
| GCST005944 | Viral capsid antigen IgG seropositivity | 29868224 | Sallah N | 2017 |
| GCST004525 | Subclinical trait of interstitial lung disease \(basilar peel-core ratio of high attentuation areas on CT scan\) | 28521775 | Manichaikul A | 2017 |
| GCST007511 | Alzheimer's disease \(late onset\) | 30820047 | Kunkle BW | 2019 |
| GCST005013 | Childhood ear infection | 28928442 | Tian C | 2017 |
| GCST003360 | Crohn's disease | 26891255 | Jung ES | 2016 |
| GCST005964 | Neuromyelitis optica | 29769526 | Estrada K | 2018 |
| GCST006937 | Neuromyelitis optica \(AQP4-IgG-positive\) | 29769526 | Estrada K | 2018 |
| GCST001263 | Height | 21998595 | N'Diaye A | 2011 |
| GCST004336 | Executive inhibition \(Stroop WIT and CIT\) in attention deficit hyperactivity disorder | 28416812 | Yang L | 2017 |
| GCST006194 | Diastolic blood pressure x smoking status \(current vs non-current\) interaction \(1df test\) | 29455858 | Sung YJ | 2018 |
| GCST003388 | Bone mineral density \(spine\) | 26733130 | Styrkarsdottir U | 2016 |
| GCST003389 | Bone mineral density \(hip\) | 26733130 | Styrkarsdottir U | 2016 |
| GCST004295 | Atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST002196 | Homoarginine levels | 24047826 | Kleber ME | 2013 |
| GCST005522 | Narcolepsy | 23459209 | Faraco J | 2013 |
| GCST000385 | Narcolepsy | 19412176 | Hallmayer J | 2009 |
| GCST002645 | Bladder cancer | 25281661 | Matsuda K | 2014 |
| GCST007919 | Creatinine levels | 29124443 | Yasukochi Y | 2017 |
| GCST006621 | Midgestational cytokine/chemokine levels \(maternal genetic effect\) | 30134952 | Traglia M | 2018 |
| GCST001963 | Alzheimer's disease \(late onset\) | 23571587 | Reitz C | 2013 |
| GCST004206 | Fasting plasma glucose | 28270201 | Nagy R | 2017 |
| GCST002603 | Creatine kinase in statin users | 25214527 | Dube MP | 2014 |
| GCST004386 | Diastolic blood pressure | 28498854 | Liang J | 2017 |
| GCST004385 | Systolic blood pressure | 28498854 | Liang J | 2017 |
| GCST005526 | Graves' disease | 22922229 | Cooper JD | 2012 |
| GCST005524 | Autoimmune thyroid diseases \(Graves disease or Hashimoto's thyroiditis\) | 22922229 | Cooper JD | 2012 |
| GCST002466 | Lung cancer | 24880342 | Wang Y | 2014 |
| GCST004748 | Lung cancer | 28604730 | McKay JD | 2017 |
| GCST004746 | Small cell lung carcinoma | 28604730 | McKay JD | 2017 |
| GCST008260 | group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP | 31070471 | Akinkuolie AO | 2019 |
| GCST000144 | Systemic lupus erythematosus | 18204098 | Hom G | 2008 |
| GCST005689 | Major depressive disorder \(unexposed to adversity\) | 29495898 | Peterson RE | 2018 |
| GCST003127 | Lipoprotein \(a\) levels | 26377243 | Li J | 2015 |
| GCST002320 | Cognitive decline \(age-related\) | 24468470 | Zhang C | 2013 |
| GCST005899 | Type 2 diabetes | 29358691 | Bonas-Guarch S | 2018 |
| GCST000780 | Protein C levels | 20802025 | Tang W | 2010 |
| GCST006186 | Systolic blood pressure x smoking status \(current vs non-current\) interaction \(1df test\) | 29455858 | Sung YJ | 2018 |
| GCST000134 | LDL cholesterol | 18193044 | Kathiresan S | 2008 |
| GCST006284 | Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease | 29748315 | Pott J | 2018 |
| GCST002481 | Acne \(severe\) | 24927181 | Navarini AA | 2014 |
| GCST008280 | Intertrochanteric region size | 31053729 | Styrkarsdottir U | 2019 |
| GCST004301 | Prevalent atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST003944 | Hepcidin/ferritin ratio | 27846281 | Galesloot TE | 2016 |
| GCST004571 | Iron status biomarkers \(total iron binding capacity\) | 28334935 | Raffield LM | 2017 |
| GCST007712 | Cortical brain region measurements \(area, volume and thickness\) | 30941828 | Bi X | 2019 |
| GCST002186 | Platelet count | 24026423 | Shameer K | 2013 |
| GCST000250 | Male-pattern baldness | 18849991 | Richards JB | 2008 |
| GCST003075 | Cognitive decline rate in late mild cognitive impairment | 26252872 | Li QS | 2015 |
| GCST007600 | Alzheimer's disease | 30636644 | Nazarian A | 2019 |
| GCST002042 | LDL cholesterol | 23726366 | Coram MA | 2013 |
| GCST001650 | C-reactive protein | 22939635 | Reiner AP | 2012 |
| GCST003325 | Lung cancer | 26732429 | Wang Z | 2016 |
| GCST003326 | Adenocarcinoma | 26732429 | Wang Z | 2016 |
| GCST006886 | Subiculum volume | 30279459 | van der Meer D | 2018 |
| GCST006891 | Dentate gyrus molecular layer volume | 30279459 | van der Meer D | 2018 |
| GCST004212 | Height | 28270201 | Nagy R | 2017 |
| GCST007040 | Carotid intima media thickness in rheumatoid arthritis | 30251476 | Lopez-Mejias R | 2018 |
| GCST002757 | Immunoglobulin G index levels in multiple sclerosis | 25616667 | Goris A | 2015 |
| GCST007739 | Skin reflectance \(Melanin index\) | 30895295 | Jonnalagadda M | 2019 |
| GCST004749 | Lung cancer in ever smokers | 28604730 | McKay JD | 2017 |
| GCST006228 | Systolic blood pressure | 27618448 | Liu C | 2016 |
| GCST006230 | Pulse pressure | 27618448 | Liu C | 2016 |
| GCST001160 | Systemic sclerosis | 21779181 | Gorlova O | 2011 |
| GCST003664 | Metabolite levels \(lipid measures\) | 27005778 | Kettunen J | 2016 |
| GCST006982 | Waldenstr?m macroglobulinemia / lymphoplasmacytic lymphoma | 30305637 | McMaster ML | 2018 |
| GCST002636 | Diffuse large B cell lymphoma | 25261932 | Cerhan JR | 2014 |
| GCST007896 | Primary central nervous system lymphoma | 31102405 | Labreche K | 2019 |
| GCST007664 | Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer | 30648747 | Dudenkov TM | 2019 |
| GCST007506 | Prostate cancer | 30410027 | Gudmundsson J | 2018 |
| GCST004417 | Ovarian clear cell cancer | 28346442 | Phelan CM | 2017 |
| GCST002830 | Urate levels in lean individuals | 25811787 | Huffman JE | 2015 |
| GCST004198 | Severe gingival inflammation | 28459102 | Zhang S | 2016 |
| GCST001439 | Mean platelet volume | 22423221 | Qayyum R | 2012 |
| GCST001784 | Pulmonary function \(smoking interaction\) | 23284291 | Hancock DB | 2012 |
| GCST002319 | Musician's dystonia | 24375517 | Lohmann K | 2013 |
| GCST006140 | Hematoma volume in non-lobar spontaneous intracerebral hemorrhage | 29915124 | Marini S | 2018 |
| GCST002991 | Pancreatic cancer | 26098869 | Childs EJ | 2015 |
| GCST004080 | Drug-induced liver injury \(statins\) | 28043905 | Nicoletti P | 2016 |
| GCST001506 | Intraocular pressure | 22570627 | van Koolwijk LM | 2012 |
| GCST001290 | Height | 22021425 | Carty CL | 2011 |
| GCST008276 | Corneal resistance factor | 31246245 | Khawaja AP | 2019 |
| GCST000646 | Intracranial aneurysm | 20364137 | Yasuno K | 2010 |
| GCST005666 | Fractional excretion of metabolites in chronic kidney disease | 29545352 | Li Y | 2018 |
| GCST006575 | Takayasu arteritis | 25604533 | Renauer PA | 2015 |
| GCST002689 | Very long-chain saturated fatty acid levels \(fatty acid 24:0\) | 25378659 | Lemaitre RN | 2014 |
| GCST002690 | Very long-chain saturated fatty acid levels \(fatty acid 20:0\) | 25378659 | Lemaitre RN | 2014 |
| GCST002688 | Very long-chain saturated fatty acid levels \(fatty acid 22:0\) | 25378659 | Lemaitre RN | 2014 |
| GCST000975 | LDL cholesterol | 21347282 | Lettre G | 2011 |
| GCST001415 | Body mass index | 22344219 | Wen W | 2012 |
| GCST004518 | Waist-to-hip ratio adjusted for body mass index | 28430825 | Ng MCY | 2017 |
| GCST001714 | Prostate cancer | 23065704 | Amin Al Olama A | 2012 |
| GCST007179 | Fasting glucose in pregnancy \(gestational week 14-16\) | 30324795 | Moen GH | 2018 |
| GCST001207 | Butyrylcholinesterase levels | 21862451 | Benyamin B | 2011 |
| GCST006898 | Hypothyroidism | 30367059 | Teumer A | 2018 |
| GCST002373 | Thyroid peroxidase antibody levels | 24586183 | Medici M | 2014 |
| GCST003177 | Childhood body mass index | 26604143 | Felix JF | 2015 |
| GCST002894 | Body mass index | 25953783 | Warrington NM | 2015 |
| GCST002538 | Height adjusted BMI | 25044758 | Stergiakouli E | 2014 |
| GCST003674 | Obstructive sleep apnea trait \(apnea hypopnea index\) | 26977737 | Cade BE | 2016 |
| GCST003661 | Triglycerides | 27036123 | van Leeuwen EM | 2016 |
| GCST007850 | HDL cholesterol | 24507774 | Peloso GM | 2014 |
| GCST003603 | Thiopurine-induced leukopenia in inflammatory bowel disease | 27558924 | Kim HS | 2016 |
| GCST007229 | Thiopurine-induced early leukopenia in Crohn's disease | 25108385 | Yang SK | 2014 |
| GCST003018 | Thionamide-induced agranulocytosis in Graves' disease | 26151496 | Chen PL | 2015 |
| GCST004826 | P wave duration | 28794112 | Christophersen IE | 2017 |
| GCST004144 | Thyroid cancer | 28195142 | Gudmundsson J | 2017 |
| GCST001382 | Thyroid cancer | 22267200 | Gudmundsson J | 2012 |
| GCST004428 | Stem cell growth factor beta levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003028 | Serum alpha1-antitrypsin levels | 26174136 | Setoh K | 2015 |
| GCST001307 | Gamma glutamyl transferase levels | 22010049 | Middelberg RP | 2011 |
| GCST000179 | C-reactive protein | 18439552 | Reiner AP | 2008 |
| GCST005586 | Breast milk fatty acid composition \(maternal genotype effect\) | 29514873 | Mychaleckyj JC | 2018 |
| GCST003072 | Cerebrospinal fluid AB1-42 levels | 26252872 | Li QS | 2015 |
| GCST007390 | Suicidality \(suicidal ideation/attempts\) | 30745170 | Strawbridge RJ | 2019 |
| GCST004726 | Vitamin D levels | 28757204 | Manousaki D | 2017 |
| GCST001094 | Response to hepatitis C treatment | 21659334 | Tanaka Y | 2011 |
| GCST003604 | Sj?gren's syndrome | 27503288 | Song IW | 2016 |
| GCST002882 | Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor | 25935875 | Varenhorst C | 2015 |
| GCST003622 | Systemic lupus erythematosus | 27399966 | Morris DL | 2016 |
| GCST003094 | Mitral valve prolapse | 26301497 | Dina C | 2015 |
| GCST003246 | Testicular germ cell tumor | 26503584 | Litchfield K | 2015 |
| GCST005287 | Intrinsic epigenetic age acceleration | 29374233 | Lu AT | 2018 |
| GCST004643 | 1,5-anhydroglucitol levels | 28588231 | Li M | 2017 |
| GCST000872 | QRS duration | 21076409 | Sotoodehnia N | 2010 |
| GCST000959 | Parkinson's disease | 21292315 | Nalls MA | 2011 |
| GCST006920 | Regular attendance at a gym or sports club | 29970889 | Day FR | 2018 |
| GCST006705 | Infantile hypertrophic pyloric stenosis | 30281099 | Fadista J | 2018 |
| GCST002145 | Infantile hypertrophic pyloric stenosis | 23989729 | Feenstra B | 2013 |
| GCST001399 | Infantile hypertrophic pyloric stenosis | 22306654 | Feenstra B | 2012 |
| GCST007987 | Daytime nap | 30804565 | Jansen PR | 2019 |
| GCST002355 | Serum uric acid levels | 24513273 | Yang B | 2014 |
| GCST000581 | Urate levels | 20139978 | Kamatani Y | 2010 |
| GCST001876 | Pubertal anthropometrics | 23449627 | Cousminer DL | 2013 |
| GCST006868 | Type 2 diabetes | 30054458 | Xue A | 2018 |
| GCST003129 | Primary biliary cholangitis | 26394269 | Cordell HJ | 2015 |
| GCST003652 | Parkinson's disease \(familial, age at onset\) | 27402877 | Hill-Burns EM | 2016 |
| GCST000403 | Menarche and menopause \(age at onset\) | 19448621 | He C | 2009 |
| GCST000401 | Menopause \(age at onset\) | 19448619 | Stolk L | 2009 |
| GCST008137 | Alcohol withdrawal symptoms | 30252935 | Smith AH | 2018 |
| GCST003019 | Black vs. non-black hair color | 26184321 | Lin BD | 2015 |
| GCST001735 | PR interval | 23139255 | Butler AM | 2012 |
| GCST006717 | Alcohol use disorder \(dependence and problematic use scores\) | 30336701 | Sanchez-Roige S | 2018 |
| GCST006716 | Alcohol use disorder \(total score\) | 30336701 | Sanchez-Roige S | 2018 |
| GCST006303 | Nicotine withdrawal symptom count | 29532581 | Hallfors J | 2018 |
| GCST003275 | Mean arterial pressure | 26390057 | Kato N | 2015 |
| GCST001238 | Hypertension | 21909115 | Ehret GB | 2011 |
| GCST001228 | Diastolic blood pressure | 21909115 | Ehret GB | 2011 |
| GCST006491 | Circulating fibroblast growth factor 23 levels | 30217807 | Robinson-Cohen C | 2018 |
| GCST005672 | Cholesteryl ester transfer protein levels | 29728394 | Blauw LL | 2018 |
| GCST004123 | Mathematical ability | 28155865 | Chen H | 2017 |
| GCST004307 | Facial morphology \(factor 3, length of philtrum\) | 28441456 | Lee MK | 2017 |
| GCST007272 | Pulse pressure | 30578418 | Giri A | 2018 |
| GCST007136 | Resistant hypertension | 30237584 | El Rouby N | 2018 |
| GCST000808 | Alzheimer's disease \(late onset\) | 20885792 | Naj AC | 2010 |
| GCST004867 | Systemic lupus erythematosus | 19838195 | Gateva V | 2009 |
| GCST002041 | Blood trace element \(Cu levels\) | 23720494 | Evans DM | 2013 |
| GCST000258 | Type 1 diabetes | 18978792 | Cooper JD | 2008 |
| GCST000363 | QT interval | 19305408 | Newton-Cheh C | 2009 |
| GCST002081 | Migraine | 23793025 | Anttila V | 2013 |
| GCST001038 | Dehydroepiandrosterone sulphate levels | 21533175 | Zhai G | 2011 |
| GCST002562 | Vogt-Koyanagi-Harada syndrome | 25108386 | Hou S | 2014 |
| GCST001632 | Response to fenofibrate | 22890011 | Frazier-Wood AC | 2012 |
| GCST003383 | Platelet count | 26805783 | Schick UM | 2016 |
| GCST001026 | Alzheimer's disease \(late onset\) | 21460841 | Naj AC | 2011 |
| GCST005850 | Heart rate response to recovery post exercise \(30 sec\) | 29497042 | Verweij N | 2018 |
| GCST004964 | Myocardial infarction in darapladib-treated cardiovascular disease \(time to event\) | 28753643 | Yeo A | 2017 |
| GCST002535 | PR interval | 25035420 | Hong KW | 2014 |
| GCST004041 | Response to paliperidone in schizophrenia \(negative Marder score\) | 27846195 | Li Q | 2016 |
| GCST007458 | Age of smoking initiation | 30643251 | Liu M | 2019 |
| GCST005810 | Osteoarthritis of the hip \(hospital diagnosed\) | 29559693 | Zengini E | 2018 |
| GCST001231 | Carotid intima media thickness | 21909108 | Bis JC | 2011 |
| GCST007554 | Autism and educational attainment \(MTAG\) | 30804558 | Grove J | 2019 |
| GCST006119 | Protein C levels | 28082259 | Pankow JS | 2017 |
| GCST005729 | Serum 25-Hydroxyvitamin D levels | 29545823 | O'Brien KM | 2018 |
| GCST008210 | Soluble ICAM-1 | 31217265 | Sliz E | 2019 |
| GCST002030 | Primary tooth development \(time to first tooth eruption\) | 23704328 | Fatemifar G | 2013 |
| GCST000519 | Hair morphology | 19896111 | Medland SE | 2009 |
| GCST004710 | Renal cell carcinoma | 28598434 | Scelo G | 2017 |
| GCST002467 | Cholesterol, total | 24886709 | Ko A | 2014 |
| GCST000372 | Height | 19343178 | Soranzo N | 2009 |
| GCST007427 | Triiodothyronine/thyroxine ratio | 30824882 | Gunjaca I | 2019 |
| GCST001004 | Triglycerides-Blood Pressure \(TG-BP\) | 21386085 | Kraja AT | 2011 |
| GCST003239 | Plasma omega-6 polyunsaturated fatty acid levels \(linoleic acid\) | 26584805 | Dorajoo R | 2015 |
| GCST000418 | Uric acid levels | 19503597 | Kolz M | 2009 |
| GCST000713 | Conduct disorder \(symptom count\) | 20585324 | Dick DM | 2010 |
| GCST000430 | C-reactive protein | 19567438 | Elliott P | 2009 |
| GCST001209 | Osteoarthritis | 21871595 | Day-Williams AG | 2011 |
| GCST002525 | Local histogram emphysema pattern | 25006744 | Castaldi PJ | 2014 |
| GCST000868 | Handedness in dyslexia | 21051773 | Scerri TS | 2010 |
| GCST006042 | Current cigarettes per day in chronic obstructive pulmonary disease | 29767774 | Lutz SM | 2018 |
| GCST006083 | Prostate cancer \(advanced\) | 29892016 | Schumacher FR | 2018 |
| GCST005892 | Glomerular filtration rate in type 2 diabetes | 29703844 | van Zuydam NR | 2018 |
| GCST007296 | Chronic central serous retinopathy | 30480742 | Miki A | 2018 |
| GCST001257 | Hepatitis B | 22004137 | Liu L | 2011 |
| GCST005715 | Myopic maculopathy | 29725004 | Hosoda Y | 2018 |
| GCST006522 | Upper eyelid sagging severity | 24869959 | Jacobs LC | 2014 |
| GCST006977 | Predicted suicide risk | 30610202 | Ruderfer DM | 2019 |
| GCST002364 | Urinary metabolites \(H-NMR features\) | 24586186 | Rueedi R | 2014 |
| GCST000150 | Fetal hemoglobin levels | 18245381 | Uda M | 2008 |
| GCST000055 | Gallstone disease | 17632509 | Buch S | 2007 |
| GCST003725 | Gallstone disease | 27094239 | Joshi AD | 2016 |
| GCST007050 | Gallstone disease | 30692554 | Bustos BI | 2019 |
| GCST001785 | Crohn's disease | 23266558 | Yamazaki K | 2012 |
| GCST004351 | Bone ultrasound measurement \(broadband ultrasound attenuation\) | 28472463 | Mullin BH | 2017 |
| GCST004350 | Bone ultrasound measurement \(velocity of sound\) | 28472463 | Mullin BH | 2017 |
| GCST001787 | Colorectal cancer | 23266556 | Peters U | 2012 |
| GCST002498 | Age-related nuclear cataracts | 24951543 | Liao J | 2014 |
| GCST004967 | Moderate or severe diarrhoea in darapladib-treated cardiovascular disease \(time to event\) | 28753643 | Yeo A | 2017 |
| GCST000699 | Optic disc parameters | 20548946 | Ramdas WD | 2010 |
| GCST000970 | Optic disc area | 21307088 | Khor CC | 2011 |
| GCST002765 | Optic disc area | 25631615 | Springelkamp H | 2015 |
| GCST002729 | Crohn's disease-related phenotypes | 25557950 | Alonso A | 2014 |
| GCST000812 | Adiponectin levels | 20876611 | Wu Y | 2010 |
| GCST002576 | Epithelial ovarian cancer | 25134534 | Chen K | 2014 |
| GCST004887 | Alcohol consumption in current drinkers | 28937693 | Clarke TK | 2017 |
| GCST004026 | Alcohol consumption | 27911795 | Schumann G | 2016 |
| GCST001962 | Bone mineral density | 23572186 | Zheng HF | 2013 |
| GCST007536 | Serum urea levels | 30808845 | Thio CHL | 2019 |
| GCST000587 | Mean corpuscular hemoglobin | 20139978 | Kamatani Y | 2010 |
| GCST000692 | Vitiligo | 20526339 | Quan C | 2010 |
| GCST007590 | Hippocampal volume | 30818988 | Klein M | 2019 |
| GCST005969 | Acute lymphoblastic leukemia in childhood \(B cell precursor\) | 29296818 | Clay-Gilmour AI | 2017 |
| GCST005972 | Acute lymphoblastic leukemia \(B-cell precursor\) | 29296818 | Clay-Gilmour AI | 2017 |
| GCST003259 | Ischemic stroke \(large artery atherosclerosis\) | 26708676 | Pulit SL | 2015 |
| GCST001400 | Stroke | 22306652 | Bellenguez C | 2012 |
| GCST000495 | Bone mineral density \(hip\) | 19801982 | Rivadeneira F | 2009 |
| GCST007411 | Depressive symptoms x dependent stressful life events interaction \(2df test\) | 30718454 | Arnau-Soler A | 2019 |
| GCST001049 | D-dimer levels | 21502573 | Smith NL | 2011 |
| GCST006656 | Dysmenorrheic pain severity | 29855537 | Hirata T | 2018 |
| GCST001120 | Erythrocyte sedimentation rate | 21700265 | Kullo IJ | 2011 |
| GCST001463 | Adiponectin levels | 22479202 | Dastani Z | 2012 |
| GCST003082 | Longitudinal change in brain amyloid plaque burden | 26268530 | Ramanan VK | 2015 |
| GCST001850 | Major depressive disorder | 23377640 | GENDEP Investigators | 2013 |
| GCST002640 | Inflammatory biomarkers in Kawasaki disease | 25266886 | Kim JJ | 2014 |
| GCST005538 | Sarcoidosis | 26051272 | Fischer A | 2015 |
| GCST001302 | White blood cell count | 22037903 | Crosslin DR | 2011 |
| GCST004457 | Growth-regulated protein alpha levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST008204 | Monocyte chemoattractant protein-1 levels | 31217265 | Sliz E | 2019 |
| GCST003180 | Atopic march | 26542096 | Marenholz I | 2015 |
| GCST001750 | Renal cell carcinoma | 23184150 | Henrion M | 2012 |
| GCST006467 | Ewing sarcoma | 30093639 | Machiela MJ | 2018 |
| GCST000381 | Biomedical quantitative traits | 19396169 | Cho YS | 2009 |
| GCST001780 | Mean corpuscular hemoglobin | 23263863 | Li J | 2012 |
| GCST001781 | Mean corpuscular volume | 23263863 | Li J | 2012 |
| GCST001779 | Hematology traits | 23263863 | Li J | 2012 |
| GCST003520 | Breast cancer | 27354352 | Han MR | 2016 |
| GCST000138 | Triglycerides | 18193044 | Kathiresan S | 2008 |
| GCST005780 | Triglyceride levels | 29615537 | Kulminski AM | 2018 |
| GCST002087 | Homocysteine levels | 23824729 | van Meurs JB | 2013 |
| GCST003938 | Carotenoid levels \(alpha-carotene\) | 28002826 | D'Adamo CR | 2016 |
| GCST001746 | QT interval | 23166209 | Smith JG | 2012 |
| GCST002542 | Electrocardiographic traits | 25055868 | Sano M | 2014 |
| GCST007147 | Lateral ventricular volume in normal aging | 30258056 | Vojinovic D | 2018 |
| GCST001612 | Sex hormone-binding globulin levels | 22829776 | Coviello AD | 2012 |
| GCST001264 | Testosterone levels | 21998597 | Ohlsson C | 2011 |
| GCST002100 | Atopic dermatitis | 23886662 | Weidinger S | 2013 |
| GCST001585 | Breast size | 22747683 | Eriksson N | 2012 |
| GCST007345 | Childhood absence epilepsy | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST000835 | Psoriatic arthritis | 20953186 | Huffmeier U | 2010 |
| GCST005389 | Tooth agenesis | 29364747 | Jonsson L | 2018 |
| GCST002643 | Follicular lymphoma | 25279986 | Skibola CF | 2014 |
| GCST000811 | Breast cancer | 20872241 | Li J | 2010 |
| GCST000036 | Breast cancer | 17529973 | Hunter DJ | 2007 |
| GCST002785 | Facial pigmentation | 25705849 | Jacobs LC | 2015 |
| GCST000190 | Black vs. blond hair color | 18483556 | Han J | 2008 |
| GCST002906 | Skin colour saturation | 25963972 | Liu F | 2015 |
| GCST001940 | Non-melanoma skin cancer | 23548203 | Zhang M | 2013 |
| GCST000710 | Eye color | 20585627 | Eriksson N | 2010 |
| GCST001932 | Hair color | 23548203 | Zhang M | 2013 |
| GCST000191 | Black vs. red hair color | 18483556 | Han J | 2008 |
| GCST004574 | Skin aging \(microtopography measurement\) | 28502801 | Law MH | 2017 |
| GCST000707 | Hair color | 20585627 | Eriksson N | 2010 |
| GCST001116 | Progressive supranuclear palsy | 21685912 | Hoglinger GU | 2011 |
| GCST000708 | Freckling | 20585627 | Eriksson N | 2010 |
| GCST006567 | Response to ketogenic dietary therapies in epilepsy | 30009487 | Schoeler NE | 2018 |
| GCST001124 | Basal cell carcinoma | 21700618 | Nan H | 2011 |
| GCST006890 | Dentate gyrus granule cell layer volume | 30279459 | van der Meer D | 2018 |
| GCST006871 | Total hippocampal volume | 30279459 | van der Meer D | 2018 |
| GCST006889 | Hippocampal subfield CA4 volume | 30279459 | van der Meer D | 2018 |
| GCST007440 | Alanine aminotransferase levels | 30718733 | Moon S | 2019 |
| GCST007439 | Aspartate aminotransferase levels | 30718733 | Moon S | 2019 |
| GCST008128 | Body mass index | 29273807 | Turcot V | 2017 |
| GCST007936 | Medication use \(opioids\) | 31015401 | Wu Y | 2019 |
| GCST002561 | Colorectal cancer | 25105248 | Wang H | 2014 |
| GCST003170 | Subcutaneous adipose tissue | 26480920 | Sung YJ | 2015 |
| GCST007006 | Logical memory \(delayed recall\) in normal cognition | 29274321 | Chung J | 2017 |
| GCST000282 | LDL cholesterol | 19060911 | Aulchenko YS | 2008 |
| GCST000324 | Carotenoid and tocopherol levels | 19185284 | Ferrucci L | 2009 |
| GCST004772 | Bone mineral density \(paediatric, total body less head\) | 28743860 | Medina-Gomez C | 2017 |
| GCST001859 | Thiazide-induced adverse metabolic effects in hypertensive patients | 23400010 | Del-Aguila JL | 2013 |
| GCST001826 | Lymphoma | 23349640 | Vijai J | 2013 |
| GCST004957 | Major coronary event in darapladib-treated cardiovascular disease \(time to event\) | 28753643 | Yeo A | 2017 |
| GCST001827 | Squamous cell carcinoma | 23341777 | Dong J | 2013 |
| GCST002966 | Amino acid levels | 26068415 | Draisma HHM | 2015 |
| GCST008258 | Alcohol use disorder \(consumption score\) | 30940813 | Kranzler HR | 2019 |
| GCST001011 | Oral cavity and pharyngeal cancer | 21437268 | McKay JD | 2011 |
| GCST004711 | Alcohol dependence | 24166409 | Gelernter J | 2014 |
| GCST000466 | Esophageal cancer | 19698717 | Cui R | 2009 |
| GCST004405 | Alcohol consumption \(drinks per week\) | 28485404 | Jorgenson E | 2017 |
| GCST007152 | Chronic back pain | 30261039 | Suri P | 2018 |
| GCST000589 | White blood cell count | 20139978 | Kamatani Y | 2010 |
| GCST006623 | Midgestational cytokine/chemokine levels \(fetal genetic effect\) | 30134952 | Traglia M | 2018 |
| GCST002884 | Cutaneous lupus erythematosus | 25827949 | Kunz M | 2015 |
| GCST000611 | Height | 20189936 | Okada Y | 2010 |
| GCST002840 | Myeloproliferative neoplasms | 25849990 | Tapper W | 2015 |
| GCST002499 | Birth weight | 24950379 | Metrustry SJ | 2014 |
| GCST005205 | N-terminal pro B-type natriuretic peptide levels | 29237677 | Salo PP | 2017 |
| GCST007816 | Trunk fat mass adjusted for trunk lean mass | 30944420 | Liu L | 2019 |
| GCST001350 | Pancreatic cancer | 22158540 | Wu C | 2011 |
| GCST001221 | Permanent tooth development | 21931568 | Geller F | 2011 |
| GCST006619 | Tuberculosis | 30287856 | Zheng R | 2018 |
| GCST001688 | Type 1 diabetes nephropathy | 23028342 | Sandholm N | 2012 |
| GCST004652 | Peak velocity of the mitral A-wave | 28394258 | Wild PS | 2017 |
| GCST005368 | Opioid dependence | 29478698 | Cheng Z | 2018 |
| GCST004020 | Small vessel stroke | 27997041 | Traylor M | 2016 |
| GCST002376 | Urinary uromodulin levels | 24578125 | Olden M | 2014 |
| GCST000683 | Central corneal thickness | 20485516 | Lu Y | 2010 |
| GCST008277 | Corneal hysteresis | 31246245 | Khawaja AP | 2019 |
| GCST003856 | Central corneal thickness | 28171582 | Gao X | 2016 |
| GCST005414 | Type 2 diabetes | 29358691 | Bonas-Guarch S | 2018 |
| GCST003658 | Modified Stumvoll Insulin Sensitivity Index \(model adjusted for BMI\) | 27416945 | Walford GA | 2016 |
| GCST006701 | Parental longevity \(father's attained age\) | 29227965 | Pilling LC | 2017 |
| GCST002021 | Body mass index | 23669352 | Graff M | 2013 |
| GCST006461 | Self-reported risk-taking behaviour | 30181555 | Strawbridge RJ | 2018 |
| GCST001027 | Uterine fibroids | 21460842 | Cha PC | 2011 |
| GCST000305 | Mean platelet volume | 19110211 | Meisinger C | 2008 |
| GCST007106 | Response to opioid analgesics in cancer \(pain decrease\) | 30277654 | Yokoshima Y | 2018 |
| GCST002304 | Fractional exhaled nitric oxide \(childhood\) | 24315451 | van der Valk RJ | 2013 |
| GCST003302 | Cholesterol, total | 26780889 | Below JE | 2016 |
| GCST005568 | Rheumatoid arthritis \(ACPA-positive\) | 23143596 | Eyre S | 2012 |
| GCST007240 | Obese vs. thin | 30677029 | Riveros-McKay F | 2019 |
| GCST008281 | Hip bone size | 31053729 | Styrkarsdottir U | 2019 |
| GCST008278 | Femoral neck size | 31053729 | Styrkarsdottir U | 2019 |
| GCST001158 | Fibrinogen | 21757653 | Lovely RS | 2011 |
| GCST005181 | Body mass index | 27455349 | Minster RL | 2016 |
| GCST004172 | Rheumatoid arthritis | 28118524 | Saxena R | 2017 |
| GCST007934 | Medication use \(anti-inflammatory and antirheumatic products, non-steroids\) | 31015401 | Wu Y | 2019 |
| GCST008047 | Platelet count | 22423221 | Qayyum R | 2012 |
| GCST001708 | Systemic lupus erythematosus | 23053960 | Lee YH | 2012 |
| GCST001364 | IgA nephropathy | 22197929 | Yu XQ | 2011 |
| GCST002943 | IgA nephropathy | 26028593 | Li M | 2015 |
| GCST000142 | Systemic lupus erythematosus | 18204446 | Harley JB | 2008 |
| GCST001628 | Orofacial clefts | 22863734 | Ludwig KU | 2012 |
| GCST005213 | Asthma \(childhood onset\) | 29273806 | Demenais F | 2017 |
| GCST002874 | Psoriasis | 25903422 | Yin X | 2015 |
| GCST008171 | Platelet aggregation | 29185836 | Chen MH | 2017 |
| GCST002875 | Diisocyanate-induced asthma | 25918132 | Yucesoy B | 2015 |
| GCST006092 | Double-edged eyelids | 29895819 | Endo C | 2018 |
| GCST000657 | Optic nerve measurement \(disc area\) | 20395239 | Macgregor S | 2010 |
| GCST004139 | Bipolar disorder | 28115744 | Ikeda M | 2017 |
| GCST004259 | Mean arterial pressure \(long-term average\) | 28348047 | Li C | 2017 |
| GCST002712 | Red blood cell fatty acid levels | 25500335 | Tintle NL | 2014 |
| GCST007134 | Total cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST001159 | Restless legs syndrome | 21779176 | Winkelmann J | 2011 |
| GCST000056 | Restless legs syndrome | 17637780 | Winkelmann J | 2007 |
| GCST004174 | Rheumatoid arthritis \(rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive\) | 28118524 | Saxena R | 2017 |
| GCST002270 | Glycated hemoglobin levels | 24244560 | Chen P | 2013 |
| GCST002773 | Gout | 25646370 | Matsuo H | 2015 |
| GCST000737 | Hypertriglyceridemia | 20657596 | Johansen CT | 2010 |
| GCST002110 | Glycemic traits \(pregnancy\) | 23903356 | Hayes MG | 2013 |
| GCST007858 | Fasting blood glucose adjusted for BMI | 25625282 | Mahajan A | 2015 |
| GCST005789 | Resting heart rate | 29769521 | Ramirez J | 2018 |
| GCST003147 | Plasma lactate levels | 26433129 | Tin A | 2015 |
| GCST000292 | Metabolic traits | 19060910 | Sabatti C | 2008 |
| GCST005308 | Nonalcoholic fatty liver disease | 29385134 | Kawaguchi T | 2018 |
| GCST003924 | Renal overload gout | 27899376 | Nakayama A | 2016 |
| GCST006057 | Percent glycated albumin | 29844224 | Loomis SJ | 2018 |
| GCST001905 | Hypertriglyceridemia | 23505323 | Weissglas-Volkov D | 2013 |
| GCST000286 | Triglycerides | 19060906 | Kathiresan S | 2008 |
| GCST006077 | Branched-chain amino acid levels \(Isoleucine\) | 27898682 | Lotta LA | 2016 |
| GCST007857 | Fasting blood insulin adjusted for BMI | 25625282 | Mahajan A | 2015 |
| GCST003214 | Cholesterol, total | 26582766 | Lu X | 2015 |
| GCST002964 | Sphingolipid levels | 26068415 | Draisma HHM | 2015 |
| GCST002879 | Chronic hepatitis B infection | 25802187 | Jiang DK | 2015 |
| GCST005306 | Atrial fibrillation | 29290336 | Nielsen JB | 2018 |
| GCST007993 | Asthma \(adult onset\) | 31036433 | Pividori M | 2019 |
| GCST000339 | Eosinophil counts | 19198610 | Gudbjartsson DF | 2009 |
| GCST000488 | Prostate cancer | 19767753 | Eeles RA | 2009 |
| GCST004814 | Interleukin-6 \(red blood cell fatty acid level interaction\) | 28820441 | Veenstra J | 2017 |
| GCST002496 | Bone mineral density \(paediatric, upper limb\) | 24945404 | Kemp JP | 2014 |
| GCST005143 | Telomere length | 29151059 | Delgado DA | 2017 |
| GCST002286 | Ischemic stroke | 24262325 | Dichgans M | 2013 |
| GCST001186 | Nevirapine-induced rash | 21810746 | Chantarangsu S | 2011 |
| GCST007591 | Attention deficit hyperactivity disorder or caudate nucleus volume \(pleiotropy\) | 30818988 | Klein M | 2019 |
| GCST000750 | Prostate cancer | 20676098 | Takata R | 2010 |
| GCST001984 | Graves' disease | 23612905 | Zhao SX | 2013 |
| GCST000731 | Resting heart rate | 20639392 | Eijgelsheim M | 2010 |
| GCST007113 | Huntington's disease \(age at onset\) | 29750799 | Chao MJ | 2018 |
| GCST003215 | HDL cholesterol | 26582766 | Lu X | 2015 |
| GCST003364 | Triglyceride levels | 26763881 | Kurano M | 2016 |
| GCST003448 | Erythrocyte cadmium concentration in never smokers | 27005419 | Borne Y | 2016 |
| GCST006088 | Familial squamous cell lung carcinoma | 29924316 | Byun J | 2018 |
| GCST002625 | Chronic bronchitis and chronic obstructive pulmonary disease | 25241909 | Lee JH | 2014 |
| GCST000586 | Telomere length | 20139977 | Codd V | 2010 |
| GCST001068 | Telomere length | 21573004 | Prescott J | 2011 |
| GCST002023 | Testicular germ cell tumor | 23666239 | Chung CC | 2013 |
| GCST000916 | Endometriosis | 21151130 | Painter JN | 2010 |
| GCST000038 | Type 1 diabetes | 17554260 | Todd JA | 2007 |
| GCST006292 | Response to antipsychotic treatment in schizophrenia | 29503163 | Yu H | 2018 |
| GCST000833 | Psoriasis | 20953190 | Strange A | 2010 |
| GCST002044 | Triglycerides | 23726366 | Coram MA | 2013 |
| GCST000062 | Multiple sclerosis | 17660530 | Hafler DA | 2007 |
| GCST004454 | Interleukin-2 receptor antagonist levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST007924 | Medication use \(antithrombotic agents\) | 31015401 | Wu Y | 2019 |
| GCST007014 | Lumbar spine bone mineral density \(trabecular\) | 27476799 | Nielson CM | 2016 |
| GCST007015 | Lumbar spine bone mineral density \(integral\) | 27476799 | Nielson CM | 2016 |
| GCST004250 | Alanine aminotransferase \(ALT\) levels after remission induction therapy in actute lymphoblastic leukemia \(ALL\) | 28090653 | Liu Y | 2017 |
| GCST003762 | Essential tremor | 27797806 | Muller SH | 2016 |
| GCST004403 | Bone fracture in osteoporosis | 28580392 | Taylor KC | 2016 |
| GCST002033 | Malaria | 23717212 | Band G | 2013 |
| GCST005908 | Height | 29782485 | Rueger S | 2018 |
| GCST001163 | Urate levels | 21768215 | Tin A | 2011 |
| GCST005933 | Non-glioblastoma glioma | 29743610 | Ostrom QT | 2018 |
| GCST003238 | Plasma omega-6 polyunsaturated fatty acid levels \(gamma-linolenic acid\) | 26584805 | Dorajoo R | 2015 |
| GCST004939 | Glycated hemoglobin levels | 28887542 | Prins BP | 2017 |
| GCST000118 | Blond vs. brown hair color | 17952075 | Sulem P | 2007 |
| GCST003928 | Giant cell arteritis | 28041642 | Carmona FD | 2016 |
| GCST001929 | Eye color | 23548203 | Zhang M | 2013 |
| GCST000117 | Blue vs. green eyes | 17952075 | Sulem P | 2007 |
| GCST007743 | Iris color \(L\* coordinate\) | 30895295 | Jonnalagadda M | 2019 |
| GCST007742 | Iris heterochromicity | 30895295 | Jonnalagadda M | 2019 |
| GCST005845 | Heart rate increase in response to exercise | 29497042 | Verweij N | 2018 |
| GCST003848 | Caffeine metabolism \(plasma 1,3-dimethylxanthine \(theophylline\) level\) | 27702941 | Cornelis MC | 2016 |
| GCST007157 | Corneal astigmatism | 30306274 | Shah RL | 2018 |
| GCST002907 | Perceived skin darkness | 25963972 | Liu F | 2015 |
| GCST003761 | Emphysema distribution in smoking | 27669027 | Boueiz A | 2016 |
| GCST002351 | Chronic obstructive pulmonary disease \(moderate to severe\) | 24621683 | Cho MH | 2014 |
| GCST002350 | Chronic obstructive pulmonary disease \(severe\) | 24621683 | Cho MH | 2014 |
| GCST002720 | Kidney function decline traits | 25493955 | Gorski M | 2014 |
| GCST000397 | Renal function and chronic kidney disease | 19430482 | Kottgen A | 2009 |
| GCST003373 | Glomerular filtration rate in diabetics \(creatinine\) | 26831199 | Pattaro C | 2016 |
| GCST002234 | Breast cancer | 24143190 | Low SK | 2013 |
| GCST002908 | Skin sensitivity to sun | 25963972 | Liu F | 2015 |
| GCST001980 | Circulating myeloperoxidase levels \(plasma\) | 23620142 | Reiner AP | 2013 |
| GCST002169 | Adolescent idiopathic scoliosis \(severe\) | 24023777 | Miyake A | 2013 |
| GCST002846 | Lifespan | 25918517 | Yashin AI | 2015 |
| GCST005952 | Body mass index \(age&gt;50\) | 26426971 | Winkler TW | 2015 |
| GCST000184 | Waist circumference and related phenotypes | 18454146 | Chambers JC | 2008 |
| GCST000296 | Body mass index | 19079260 | Thorleifsson G | 2008 |
| GCST005647 | Amyotrophic lateral sclerosis | 29566793 | Nicolas A | 2018 |
| GCST004129 | White blood cell count \(monocyte\) | 28158719 | Jain D | 2017 |
| GCST002043 | HDL cholesterol | 23726366 | Coram MA | 2013 |
| GCST000465 | Response to hepatitis C treatment | 19684573 | Ge D | 2009 |
| GCST001516 | Osteoarthritis | 22566624 | Castano Betancourt MC | 2012 |
| GCST004714 | Heart rate variability traits \(SDNN\) | 28610988 | Kerr KF | 2017 |
| GCST007018 | Serum bilirubin levels in metabolic syndrome | 30621171 | Coltell O | 2019 |
| GCST004752 | Relapse in multiple sclerosis | 28739605 | Zhou Y | 2017 |
| GCST003781 | Breast cancer \(estrogen-receptor positive\) | 28171663 | Huo D | 2016 |
| GCST007844 | Ankylosing spondylitis | 30946743 | Li Z | 2019 |
| GCST002842 | Basal cell carcinoma | 25855136 | Stacey SN | 2015 |
| GCST000157 | Celiac disease | 18311140 | Hunt KA | 2008 |
| GCST003468 | Chronic lymphocytic leukemia | 26956414 | Berndt SI | 2016 |
| GCST002568 | Esophageal squamous cell carcinoma | 25129146 | Wu C | 2014 |
| GCST001267 | Melanoma | 21983787 | Barrett JH | 2011 |
| GCST000420 | Rheumatoid arthritis | 19503088 | Gregersen PK | 2009 |
| GCST001580 | QT interval | 22726844 | Kim JW | 2012 |
| GCST007681 | Thyroid stimulating hormone levels | 30843173 | Popovic M | 2019 |
| GCST002811 | Nonsyndromic cleft lip with or without cleft palate | 25775280 | Sun Y | 2015 |
| GCST000781 | Amyotrophic lateral sclerosis | 20801718 | Laaksovirta H | 2010 |
| GCST002911 | Calcium levels | 25972035 | Vinayagamoorthy N | 2015 |
| GCST001318 | Serum ceruloplasmin levels | 22075249 | Tang WH | 2011 |
| GCST004135 | White blood cell count \(eosinophil\) | 28158719 | Jain D | 2017 |
| GCST005080 | PR interval | 29127183 | Seyerle AA | 2017 |
| GCST006777 | Brain imaging measurements | 30305740 | Elliott LT | 2018 |
| GCST005772 | Diastolic blood pressure | 29615537 | Kulminski AM | 2018 |
| GCST005782 | Serum 25-Hydroxyvitamin D levels | 29325163 | Hong J | 2018 |
| GCST006426 | Serum urate levels in chronic kidney disease | 30181573 | Jing J | 2018 |
| GCST002082 | Cervical cancer | 23817570 | Shi Y | 2013 |
| GCST001374 | Uric acid levels | 22229870 | Karns R | 2012 |
| GCST000328 | Biochemical measures | 19260141 | Zemunik T | 2009 |
| GCST004030 | Primary sclerosing cholangitis | 27992413 | Ji SG | 2016 |
| GCST002945 | Emphysema imaging phenotypes | 26030696 | Cho MH | 2015 |
| GCST001620 | Resistin levels | 22843503 | Qi Q | 2012 |
| GCST000362 | Pulmonary function | 19300500 | Wilk JB | 2009 |
| GCST006046 | Number of children ever born | 27798627 | Barban N | 2016 |
| GCST006064 | White matter integrity \(mean diffusivity\) | 29752348 | Rutten-Jacobs LCA | 2018 |
| GCST001697 | Telomere length | 23001564 | Mangino M | 2012 |
| GCST000560 | Osteoporosis | 20072603 | Guo Y | 2010 |
| GCST007350 | Focal epilepsy \(with hippocampal sclerosis\) | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST003766 | Subjective well-being | 27089181 | Okbay A | 2016 |
| GCST002756 | Subcortical brain region volumes | 25607358 | Hibar DP | 2015 |
| GCST000677 | Rheumatoid arthritis | 20453841 | Kochi Y | 2010 |
| GCST006488 | Insomnia complaints | 28604731 | Hammerschlag AR | 2017 |
| GCST001050 | Bone mineral density | 21533022 | Duncan EL | 2011 |
| GCST002143 | Blood pressure | 23972371 | Franceschini N | 2013 |
| GCST001893 | Electrocardiographic conduction measures | 23463857 | Ritchie MD | 2013 |
| GCST001646 | Prostate cancer | 22923026 | Cheng I | 2012 |
| GCST007266 | Adult asthma | 30787307 | Daya M | 2019 |
| GCST001232 | Age-related macular degeneration | 21909106 | Arakawa S | 2011 |
| GCST000035 | Breast cancer | 17529967 | Easton DF | 2007 |
| GCST008108 | N-glycan levels | 31163085 | Sharapov SZ | 2019 |
| GCST004542 | Mean corpuscular hemoglobin | 28548082 | Southam L | 2017 |
| GCST003374 | Chronic kidney disease | 26831199 | Pattaro C | 2016 |
| GCST007925 | Medication use \(vasodilators used in cardiac diseases\) | 31015401 | Wu Y | 2019 |
| GCST002289 | Coronary artery disease | 24262325 | Dichgans M | 2013 |
| GCST000057 | Coronary heart disease | 17634449 | Samani NJ | 2007 |
| GCST000045 | Coronary heart disease | 17554300 | Wellcome Trust Case Control Consortium | 2007 |
| GCST005582 | Coronary artery disease | 29472232 | Li Y | 2018 |
| GCST001347 | Coronary artery calcification | 22144573 | O'Donnell CJ | 2011 |
| GCST001079 | Coronary heart disease | 21606135 | Wild PS | 2011 |
| GCST001070 | Type 2 diabetes | 21573907 | Parra EJ | 2011 |
| GCST007586 | Attention deficit hyperactivity disorder or intracranial volume \(pleiotropy\) | 30818988 | Klein M | 2019 |
| GCST000849 | Hypertension | 21082022 | Padmanabhan S | 2010 |
| GCST007494 | Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST003218 | Non-cardia gastric cancer | 26701879 | Wang Z | 2015 |
| GCST000602 | Atrial fibrillation | 20173747 | Ellinor PT | 2010 |
| GCST004531 | Diastolic blood pressure | 28548082 | Southam L | 2017 |
| GCST000037 | Breast cancer | 17529974 | Stacey SN | 2007 |
| GCST000952 | Breast cancer | 21263130 | Fletcher O | 2011 |
| GCST005913 | Fasting blood glucose | 29621232 | Spracklen CN | 2018 |
| GCST004705 | Blood pressure | 24903457 | Kim YK | 2014 |
| GCST005590 | Nontyphoidal Salmonella bacteraemia | 29523850 | Gilchrist JJ | 2018 |
| GCST003303 | LDL cholesterol | 26780889 | Below JE | 2016 |
| GCST001457 | Breast cancer | 22452962 | Kim HC | 2012 |
| GCST007153 | Delayed reward discounting | 30265060 | MacKillop J | 2018 |
| GCST003128 | Adolescent idiopathic scoliosis | 26394188 | Zhu Z | 2015 |
| GCST004288 | Adolescent idiopathic scoliosis | 28334814 | Zhu Z | 2017 |
| GCST002598 | Educational attainment | 25201988 | Rietveld CA | 2014 |
| GCST002073 | Chronic lymphocytic leukemia | 23770605 | Berndt SI | 2013 |
| GCST001701 | Asthma | 23028483 | Ramasamy A | 2012 |
| GCST000804 | Asthma | 20860503 | Moffatt MF | 2010 |
| GCST004329 | Mean corpuscular hemoglobin concentration | 28453575 | Hodonsky CJ | 2017 |
| GCST002119 | Metabolite levels  \(X-11787\) | 23934736 | Yu B | 2013 |
| GCST001783 | Platelet count | 23263863 | Li J | 2012 |
| GCST001799 | Prostate-specific antigen levels | 23359319 | Jin G | 2013 |
| GCST004565 | Waist circumference adjusted for BMI in inactive individuals | 28448500 | Graff M | 2017 |
| GCST000394 | Diastolic blood pressure | 19430483 | Newton-Cheh C | 2009 |
| GCST004694 | Sleep duration | 28604731 | Hammerschlag AR | 2017 |
| GCST003839 | Sleep duration | 27494321 | Jones SE | 2016 |
| GCST002707 | Serum thyroid-stimulating hormone levels | 25436638 | Malinowski JR | 2014 |
| GCST002315 | Thrombin generation potential phenotypes | 24357727 | Rocanin-Arjo A | 2013 |
| GCST003322 | Ischemic stroke \(large artery atherosclerosis\) | 26732560 | Cheng YC | 2016 |
| GCST004326 | Facial morphology \(factor 22\) | 28441456 | Lee MK | 2017 |
| GCST007630 | Drug experimentation measurement | 30718321 | Sanchez-Roige S | 2019 |
| GCST002624 | Chronic obstructive pulmonary disease | 25241909 | Lee JH | 2014 |
| GCST005416 | Airflow obstruction | 29394082 | Burkart KM | 2018 |
| GCST000291 | Fasting plasma glucose | 19060909 | Bouatia-Naji N | 2008 |
| GCST004961 | Major coronary event in placebo-treated cardiovascular disease \(time to event\) | 28753643 | Yeo A | 2017 |
| GCST004068 | Venous thromboembolism adjusted for sickle cell variant rs77121243-T | 28203683 | Heit JA | 2017 |
| GCST007393 | Mitochondrial DNA copy number | 30704525 | Guyatt AL | 2019 |
| GCST007444 | Chronic rhinosinusitis | 30643255 | Kristjansson RP | 2019 |
| GCST005010 | Bacterial meningitis | 28928442 | Tian C | 2017 |
| GCST004142 | Melanoma | 28212542 | Ransohoff KJ | 2017 |
| GCST000437 | Melanoma | 19578364 | Bishop DT | 2009 |
| GCST001907 | Multiple myeloma \(hyperdiploidy\) | 23502783 | Weinhold N | 2013 |
| GCST005022 | Major depression and alcohol dependence | 29071344 | Zhou H | 2017 |
| GCST007270 | Systolic blood pressure | 30578418 | Giri A | 2018 |
| GCST007271 | Diastolic blood pressure | 30578418 | Giri A | 2018 |
| GCST003489 | Food addiction | 27106561 | Cornelis MC | 2016 |
| GCST002468 | Triglycerides | 24886709 | Ko A | 2014 |
| GCST005549 | Alzheimer's disease \(late onset\) | 28714976 | Sims R | 2017 |
| GCST007829 | Systolic blood pressure | 28234671 | Nandakumar P | 2017 |
| GCST002662 | Breast cancer | 25327703 | Fejerman L | 2014 |
| GCST004555 | Waist-hip ratio | 28548082 | Southam L | 2017 |
| GCST005411 | Thrombin-activatable fibrinolysis inhibitor activation peptide | 29378355 | Stanne TM | 2018 |
| GCST002685 | Refractive astigmatism | 25367360 | Li Q | 2014 |
| GCST002383 | Anterior chamber depth | 24603532 | Nongpiur ME | 2014 |
| GCST005560 | Menopause \(age at onset\) | 26414677 | Day FR | 2015 |
| GCST000303 | Glycated hemoglobin levels | 19096518 | Pare G | 2008 |
| GCST007937 | Medication use \(salicylic acid and derivatives\) | 31015401 | Wu Y | 2019 |
| GCST000510 | Hematology traits | 19853236 | Ferreira MA | 2009 |
| GCST000192 | Blue vs. green eyes | 18488028 | Sulem P | 2008 |
| GCST000440 | Glioma \(high-grade\) | 19578366 | Wrensch M | 2009 |
| GCST003654 | Bone mineral density \(Ward's triangle area\) | 27397699 | Pei YF | 2016 |
| GCST000564 | Electrocardiographic traits | 20062061 | Chambers JC | 2010 |
| GCST007281 | HDL cholesterol x physical activity interaction \(1df test\) | 30670697 | Kilpelainen TO | 2019 |
| GCST007117 | Cholesterol efflux capacity \(BHK stimulated assay\) | 30369316 | Low-Kam C | 2018 |
| GCST007719 | Albuminuria | 30910378 | Zanetti D | 2019 |
| GCST007596 | Adult asthma | 30578877 | Dahlin A | 2018 |
| GCST000317 | Obesity | 19151714 | Meyre D | 2009 |
| GCST006388 | Dietary macronutrient intake | 29988085 | Merino J | 2018 |
| GCST001989 | Dietary macronutrient intake | 23636237 | Tanaka T | 2013 |
| GCST002941 | Airway imaging phenotypes | 26030696 | Cho MH | 2015 |
| GCST003979 | Excessive daytime sleepiness | 27992416 | Lane JM | 2016 |
| GCST003759 | Resistin levels | 27664181 | Kawamura R | 2016 |
| GCST006403 | Energy expenditure | 30071075 | Jiang L | 2018 |
| GCST002546 | Osteoprotegerin levels | 25080503 | Kwan JS | 2014 |
| GCST004015 | Extraversion | 27918536 | Lo MT | 2016 |
| GCST007741 | Iris color \(b\* coordinate\) | 30895295 | Jonnalagadda M | 2019 |
| GCST004213 | Resting heart rate | 28270201 | Nagy R | 2017 |
| GCST004444 | Interleukin-10 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST000851 | Hodgkin's lymphoma | 21037568 | Enciso-Mora V | 2010 |
| GCST005236 | Problematic alcohol use in trauma-exposed individuals | 29082582 | Almli LM | 2017 |
| GCST006566 | Developmental dysplasia of the hip | 30273415 | Hatzikotoulas K | 2018 |
| GCST005929 | Severity of nausea and vomiting of pregnancy | 29563502 | Fejzo MS | 2018 |
| GCST005439 | Response to alcohol consumption \(flushing response\) | 29460428 | Gelernter J | 2018 |
| GCST006076 | Branched-chain amino acid levels \(Leucine\) | 27898682 | Lotta LA | 2016 |
| GCST006078 | Branched-chain amino acid levels \(Valine\) | 27898682 | Lotta LA | 2016 |
| GCST002455 | Parkinson's disease | 24842889 | Vacic V | 2014 |
| GCST005330 | Coffee consumption | 29367735 | Nakagawa-Senda H | 2018 |
| GCST000019 | Prostate cancer | 17401366 | Gudmundsson J | 2007 |
| GCST000017 | Prostate cancer | 17401363 | Yeager M | 2007 |
| GCST007220 | Schizophrenia and type 2 diabetes | 30470734 | Hackinger S | 2018 |
| GCST008321 | Corneal endothelial cell shape \(percentage of hexagonally shaped cells\) | 30894546 | Ivarsdottir EV | 2019 |
| GCST001615 | Sclerosing cholangitis and ulcerative colitis \(combined\) | 22821403 | Ellinghaus D | 2012 |
| GCST004759 | Very low density lipoprotein cholesterol levels | 28548082 | Southam L | 2017 |
| GCST004550 | Triglyceride levels | 28548082 | Southam L | 2017 |
| GCST007237 | Systolic blood pressure | 27736895 | Franceschini N | 2016 |
| GCST003220 | Glioblastoma | 26424050 | Kinnersley B | 2015 |
| GCST006730 | Infant, child and juvenile death in continuous marriage \(proportion of children died &lt;15 years\) | 30188897 | Jeong C | 2018 |
| GCST006634 | Hedonic well-being | 30279531 | Baselmans BML | 2018 |
| GCST001312 | Abdominal aortic aneurysm | 22055160 | Bown MJ | 2011 |
| GCST005898 | Type 2 diabetes | 29358691 | Bonas-Guarch S | 2018 |
| GCST006062 | White matter hyperintensity volume | 29752348 | Rutten-Jacobs LCA | 2018 |
| GCST005012 | Urinary tract infection frequency | 28928442 | Tian C | 2017 |
| GCST003022 | Light vs. dark hair color | 26184321 | Lin BD | 2015 |
| GCST003021 | Brown vs. non-brown hair color | 26184321 | Lin BD | 2015 |
| GCST003020 | Red vs non-red hair color | 26184321 | Lin BD | 2015 |
| GCST001809 | Type 2 diabetes | 23300278 | Saxena R | 2013 |
| GCST004264 | Clopidogrel active metabolite levels | 28207573 | Backman JD | 2017 |
| GCST004423 | Macrophage Migration Inhibitory Factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST006396 | Disrupted circadian rhythm \(low relative amplitude of rest-activity cycles\) | 30120083 | Ferguson A | 2018 |
| GCST008309 | Cardiac troponin-I levels | 31014085 | Welsh P | 2019 |
| GCST008157 | Body fat mass | 28552196 | Tachmazidou I | 2017 |
| GCST001790 | Gout | 23263486 | Kottgen A | 2012 |
| GCST003841 | Thiopurine S-methyltransferase activity | 27770449 | Tamm R | 2016 |
| GCST001964 | Anthropometric traits in newborns | 23575227 | Urbanek M | 2013 |
| GCST006191 | Diastolic blood pressure x smoking status \(ever vs never\) interaction \(1df test\) | 29455858 | Sung YJ | 2018 |
| GCST002861 | Breast cancer \(survival\) | 25890600 | Guo Q | 2015 |
| GCST005546 | Forearm bone mineral density | 26367794 | Zheng HF | 2015 |
| GCST005006 | Tuberculosis | 28928442 | Tian C | 2017 |
| GCST004845 | Spontaneous preterm birth \(maternal effect\) | 28598419 | Hong X | 2017 |
| GCST003744 | Chronic periodontitis \(mean interproximal clinical attachment level\) | 27601451 | Sanders AE | 2016 |
| GCST004069 | Cerebrospinal fluid AB1-42 levels | 28247064 | Deming Y | 2017 |
| GCST005440 | Alcohol dependence symptom count | 29460428 | Gelernter J | 2018 |
| GCST005441 | Alcohol consumption \(max-drinks\) | 29460428 | Gelernter J | 2018 |
| GCST004962 | Diarrhoea in darapladib-treated cardiovascular disease \(time to event\) | 28753643 | Yeo A | 2017 |
| GCST006145 | Type 2 diabetes | 28838971 | Mercader JM | 2017 |
| GCST003027 | Cough in response to angiotensin-converting enzyme inhibitor drugs | 26169577 | Mosley JD | 2015 |
| GCST007897 | Liver injury in anti-tuberculosis drug treatment | 31109976 | Suvichapanich S | 2019 |
| GCST000728 | Behcet's disease | 20622879 | Mizuki N | 2010 |
| GCST002697 | Eosinophilic esophagitis | 25407941 | Sleiman PM | 2014 |
| GCST004216 | Waist-to-hip ratio adjusted for body mass index | 28270201 | Nagy R | 2017 |
| GCST006275 | Vestibular neuritis | 30079052 | Rujescu D | 2018 |
| GCST005166 | GIP levels in response to oral glucose tolerance test \(120 minutes\) | 29093273 | Almgren P | 2017 |
| GCST003486 | Response to fenofibrate \(LDL cholesterol levels\) | 27002377 | Irvin MR | 2016 |
| GCST007604 | Smoking cessation | 30617275 | Erzurumluoglu AM | 2019 |
| GCST005831 | Systemic lupus erythematosus | 29848360 | Julia A | 2018 |
| GCST004541 | Low density lipoprotein cholesterol levels | 28548082 | Southam L | 2017 |
| GCST004548 | Total cholesterol levels | 28548082 | Southam L | 2017 |
| GCST008113 | Proinsulin levels \(late-phase conversion\) | 23263489 | Huyghe JR | 2012 |
| GCST000773 | Keloid | 20711176 | Nakashima M | 2010 |
| GCST003826 | Pre bronchodilator FEV1/FVC ratio in never-smokers | 27612410 | van der Plaat DA | 2016 |
| GCST005849 | Heart rate response to recovery post exercise \(40 sec\) | 29497042 | Verweij N | 2018 |
| GCST002529 | Glaucoma | 25027321 | Hoffmann TJ | 2014 |
| GCST004442 | Interleukin-17 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST002036 | Congenital heart malformation | 23708190 | Hu Z | 2013 |
| GCST000288 | HDL cholesterol | 19060911 | Aulchenko YS | 2008 |
| GCST000284 | HDL cholesterol | 19060910 | Sabatti C | 2008 |
| GCST002040 | Blood trace element \(Zn levels\) | 23720494 | Evans DM | 2013 |
| GCST001351 | Type 2 diabetes | 22158537 | Cho YS | 2011 |
| GCST001902 | Coronary artery calcification | 23561647 | van Setten J | 2013 |
| GCST000521 | Periodontitis | 19897590 | Schaefer AS | 2009 |
| GCST000366 | Fibrinogen | 20031576 | Dehghan A | 2009 |
| GCST000406 | Amyotrophic lateral sclerosis | 19451621 | Landers JE | 2009 |
| GCST002301 | Body mass index | 24348519 | Namjou B | 2013 |
| GCST001056 | Major depressive disorder | 21521612 | Kohli MA | 2011 |
| GCST000730 | Bilirubin levels | 20639394 | Kang TW | 2010 |
| GCST006702 | Parental longevity \(combined parental age at death\) | 29227965 | Pilling LC | 2017 |
| GCST006700 | Parental longevity \(father's age at death\) | 29227965 | Pilling LC | 2017 |
| GCST004429 | Stem cell factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004201 | Gallbladder cancer | 28274756 | Mhatre S | 2017 |
| GCST003743 | Hypertriglyceridemia | 27599772 | Ram R | 2016 |
| GCST000137 | Triglycerides | 18193046 | Kooner JS | 2008 |
| GCST003435 | Body fat percentage | 26833246 | Lu Y | 2016 |
| GCST000663 | Obesity \(early onset extreme\) | 20421936 | Scherag A | 2010 |
| GCST005187 | Matrix metalloproteinase-8 levels | 29212897 | Salminen A | 2017 |
| GCST001456 | Kawasaki disease | 22446961 | Lee YC | 2012 |
| GCST006386 | Cannabis use \(age at onset\) | 30003630 | Minica CC | 2018 |
| GCST002331 | Basal cell carcinoma | 24403052 | Stacey SN | 2014 |
| GCST002817 | Alzheimer's disease in APOE e4- carriers | 25778476 | Jun G | 2015 |
| GCST000389 | Asthma | 19426955 | Himes BE | 2009 |
| GCST001574 | Activated partial thromboplastin time | 22703881 | Tang W | 2012 |
| GCST006874 | Hippocampal subfield CA1 volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST006877 | Dentate gyrus granule cell layer volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST004864 | Perceived unattractiveness to mosquitoes | 28199695 | Jones AV | 2017 |
| GCST002996 | Folding of antihelix | 26105758 | Adhikari K | 2015 |
| GCST004642 | QT interval \(ambient particulate matter interaction\) | 28749367 | Gondalia R | 2017 |
| GCST007200 | Radiation-induced brain injury in nasopharyngeal carcinoma | 30299488 | Wang TM | 2018 |
| GCST000254 | Height | 18952825 | Johansson A | 2008 |
| GCST000538 | Adiponectin levels | 20011104 | Richards JB | 2009 |
| GCST000120 | Blue vs. brown eyes | 17952075 | Sulem P | 2007 |
| GCST001723 | Eye color | 23118974 | Candille SI | 2012 |
| GCST000149 | Recombination rate \(females\) | 18239089 | Kong A | 2008 |
| GCST006229 | Hypertension | 27618448 | Liu C | 2016 |
| GCST006023 | Hypertension | 27618447 | Surendran P | 2016 |
| GCST002181 | Adverse response to chemotherapy in breast cancer \(alopecia\) | 24025145 | Chung S | 2013 |
| GCST001213 | Type 2 diabetes | 21874001 | Kooner JS | 2011 |
| GCST001557 | Venous thromboembolism | 22672568 | Heit JA | 2012 |
| GCST008310 | Cardiac Troponin-T levels | 31014085 | Welsh P | 2019 |
| GCST000334 | Hirschsprung disease | 19196962 | Garcia-Barcelo MM | 2009 |
| GCST005204 | Systolic blood pressure \(dietary potassium intake interaction\) | 29212900 | Li C | 2017 |
| GCST002249 | Blood pressure measurement \(high sodium intervention\) | 24165912 | He J | 2013 |
| GCST000242 | Urate levels | 18834626 | Dehghan A | 2008 |
| GCST003359 | Serum uric acid levels | 26902266 | Giri AK | 2016 |
| GCST004219 | Skin pigmentation | 28300201 | Hernandez-Pacheco N | 2017 |
| GCST001863 | Beta-2 microglubulin plasma levels | 23417110 | Tin A | 2013 |
| GCST005809 | Photic sneeze reflex | 29559738 | Sasayama D | 2018 |
| GCST006367 | Central corneal thickness | 29760442 | Iglesias AI | 2018 |
| GCST006294 | Response to risperidone in schizophrenia | 29503163 | Yu H | 2018 |
| GCST007470 | Rapid automised naming of letters | 30741946 | Gialluisi A | 2019 |
| GCST002887 | Pharmacokinetics of antiepileptic drugs in severe mental disorder \(concentration drug ratio\) | 25944848 | Athanasiu L | 2015 |
| GCST001938 | Ulcerative colitis | 23511034 | Yang SK | 2013 |
| GCST001292 | Leprosy | 22019778 | Zhang F | 2011 |
| GCST001886 | Melanoma | 23455637 | Iles MM | 2013 |
| GCST003602 | Inflammatory bowel disease | 27569725 | Yang SK | 2016 |
| GCST004072 | Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis \(SJS/TEN\) with severe ocular complications | 28100913 | Ueta M | 2017 |
| GCST002486 | Exfoliation glaucoma or exfoliation syndrome | 24938310 | Nakano M | 2014 |
| GCST002559 | Vitamin B levels in ischemic stroke | 25147783 | Keene KL | 2014 |
| GCST000703 | Phosphorus levels | 20558539 | Kestenbaum B | 2010 |
| GCST003828 | Otitis media \(chronic\) | 27632927 | Einarsdottir E | 2016 |
| GCST005930 | Hyperemesis gravidarum | 29563502 | Fejzo MS | 2018 |
| GCST002553 | Pancreatic cancer | 25086665 | Wolpin BM | 2014 |
| GCST007363 | Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age | 30649302 | Ruth KS | 2019 |
| GCST001768 | Behcet's disease | 23001997 | Hou S | 2012 |
| GCST000141 | Type 1 diabetes | 18198356 | Hakonarson H | 2008 |
| GCST002276 | Bone mineral density | 24249740 | Zhang L | 2013 |
| GCST006285 | Response to aripiprazole in schizophrenia | 29503163 | Yu H | 2018 |
| GCST003003 | Antitragus size | 26105758 | Adhikari K | 2015 |
| GCST004330 | Hematocrit | 28453575 | Hodonsky CJ | 2017 |
| GCST004331 | Hemoglobin | 28453575 | Hodonsky CJ | 2017 |
| GCST001687 | Disc degeneration \(lumbar\) | 22993228 | Williams FM | 2012 |
| GCST007898 | Fasting blood insulin | 25631608 | Wessel J | 2015 |
| GCST001101 | Corneal curvature | 21665993 | Han S | 2011 |
| GCST005520 | Heart rate response to beta blockers \(atenolol add-on therapy\) | 29478026 | Shahin MH | 2018 |
| GCST004160 | Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy | 28163062 | Matsuura K | 2017 |
| GCST001660 | Neuroblastoma | 22941191 | Diskin SJ | 2012 |
| GCST004510 | Sporadic neuroblastoma | 28545128 | McDaniel LD | 2017 |
| GCST007410 | Depressive symptoms x dependent stressful life events interaction \(1df test\) | 30718454 | Arnau-Soler A | 2019 |
| GCST008211 | Tumor necrosis factor alpha levels | 31217265 | Sliz E | 2019 |
| GCST001803 | Corneal curvature | 23401653 | Guggenheim JA | 2013 |
| GCST000458 | Orofacial clefts | 19656524 | Grant SF | 2009 |
| GCST003370 | Anxiety disorder | 26754954 | Otowa T | 2016 |
| GCST000681 | Biliary atresia | 20460270 | Garcia-Barcelo MM | 2010 |
| GCST001345 | Ankylosing spondylitis | 22138694 | Lin Z | 2011 |
| GCST003641 | Cranial base width | 27560520 | Shaffer JR | 2016 |
| GCST003825 | Systolic blood pressure change trajectories | 27980656 | Justice AE | 2016 |
| GCST005519 | Heart rate response to beta blockers | 29478026 | Shahin MH | 2018 |
| GCST001129 | Melanoma | 21706340 | Teerlink C | 2011 |
| GCST002247 | Blood pressure measurement \(cold pressor test\) | 24165912 | He J | 2013 |
| GCST002026 | Coronary arterial lesions in patients with Kawasaki disease | 23677057 | Kim JJ | 2013 |
| GCST006625 | Neonatal cytokine/chemokine levels \(maternal genetic effect\) | 30134952 | Traglia M | 2018 |
| GCST006888 | Hippocampal subfield CA3 volume | 30279459 | van der Meer D | 2018 |
| GCST006892 | Hippocampal fissure volume | 30279459 | van der Meer D | 2018 |
| GCST006872 | Presubiculum volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST001485 | Hippocampal volume | 22504421 | Bis JC | 2012 |
| GCST006887 | Hippocampal subfield CA1 volume | 30279459 | van der Meer D | 2018 |
| GCST006638 | Menstruation quality of life impact \(fever\) | 29855537 | Hirata T | 2018 |
| GCST002261 | Narcolepsy \(age of onset\) | 24204295 | Han F | 2013 |
| GCST002358 | Pit-and-Fissure caries | 24556642 | Zeng Z | 2014 |
| GCST002167 | Blood pressure | 24001895 | Kelly TN | 2013 |
| GCST000769 | Calcium levels | 20705733 | O'Seaghdha CM | 2010 |
| GCST003929 | Urinary electrolytes \(magnesium/calcium ratio\) | 27915449 | Corre T | 2016 |
| GCST008019 | Bitter taste perception \(phenylthiocarbamide\) in obesity with metabolic syndrome | 31005965 | Coltell O | 2019 |
| GCST008017 | Bitter taste perception \(6-n-propylthiouracil\) in obesity with metabolic syndrome | 31005965 | Coltell O | 2019 |
| GCST004343 | Chronic venous disease | 28374850 | Ellinghaus E | 2017 |
| GCST006473 | Diffusing capacity of the lung for carbon monoxide traits | 30049742 | Terzikhan N | 2018 |
| GCST000527 | Ulcerative colitis | 19915572 | Barrett JC | 2009 |
| GCST003590 | Apolipoprotein A-IV levels | 27412012 | Lamina C | 2016 |
| GCST004225 | Alcohol misuse \(trauma interaction\) | 28265120 | Polimanti R | 2017 |
| GCST007131 | Low density lipoprotein cholesterol levels | 29507422 | Hoffmann TJ | 2018 |
| GCST000935 | Iron status biomarkers | 21208937 | Pichler I | 2011 |
| GCST000537 | Adiponectin levels | 20018283 | Heid IM | 2009 |
| GCST000752 | Hepatocellular carcinoma | 20676096 | Zhang H | 2010 |
| GCST005776 | High density lipoprotein cholesterol levels | 29615537 | Kulminski AM | 2018 |
| GCST004818 | Intercellular adhesion molecule 1 \(red blood cell fatty acid level interaction\) | 28820441 | Veenstra J | 2017 |
| GCST007386 | Plasma free asparagine levels | 30659259 | Imaizumi A | 2019 |
| GCST000424 | Multiple sclerosis | 19525953 | De Jager PL | 2009 |
| GCST004337 | Gondoic acid \(20:1n-9\) levels | 28298293 | Hu Y | 2017 |
| GCST003236 | Plasma omega-6 polyunsaturated fatty acid levels \(arachidonic acid\) | 26584805 | Dorajoo R | 2015 |
| GCST004342 | Vaccenic acid \(18:1n-7\) levels | 28298293 | Hu Y | 2017 |
| GCST003237 | Plasma omega-6 polyunsaturated fatty acid levels \(dihomo-gamma-linolenic acid\) | 26584805 | Dorajoo R | 2015 |
| GCST001852 | Metabolite levels | 23378610 | Xie W | 2013 |
| GCST003244 | Delta-6 desaturase activity | 26584805 | Dorajoo R | 2015 |
| GCST002450 | Plasma omega-6 polyunsaturated fatty acid levels \(gamma-linolenic acid\) | 24823311 | Guan W | 2014 |
| GCST005781 | Total cholesterol levels | 29615537 | Kulminski AM | 2018 |
| GCST000550 | Metabolite levels | 20037589 | Illig T | 2009 |
| GCST001813 | Hematology traits | 23303382 | Hong KW | 2013 |
| GCST002448 | Plasma omega-6 polyunsaturated fatty acid levels \(adrenic acid\) | 24823311 | Guan W | 2014 |
| GCST002444 | Plasma omega-6 polyunsaturated fatty acid levels \(dihomo-gamma-linolenic acid\) | 24823311 | Guan W | 2014 |
| GCST002457 | P wave duration | 24850809 | Verweij N | 2014 |
| GCST002678 | Iron status biomarkers \(transferrin levels\) | 25352340 | Benyamin B | 2014 |
| GCST004094 | Prostate-specific antigen levels \(conditioned on lead SNPs\) | 28139693 | Hoffmann TJ | 2017 |
| GCST001804 | Behcet's disease | 23291587 | Kirino Y | 2013 |
| GCST000240 | HDL cholesterol | 20031538 | Heid IM | 2008 |
| GCST002173 | Lipid traits | 24023261 | Keller M | 2013 |
| GCST001570 | Chronic lymphocytic leukemia | 22700719 | Slager SL | 2012 |
| GCST002798 | Pulmonary artery enlargement and chronic obstructive pulmonary disease | 25101718 | Lee JH | 2015 |
| GCST001303 | IgE grass sensitization | 22036096 | Ramasamy A | 2011 |
| GCST000605 | Soluble leptin receptor levels | 20167575 | Sun Q | 2010 |
| GCST002850 | Information processing speed | 25869804 | Ibrahim-Verbaas CA | 2015 |
| GCST002494 | Bone mineral density \(paediatric, total body less head\) | 24945404 | Kemp JP | 2014 |
| GCST006099 | Accelerometer-based physical activity measurement \(average acceleration\) | 29899525 | Klimentidis YC | 2018 |
| GCST000601 | Type 2 diabetes | 20174558 | Tsai FJ | 2010 |
| GCST003582 | Response to radiotherapy in prostate cancer \(toxicity, urinary frequency\) | 27515689 | Kerns SL | 2016 |
| GCST007219 | Schizophrenia | 30470734 | Hackinger S | 2018 |
| GCST001917 | Ovarian cancer in BRCA1 mutation carriers | 23544013 | Couch FJ | 2013 |
| GCST003635 | middle facial morphology traits \(quantitative measurement\) | 27193062 | Adhikari K | 2016 |
| GCST000706 | Common traits \(Other\) | 20585627 | Eriksson N | 2010 |
| GCST001153 | Bladder cancer | 21750109 | Rafnar T | 2011 |
| GCST005167 | GIP levels in response to oral glucose tolerance test \(fasting\) | 29093273 | Almgren P | 2017 |
| GCST005165 | GLP-1 levels in response to oral glucose tolerance test \(120 minutes\) | 29093273 | Almgren P | 2017 |
| GCST002650 | Coffee consumption \(cups per day\) | 25288136 | Cornelis MC | 2014 |
| GCST002651 | Coffee consumption | 25288136 | Cornelis MC | 2014 |
| GCST001974 | Idiopathic pulmonary fibrosis | 24429156 | Noth I | 2013 |
| GCST003738 | Barrett's esophagus | 27527254 | Gharahkhani P | 2016 |
| GCST001674 | Esophageal cancer \(squamous cell\) | 22960999 | Wu C | 2012 |
| GCST000185 | Body mass index | 18454148 | Loos RJ | 2008 |
| GCST006279 | Cerebrospinal fluid -synuclein levels | 29959729 | Zhong XL | 2018 |
| GCST002824 | Behcet's disease | 25799145 | Kappen JH | 2015 |
| GCST002671 | Toenail selenium levels | 25343990 | Cornelis MC | 2014 |
| GCST003402 | Membranous nephropathy | 27333618 | Sekula P | 2016 |
| GCST002745 | Total bilirubin levels in HIV-1 infection | 25884002 | Moore CB | 2015 |
| GCST007737 | Anti-sp100 seropositivity in primary biliary cholangitis | 30854688 | Wang C | 2019 |
| GCST002680 | Iron status biomarkers \(transferrin saturation\) | 25352340 | Benyamin B | 2014 |
| GCST000360 | Warfarin maintenance dose | 19300499 | Takeuchi F | 2009 |
| GCST004573 | Iron status biomarkers \(ferritin levels\) | 28334935 | Raffield LM | 2017 |
| GCST002808 | Venous thromboembolism | 25772935 | Germain M | 2015 |
| GCST004256 | Venous thromboembolism | 28373160 | Klarin D | 2017 |
| GCST000210 | Soluble ICAM-1 | 18604267 | Pare G | 2008 |
| GCST001047 | Soluble ICAM-1 | 21533024 | Pare G | 2011 |
| GCST007248 | Stroke | 30383316 | Malik R | 2018 |
| GCST005160 | Insulin levels in response to oral glucose tolerance test \(30 minutes\) | 29093273 | Almgren P | 2017 |
| GCST007713 | Frontal fibrosing alopecia | 30850646 | Tziotzios C | 2019 |
| GCST000505 | Iron status biomarkers | 19820699 | Benyamin B | 2009 |
| GCST000814 | Red blood cell traits | 20927387 | Kullo IJ | 2010 |
| GCST002679 | Iron status biomarkers \(iron levels\) | 25352340 | Benyamin B | 2014 |
| GCST002677 | Iron status biomarkers \(ferritin levels\) | 25352340 | Benyamin B | 2014 |
| GCST001021 | Iron status biomarkers | 21483845 | McLaren CE | 2011 |
| GCST000133 | HDL cholesterol | 18193044 | Kathiresan S | 2008 |
| GCST003232 | Response to Pazopanib in cancer \(hepatotoxicity\) | 26546620 | Xu CF | 2015 |
| GCST003450 | Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia | 26876947 | Saito T | 2016 |
| GCST003566 | Multiple sclerosis | 27386562 | Andlauer TF | 2016 |
| GCST000331 | HDL cholesterol | 20031564 | Ridker PM | 2009 |
| GCST004919 | HDL cholesterol levels | 17463246 | Saxena R | 2007 |
| GCST002174 | Lipid traits | 24023260 | Wu Y | 2013 |
| GCST004430 | Interleukin-16 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST000367 | Homocysteine levels | 20031578 | Pare G | 2009 |
| GCST000988 | Urinary albumin excretion | 21355061 | Boger CA | 2011 |
| GCST001322 | Kawasaki disease | 22081228 | Khor CC | 2011 |
| GCST000736 | Calcium levels | 20661308 | Kapur K | 2010 |
| GCST004241 | Triglyceride levels | 28371326 | Zhu Y | 2017 |
| GCST000115 | Red vs non-red hair color | 17952075 | Sulem P | 2007 |
| GCST000116 | Skin sensitivity to sun | 17952075 | Sulem P | 2007 |
| GCST001273 | Lipoprotein-associated phospholipase A2 activity and mass | 22003152 | Grallert H | 2011 |
| GCST000644 | Height | 20397748 | Liu JZ | 2010 |
| GCST004042 | Response to paliperidone in schizophrenia \(PANSS score\) | 27846195 | Li Q | 2016 |
| GCST002711 | Sleep duration | 25469926 | Gottlieb DJ | 2014 |
| GCST004451 | Interleukin-7 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004981 | Curve progression in adolescent idiopathic scoliosis | 29016859 | Ogura Y | 2017 |
| GCST000302 | Iron status biomarkers | 19084217 | Benyamin B | 2008 |
| GCST000782 | Migraine | 20802479 | Anttila V | 2010 |
| GCST004181 | Pediatric bone mineral density \(spine\) | 28181694 | Chesi A | 2017 |
| GCST005588 | Idiopathic dilated cardiomyopathy | 29495422 | Xu H | 2018 |
| GCST006913 | Sedentary behaviour duration | 30531941 | Doherty A | 2018 |
| GCST000050 | Prostate cancer | 17603485 | Gudmundsson J | 2007 |
| GCST006110 | Nose morphology | 29921221 | Cha S | 2018 |
| GCST006438 | High density lipoprotein cholesterol levels | 30108155 | Hebbar P | 2018 |
| GCST001914 | Estradiol plasma levels \(breast cancer\) | 23518928 | Liu M | 2013 |
| GCST008198 | Vascular endothelial growth factor levels | 31217265 | Sliz E | 2019 |
| GCST002669 | Percent mammographic density | 25342443 | Lindstrom S | 2014 |
| GCST007551 | Behcet's disease | 27548383 | Ortiz-Fernandez L | 2016 |
| GCST004203 | Diastolic blood pressure | 28270201 | Nagy R | 2017 |
| GCST007155 | Household income | 27818178 | Hill WD | 2016 |
| GCST001719 | Prostate cancer | 23104005 | Gudmundsson J | 2012 |
| GCST007438 | High density lipoprotein cholesterol levels | 30718733 | Moon S | 2019 |
| GCST002239 | Symmetrical dimethylarginine levels | 24159190 | Seppala I | 2013 |
| GCST005965 | B cell acute lymphoblastic leukaemia \(normal cytogenetics\) | 29296818 | Clay-Gilmour AI | 2017 |
| GCST002056 | Osteosarcoma | 23727862 | Savage SA | 2013 |
| GCST003800 | Response to bupropion in depression | 27622933 | Li QS | 2016 |
| GCST002474 | Glioma \(high-grade\) | 24908248 | Walsh KM | 2014 |
| GCST008199 | Interferon gamma-induced protein 10 levels | 31217265 | Sliz E | 2019 |
| GCST000888 | Hypospadias | 21113153 | van der Zanden LF | 2010 |
| GCST007537 | Modic changes | 30808802 | Freidin M | 2019 |
| GCST007728 | Epithelial ovarian cancer | 30898391 | Lawrenson K | 2019 |
| GCST002814 | Alzheimer's disease \(APOE e4 interaction\) | 25778476 | Jun G | 2015 |
| GCST002547 | Epilepsy | 25087078 | Anney RJ | 2014 |
| GCST007154 | Paediatric migraine | 30266756 | Chang X | 2018 |
| GCST003559 | Bone mineral density \(hip\) | 27311723 | Pei YF | 2016 |
| GCST004176 | Pediatric areal bone mineral density \(radius\) | 28181694 | Chesi A | 2017 |
| GCST006742 | Number of stillbirths in continuous marriage | 30188897 | Jeong C | 2018 |
| GCST002997 | Helix rolling | 26105758 | Adhikari K | 2015 |
| GCST005543 | Sarcoidosis \(non-Lofgren's syndrome\) | 26651848 | Rivera NV | 2016 |
| GCST005542 | Sarcoidosis \(non-Lofgren's syndrome without extrapulmonary manifestations\) | 26651848 | Rivera NV | 2016 |
| GCST002747 | Response to Dalcetrapib treatment in acute coronary syndrome | 25583994 | Tardif JC | 2015 |
| GCST000214 | Restless legs syndrome | 18660810 | Schormair B | 2008 |
| GCST005015 | Myringotomy | 28928442 | Tian C | 2017 |
| GCST003338 | Waist-to-hip ratio adjusted for body mass index | 26785701 | Wen W | 2016 |
| GCST005206 | B-type natriuretic peptide levels | 29237677 | Salo PP | 2017 |
| GCST002736 | B-type natriuretic peptide levels | 25561047 | Musani SK | 2015 |
| GCST007245 | Latent autoimmune diabetes | 30254083 | Cousminer DL | 2018 |
| GCST002912 | Narcolepsy with cataplexy | 25986216 | Toyoda H | 2015 |
| GCST000945 | Coronary artery disease | 21239051 | Reilly MP | 2011 |
| GCST005364 | Opioid requirements during laparoscopic-assisted colectomy | 29207912 | Nishizawa D | 2017 |
| GCST001435 | Haptoglobin levels | 22403646 | Froguel P | 2012 |
| GCST005362 | Attention deficit hyperactivity disorder | 29325848 | Martin J | 2017 |
| GCST001118 | Ulcerative colitis or Crohn's disease | 21699788 | Okada Y | 2011 |
| GCST004537 | High density lipoprotein cholesterol levels | 28548082 | Southam L | 2017 |
| GCST003198 | Inguinal hernia | 26686553 | Jorgenson E | 2015 |
| GCST004420 | CTACK levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004449 | Hepatocyte growth factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST002374 | Plasma plasminogen activator levels | 24578379 | Huang J | 2014 |
| GCST007362 | Acute anterior uveitis \(with or without ankylosing spondylitis\) | 25200001 | Robinson PC | 2014 |
| GCST001539 | Smoking behavior | 22832964 | David SP | 2012 |
| GCST005928 | Refractory celiac disease type II | 29787419 | Hrdlickova B | 2018 |
| GCST003384 | Bladder cancer | 27206850 | Wang M | 2016 |
| GCST001916 | Breast Cancer in BRCA1 mutation carriers | 23544013 | Couch FJ | 2013 |
| GCST000343 | Breast cancer | 19219042 | Zheng W | 2009 |
| GCST001698 | Serum total protein level | 23022100 | Franceschini N | 2012 |
| GCST003336 | Waist circumference adjusted for body mass index | 26785701 | Wen W | 2016 |
| GCST000664 | Vitamin D levels | 20418485 | Ahn J | 2010 |
| GCST000698 | Osteoporosis-related phenotypes | 20548944 | Hsu YH | 2010 |
| GCST004141 | Body fat mass | 28224759 | Pei YF | 2017 |
| GCST002480 | Hodgkin's lymphoma | 24920014 | Cozen W | 2014 |
| GCST002942 | Percentage gas trapping | 26030696 | Cho MH | 2015 |
| GCST007114 | Cholesterol efflux capacity | 30369316 | Low-Kam C | 2018 |
| GCST002977 | Advanced glycation end-product levels | 26083729 | Maruthur NM | 2015 |
| GCST000600 | Neutrophil count | 20172861 | Okada Y | 2010 |
| GCST005329 | Coffee consumption | 29367735 | Nakagawa-Senda H | 2018 |
| GCST002137 | Waist circumference | 23966867 | Liu CT | 2013 |
| GCST002195 | Hormone measurements | 24049095 | Chen Z | 2013 |
| GCST005172 | Coronary artery disease | 29263402 | Han Y | 2017 |
| GCST007437 | Triglyceride levels | 30718733 | Moon S | 2019 |
| GCST000479 | Alzheimer's disease | 19734902 | Harold D | 2009 |
| GCST000682 | Alzheimer's disease | 20460622 | Seshadri S | 2010 |
| GCST001013 | Longevity | 21418511 | Deelen J | 2011 |
| GCST001761 | Cognitive decline | 23207651 | Davies G | 2012 |
| GCST000500 | Other erythrocyte phenotypes | 19862010 | Ganesh SK | 2009 |
| GCST004003 | Hematocrit | 28017375 | van Rooij FJA | 2016 |
| GCST001042 | Rheumatoid arthritis | 21505073 | Terao C | 2011 |
| GCST004986 | Idiopathic pulmonary fibrosis | 29066090 | Allen RJ | 2017 |
| GCST000066 | Crohn's disease | 17684544 | Franke A | 2007 |
| GCST008161 | Waist circumference adjusted for body mass index | 28552196 | Tachmazidou I | 2017 |
| GCST002998 | Lobe attachment | 26105758 | Adhikari K | 2015 |
| GCST000753 | Metabolic syndrome | 20694148 | Zabaneh D | 2010 |
| GCST007605 | Glycated hemoglobin levels in type 1 diabetes | 30674623 | Syreeni A | 2019 |
| GCST000404 | Menarche \(age at onset\) | 19448620 | Perry JR | 2009 |
| GCST003230 | Survival in colorectal cancer \(distant metastatic\) | 26586795 | Phipps AI | 2015 |
| GCST000933 | C-reactive protein | 21196492 | Okada Y | 2010 |
| GCST000414 | Testicular germ cell tumor | 19483681 | Rapley EA | 2009 |
| GCST004352 | Early onset atrial fibrillation | 28460022 | Lee JY | 2017 |
| GCST001706 | Stroke \(ischemic\) | 23041239 | Traylor M | 2012 |
| GCST002288 | Large artery stroke | 24262325 | Dichgans M | 2013 |
| GCST001130 | Obesity | 21708048 | Jiao H | 2011 |
| GCST000388 | Bilirubin levels | 19419973 | Sanna S | 2009 |
| GCST006537 | Subcutaneous adipose tissue | 27918534 | Chu AY | 2016 |
| GCST001887 | Monocyte count | 23314186 | Crosslin DR | 2013 |
| GCST007595 | Appendicitis | 30392061 | Orlova E | 2018 |
| GCST001455 | Kawasaki disease | 22446962 | Onouchi Y | 2012 |
| GCST000815 | Non-small cell lung cancer | 20876614 | Yoon KA | 2010 |
| GCST005190 | Nonalcoholic fatty liver disease | 29271184 | Chung GE | 2017 |
| GCST003377 | Venous thromboembolism | 26888256 | Hernandez W | 2016 |
| GCST002111 | Personality dimensions | 23903073 | Kim HN | 2013 |
| GCST002324 | Anger | 24489884 | Mick E | 2014 |
| GCST002404 | Longevity \(90 years and older\) | 24688116 | Deelen J | 2014 |
| GCST002703 | Prostate-specific antigen levels | 25434496 | Kim S | 2014 |
| GCST001310 | Allergic rhinitis | 22036096 | Ramasamy A | 2011 |
| GCST002556 | White blood cell count | 25096241 | Keller MF | 2014 |
| GCST001363 | Atopic dermatitis | 22197932 | Paternoster L | 2011 |
| GCST000457 | Fasting plasma glucose | 19651812 | Chambers JC | 2009 |
| GCST002477 | Alcohol dependence \(age at onset\) | 24962325 | Kapoor M | 2014 |
| GCST003605 | EGFR mutation-positive lung adenocarcinoma | 27501781 | Shiraishi K | 2016 |
| GCST000162 | Breast cancer | 18326623 | Gold B | 2008 |
| GCST000251 | Male-pattern baldness | 18849994 | Hillmer AM | 2008 |
| GCST008166 | Mean corpuscular volume | 31194788 | Read RW | 2019 |
| GCST004008 | Red blood cell count | 28017375 | van Rooij FJA | 2016 |
| GCST000763 | Immunoglobulin A | 20694011 | Ferreira RC | 2010 |
| GCST000048 | Celiac disease | 17558408 | van Heel DA | 2007 |
| GCST005541 | Sarcoidosis \(Lofgren's syndrome vs non-Lofgren's syndrome\) | 26651848 | Rivera NV | 2016 |
| GCST002423 | Autoimmune hepatitis type-1 | 24768677 | de Boer YS | 2014 |
| GCST005879 | Collagenous colitis | 26525574 | Westerlind H | 2015 |
| GCST007336 | Age at first birth | 27089180 | Day FR | 2016 |
| GCST003739 | Esophageal adenocarcinoma | 27527254 | Gharahkhani P | 2016 |
| GCST002071 | Retinal arteriolar caliber | 23776548 | Sim X | 2013 |
| GCST002855 | Testicular germ cell tumor | 25877299 | Kristiansen W | 2015 |
| GCST007233 | Fragile X syndrome | 30531935 | Crowley JJ | 2018 |
| GCST003879 | Serum parathyroid hormone levels | 27927781 | Robinson-Cohen C | 2016 |
| GCST000429 | Kidney stones | 19561606 | Thorleifsson G | 2009 |
| GCST000239 | Stroke \(ischemic\) | 18991354 | Gretarsdottir S | 2008 |
| GCST003257 | Ischemic stroke \(cardioembolic\) | 26708676 | Pulit SL | 2015 |
| GCST003191 | Vitamin D levels | 26704534 | Sapkota BR | 2015 |
| GCST007352 | Focal epilepsy | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST001782 | Mean corpuscular hemoglobin concentration | 23263863 | Li J | 2012 |
| GCST001908 | Pulmonary arterial hypertension \(without BMPR2 mutations\) | 23502781 | Germain M | 2013 |
| GCST005906 | Endometriosis or endometrial cancer \(pleiotropy\) | 29608257 | Painter JN | 2018 |
| GCST004126 | White blood cell count | 28158719 | Jain D | 2017 |
| GCST002226 | Fat body mass | 24064335 | Pei YF | 2013 |
| GCST008147 | Response to allopurinol in gout \(change in serum uric acid levels\) | 30924126 | Brackman DJ | 2019 |
| GCST001269 | Serum uric acid levels | 21983786 | Sulem P | 2011 |
| GCST001268 | Gout | 21983786 | Sulem P | 2011 |
| GCST005799 | Gout | 29453348 | Chen CJ | 2018 |
| GCST006905 | Serum uric acid levels | 30305239 | Macias-Kauffer LR | 2018 |
| GCST006036 | Psoriasis vulgaris | 29031612 | Hirata J | 2017 |
| GCST001146 | Systemic sclerosis | 21750679 | Allanore Y | 2011 |
| GCST001681 | Rheumatoid arthritis | 23028356 | Myouzen K | 2012 |
| GCST000599 | Soluble levels of adhesion molecules | 20167578 | Barbalic M | 2010 |
| GCST001894 | Endometriosis | 23472165 | Albertsen HM | 2013 |
| GCST001177 | Plasma omega-3 polyunsaturated fatty acid levels \(docosahexaenoic acid\) | 21829377 | Lemaitre RN | 2011 |
| GCST006549 | Subcutaneous adipose tissue attenuation \(Hounsfield unit scale\) | 27918534 | Chu AY | 2016 |
| GCST000219 | Type 2 diabetes | 18711367 | Yasuda K | 2008 |
| GCST002317 | Type 2 diabetes | 24390345 | Williams AL | 2013 |
| GCST000221 | Type 2 diabetes | 18711366 | Unoki H | 2008 |
| GCST003494 | Colorectal cancer | 27145994 | Wang M | 2016 |
| GCST007384 | Plasma free proline levels | 30659259 | Imaizumi A | 2019 |
| GCST006293 | Response to olanzapine in schizophrenia | 29503163 | Yu H | 2018 |
| GCST000023 | Crohn's disease | 17435756 | Rioux JD | 2007 |
| GCST001407 | Ewing sarcoma | 22327514 | Postel-Vinay S | 2012 |
| GCST002560 | Type 2 diabetes | 25102180 | Ng MC | 2014 |
| GCST002623 | L-arginine levels | 25245031 | Luneburg N | 2014 |
| GCST004130 | White blood cell count \(lymphocyte\) | 28158719 | Jain D | 2017 |
| GCST002255 | Inflammatory biomarkers | 24182552 | Matteini AM | 2013 |
| GCST005011 | Yeast infection | 28928442 | Tian C | 2017 |
| GCST000222 | IgE levels | 18846228 | Weidinger S | 2008 |
| GCST003902 | Fast beta electroencephalogram | 28040410 | Meyers JL | 2016 |
| GCST002620 | Asymmetrical dimethylarginine levels | 25245031 | Luneburg N | 2014 |
| GCST004923 | Tuberculosis | 29036319 | Qi H | 2017 |
| GCST001219 | Graves' disease | 21900946 | Nakabayashi K | 2011 |
| GCST003185 | Nicotine dependence | 26440539 | Hancock DB | 2015 |
| GCST002731 | Endothelial growth factor levels | 25552591 | Lieb W | 2014 |
| GCST001711 | Protein biomarker | 23056639 | de Boer RA | 2012 |
| GCST000547 | Orofacial clefts | 20023658 | Mangold E | 2009 |
| GCST005669 | Delta-6 desaturase activity response to n3-polyunsaturated fat supplement | 29246731 | de Toro-Martin J | 2017 |
| GCST004758 | Type 2 diabetes | 28254843 | Qi Q | 2017 |
| GCST000438 | Cutaneous nevi | 19578365 | Falchi M | 2009 |
| GCST001683 | Breast cancer | 22976474 | Siddiq A | 2012 |
| GCST004813 | Laterality in neovascular age-related macular degeneration | 28775256 | Kawashima-Kumagai K | 2017 |
| GCST001718 | Multiple cancers \(lung cancer, gastric cancer, and squamous cell carcinoma\) | 23103227 | Jin G | 2012 |
| GCST005037 | Appendicular lean mass | 28724990 | Zillikens MC | 2017 |
| GCST005315 | Acute lymphoblastic leukemia \(childhood\) | 29348612 | Wiemels JL | 2018 |
| GCST004010 | QT interval \(tricyclic/tetracyclic antidepressant use interaction\) | 28039329 | Noordam R | 2016 |
| GCST001685 | Primary biliary cholangitis | 23000144 | Nakamura M | 2012 |
| GCST000454 | Bladder cancer | 19648920 | Wu X | 2009 |
| GCST000842 | Bladder cancer | 20972438 | Rothman N | 2010 |
| GCST001573 | Prothrombin time | 22703881 | Tang W | 2012 |
| GCST000539 | Type 1 diabetes | 19966805 | Wallace C | 2009 |
| GCST002275 | Asthma \(childhood onset\) | 24241537 | Bonnelykke K | 2013 |
| GCST002353 | Parkinson's disease | 24511991 | Hill-Burns EM | 2014 |
| GCST006300 | Smoking behaviour \(maximum cigarettes in a 24 hour period\) | 29532581 | Hallfors J | 2018 |
| GCST001091 | Bilirubin levels | 21646302 | Bielinski SJ | 2011 |
| GCST003304 | HDL cholesterol | 26780889 | Below JE | 2016 |
| GCST000046 | Alzheimer's disease \(late onset\) | 17553421 | Reiman EM | 2007 |
| GCST001880 | Addiction | 23533358 | Liu Z | 2013 |
| GCST007001 | Cerebrospinal AB1-42 levels in normal cognition | 29274321 | Chung J | 2017 |
| GCST002342 | Asthma \(corticosteroid response\) | 24486069 | Park HW | 2014 |
| GCST001838 | Palmitic acid \(16:0\) levels | 23362303 | Wu JH | 2013 |
| GCST002424 | C-reactive protein levels | 24763700 | Vinayagamoorthy N | 2014 |
| GCST000415 | Drug-induced liver injury \(flucloxacillin\) | 19483685 | Daly AK | 2009 |
| GCST000308 | AIDS progression | 19115949 | Limou S | 2009 |
| GCST000549 | HIV-1 control | 20041166 | Fellay J | 2009 |
| GCST000529 | Ulcerative colitis | 19915573 | Asano K | 2009 |
| GCST001740 | Lung cancer | 23143601 | Lan Q | 2012 |
| GCST004276 | Plasma thyroid-stimulating hormone levels | 28333968 | Nielsen TR | 2017 |
| GCST003974 | Tonsillectomy | 27941131 | Feenstra B | 2016 |
| GCST004007 | Mean corpuscular hemoglobin concentration | 28017375 | van Rooij FJA | 2016 |
| GCST002199 | Follicule stimulating hormone | 24049095 | Chen Z | 2013 |
| GCST007197 | Chronic periodontitis \(localised\) | 30284742 | Bevilacqua L | 2018 |
| GCST001378 | Hemostatic factors and hematological phenotypes | 22443383 | Oudot-Mellakh T | 2012 |
| GCST007302 | Breast cancer in BRCA2 mutation carriers | 23544012 | Gaudet MM | 2013 |
| GCST003643 | Nose morphology | 27560520 | Shaffer JR | 2016 |
| GCST004092 | Plasma t-tau levels | 28100725 | Chen J | 2017 |
| GCST003971 | Pericardial fat | 27918534 | Chu AY | 2016 |
| GCST006056 | Fructosamine levels | 29844224 | Loomis SJ | 2018 |
| GCST001862 | Sickle cell anemia \(haemolysis\) | 23406172 | Milton JN | 2013 |
| GCST003196 | Calcaneal bone ultrasound measurement \(speed of sound\) | 26686025 | Hwang JY | 2015 |
| GCST005707 | Neutralising antibody response to interferon beta therapy in multiple sclerosis \(mean antibody levels\) | 29521573 | Buck D | 2018 |
| GCST005708 | Neutralising antibody response to interferon beta therapy in multiple sclerosis \(area under the curve for the first two years\) | 29521573 | Buck D | 2018 |
| GCST005709 | Neutralising antibody response to interferon beta therapy in multiple sclerosis \(maximum antibody levels\) | 29521573 | Buck D | 2018 |
| GCST002426 | Puberty onset \(genital enlargement\) | 24770850 | Cousminer DL | 2014 |
| GCST001215 | Coffee consumption | 21876539 | Amin N | 2011 |
| GCST001032 | Caffeine consumption | 21490707 | Cornelis MC | 2011 |
| GCST000992 | Coffee consumption | 21357676 | Sulem P | 2011 |
| GCST006067 | Glaucoma \(primary open-angle\) | 29891935 | Choquet H | 2018 |
| GCST005388 | Glaucoma \(primary open-angle\) | 29452408 | Shiga Y | 2018 |
| GCST007115 | Cholesterol efflux capacity \(cAMP stimulated assay\) | 30369316 | Low-Kam C | 2018 |
| GCST004704 | Cardiovascular risk factors | 20838585 | Smith EN | 2010 |
| GCST003617 | Response to statins \(HDL cholesterol change\) | 27587472 | Postmus I | 2016 |
| GCST007246 | Latent autoimmune diabetes vs. type 2 diabetes | 30254083 | Cousminer DL | 2018 |
| GCST001611 | Myasthenia gravis | 23055271 | Gregersen PK | 2012 |
| GCST000679 | Rheumatoid arthritis | 20453842 | Stahl EA | 2010 |
| GCST006051 | Idiopathic inflammatory myopathy | 26362759 | Rothwell S | 2015 |
| GCST006052 | Polymyositis | 26362759 | Rothwell S | 2015 |
| GCST005525 | Hashimoto thyroiditis | 22922229 | Cooper JD | 2012 |
| GCST000452 | QT interval | 20031603 | Marroni F | 2009 |
| GCST002533 | QRS duration | 25035420 | Hong KW | 2014 |
| GCST000643 | Response to antidepressants | 20360315 | Uher R | 2010 |
| GCST003764 | Hirschsprung disease | 27702942 | Tang CS | 2016 |
| GCST006096 | Age spots | 29895819 | Endo C | 2018 |
| GCST003339 | Epstein Barr virus nuclear antigen 1 IgG levels | 26819262 | Zhou Y | 2016 |
| GCST001474 | Hypothyroidism | 22493691 | Eriksson N | 2012 |
| GCST000460 | Nasopharyngeal carcinoma | 19664746 | Tse KP | 2009 |
| GCST006407 | Philtrum width | 30067744 | Howe LJ | 2018 |
| GCST003046 | Trichloroethylene-induced hypersensitivity syndrome | 26190474 | Dai Y | 2015 |
| GCST005001 | Shingles | 28928442 | Tian C | 2017 |
| GCST001631 | Schizophrenia | 22883433 | Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2 | 2012 |
| GCST000553 | CD4:CD8 lymphocyte ratio | 20045101 | Ferreira MA | 2009 |
| GCST003793 | L-arginine levels | 27656708 | Zhang W | 2016 |
| GCST000836 | Psoriasis | 20953188 | Ellinghaus E | 2010 |
| GCST003380 | Bone mineral density \(spine\) | 26911590 | Mullin BH | 2016 |
| GCST002514 | Melanoma | 24980573 | Song F | 2014 |
| GCST005002 | Mononucleosis | 28928442 | Tian C | 2017 |
| GCST001041 | Hepatocellular carcinoma | 21499248 | Kumar V | 2011 |
| GCST000428 | Adiposity | 19557161 | Lindgren CM | 2009 |
| GCST006094 | Straight vs curly hair | 29895819 | Endo C | 2018 |
| GCST001889 | Brain connectivity | 23471985 | Jahanshad N | 2013 |
| GCST002458 | Serum thyroid-stimulating hormone levels | 24852370 | Zhan M | 2014 |
| GCST005413 | Type 2 diabetes | 29358691 | Bonas-Guarch S | 2018 |
| GCST001051 | Follicular lymphoma | 21533074 | Smedby KE | 2011 |
| GCST008110 | Insulinogenic index | 23263489 | Huyghe JR | 2012 |
| GCST002159 | Wegener's granulomatosis | 23740775 | Xie G | 2013 |
| GCST000398 | Hypertension | 19430479 | Levy D | 2009 |
| GCST005870 | Meningioma | 29762745 | Claus EB | 2018 |
| GCST006912 | Physical activity \(overall physical activity time\) | 30531941 | Doherty A | 2018 |
| GCST001593 | Cortical thickness | 22792071 | Zheng HF | 2012 |
| GCST001608 | Renal function-related traits \(urea\) | 22797727 | Okada Y | 2012 |
| GCST001881 | Myopia \(pathological\) | 23406873 | Shi Y | 2013 |
| GCST001853 | Circulating vasoactive peptide levels | 23381795 | Verweij N | 2013 |
| GCST000631 | Activated partial thromboplastin time | 20303064 | Houlihan LM | 2010 |
| GCST001239 | Stevens-Johnson syndrome and toxic epidermal necrolysis \(SJS-TEN\) | 21912425 | Tohkin M | 2011 |
| GCST004345 | Elevated serum prostate-specific antigen levels in healthy men | 28471803 | Choe EK | 2017 |
| GCST000701 | Testicular germ cell cancer | 20543847 | Turnbull C | 2010 |
| GCST001633 | Glioma | 22886559 | Rajaraman P | 2012 |
| GCST000761 | Lung adenocarcinoma | 20700438 | Hsiung CA | 2010 |
| GCST000238 | Idiopathic pulmonary fibrosis | 18835860 | Mushiroda T | 2008 |
| GCST000439 | Glioma | 19578367 | Shete S | 2009 |
| GCST001140 | Lung cancer | 21725308 | Hu Z | 2011 |
| GCST007305 | White matter hyperintensity volume | 30659137 | Traylor M | 2019 |
| GCST007217 | RR interval \(heart rate\) | 30679814 | van Setten J | 2019 |
| GCST001526 | Fasting blood insulin \(BMI interaction\) | 22581228 | Manning AK | 2012 |
| GCST002431 | Response to radiotherapy in cancer \(late toxicity\) | 24785509 | Barnett GC | 2014 |
| GCST007582 | Attention deficit hyperactivity disorder or putamen volume \(pleiotropy\) | 30818988 | Klein M | 2019 |
| GCST002743 | Neutrophil count in HIV-infection | 25884002 | Moore CB | 2015 |
| GCST004128 | White blood cell count \(neutrophil\) | 28158719 | Jain D | 2017 |
| GCST006987 | Neutrophil level response to clozapine in treatment-resistant schizophrenia | 30647433 | Legge SE | 2019 |
| GCST005579 | Low white blood cell count | 29596498 | Charles BA | 2018 |
| GCST005814 | Osteoarthritis \(hospital diagnosed\) | 29559693 | Zengini E | 2018 |
| GCST005812 | Osteoarthritis of the hip or knee \(hospital diagnosed\) | 29559693 | Zengini E | 2018 |
| GCST005957 | Waist-to-hip ratio adjusted for BMI \(age &lt;50\) | 26426971 | Winkler TW | 2015 |
| GCST002622 | Symmetrical dimethylarginine levels | 25245031 | Luneburg N | 2014 |
| GCST001503 | Electroencephalographic traits in alcoholism | 22554406 | Kang SJ | 2012 |
| GCST003518 | Daytime sleep phenotypes | 27126917 | Spada J | 2016 |
| GCST000687 | Nasopharyngeal carcinoma | 20512145 | Bei JX | 2010 |
| GCST003578 | Nasopharyngeal carcinoma | 27436580 | Cui Q | 2016 |
| GCST003967 | Visceral adipose tissue adjusted for BMI | 27918534 | Chu AY | 2016 |
| GCST003329 | Response to anti-TNF therapy in rheumatoid arthritis | 26776603 | Honne K | 2016 |
| GCST002241 | Asymmetrical dimethylarginine levels | 24159190 | Seppala I | 2013 |
| GCST002242 | Serum dimethylarginine levels \(asymmetric/symetric ratio\) | 24159190 | Seppala I | 2013 |
| GCST003775 | Lung cancer | 27393504 | Zanetti KA | 2016 |
| GCST003776 | Lung adenocarcinoma | 27393504 | Zanetti KA | 2016 |
| GCST001812 | Epstein-Barr virus immune response \(EBNA-1\) | 23326239 | Rubicz R | 2013 |
| GCST001150 | Hepatitis B | 21750111 | Mbarek H | 2011 |
| GCST000771 | Narcolepsy | 20711174 | Hor H | 2010 |
| GCST007984 | Daytime sleepiness | 30804565 | Jansen PR | 2019 |
| GCST007740 | Iris color \(a\* coordinate\) | 30895295 | Jonnalagadda M | 2019 |
| GCST004421 | beta-nerve growth factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST005945 | ADAMTS13 levels | 29296746 | Ma Q | 2017 |
| GCST005005 | Plantar warts | 28928442 | Tian C | 2017 |
| GCST008154 | Trunk fat mass | 28552196 | Tachmazidou I | 2017 |
| GCST003421 | Mosaic loss of chromosome Y | 27064253 | Zhou W | 2016 |
| GCST006309 | Post bronchodilator percent predicted FEV1 in smoking | 30068317 | Li X | 2018 |
| GCST003976 | Antineutrophil cytoplasmic antibody-associated vasculitis | 28029757 | Merkel PA | 2016 |
| GCST004940 | Alanine transaminase levels | 28887542 | Prins BP | 2017 |
| GCST006310 | Post bronchodilator FEV1/FVC ratio in smoking | 30068317 | Li X | 2018 |
| GCST005309 | Nonalcoholic steatohepatitis-derived hepatocellular carcinoma | 29385134 | Kawaguchi T | 2018 |
| GCST001928 | Pediatric non-alcoholic fatty liver disease activity score | 23535911 | Kitamoto T | 2013 |
| GCST000876 | Amyloid A serum levels | 21124955 | Marzi C | 2010 |
| GCST004359 | Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer | 28429243 | Dudenkov TM | 2017 |
| GCST000993 | Vascular dementia | 23480133 | Kim Y | 2011 |
| GCST004162 | Carotid plaque burden | 28282560 | Pott J | 2017 |
| GCST002492 | Bone mineral density \(paediatric, lower limb\) | 24945404 | Kemp JP | 2014 |
| GCST001595 | Bone mineral density | 22792071 | Zheng HF | 2012 |
| GCST002334 | Bone properties \(heel\) | 24430505 | Moayyeri A | 2014 |
| GCST004941 | Dehydroepiandrosterone sulphate levels | 28887542 | Prins BP | 2017 |
| GCST001175 | Epirubicin-induced leukopenia | 21799462 | Srinivasan Y | 2011 |
| GCST003542 | Night sleep phenotypes | 27126917 | Spada J | 2016 |
| GCST002742 | Marginal zone lymphoma | 25569183 | Vijai J | 2015 |
| GCST005940 | Maximum cranial width | 29698431 | Roosenboom J | 2018 |
| GCST000478 | Type 2 diabetes | 19734900 | Rung J | 2009 |
| GCST001128 | Adiposity | 21706003 | Kilpelainen TO | 2011 |
| GCST003301 | Triglycerides | 26780889 | Below JE | 2016 |
| GCST004899 | Gestational age at birth \(maternal effect\) | 28877031 | Zhang G | 2017 |
| GCST000672 | Paget's disease | 20436471 | Albagha OM | 2010 |
| GCST003428 | Chronotype | 26835600 | Hu Y | 2016 |
| GCST002389 | Intracerebral hemorrhage | 24656865 | Woo D | 2014 |
| GCST001172 | Asthma | 21814517 | Noguchi E | 2011 |
| GCST000623 | Ulcerative colitis | 20228798 | Franke A | 2010 |
| GCST000243 | Ulcerative colitis | 18836448 | Franke A | 2008 |
| GCST001582 | Hepatitis B \(viral clearance\) | 22737229 | Nishida N | 2012 |
| GCST001181 | Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis \(SJS/TEN\) | 21801394 | Genin E | 2011 |
| GCST000738 | Neonatal lupus | 20662065 | Clancy RM | 2010 |
| GCST003143 | Lung disease severity in cystic fibrosis | 26417704 | Corvol H | 2015 |
| GCST000257 | Lung cancer | 18978787 | Wang Y | 2008 |
| GCST001903 | Central corneal thickness | 23493294 | Gao X | 2013 |
| GCST003334 | Length of menstrual cycle | 26732621 | Ruth KS | 2016 |
| GCST001627 | Thyrotoxic hypokalemic periodic paralysis | 22863731 | Cheung CL | 2012 |
| GCST001156 | Systemic sclerosis | 21779181 | Gorlova O | 2011 |
| GCST006053 | Dermatomyositis or juvenile dermatomyositis | 26362759 | Rothwell S | 2015 |
| GCST004165 | Acute-on-chronic liver failure in hepatitis B | 28130311 | Tan W | 2017 |
| GCST001815 | Hepatitis C induced liver cirrhosis | 23321320 | Urabe Y | 2013 |
| GCST000735 | Lumiracoxib-related liver injury | 20639878 | Singer JB | 2010 |
| GCST001459 | Multiple sclerosis | 22457343 | Martinelli-Boneschi F | 2012 |
| GCST000252 | Multiple sclerosis | 18941528 | Comabella M | 2008 |
| GCST005540 | Sarcoidosis \(Lofgren's syndrome\) | 26651848 | Rivera NV | 2016 |
| GCST006696 | Parental longevity \(mother's attained age\) | 29227965 | Pilling LC | 2017 |
| GCST002246 | Hepatitis B | 24162738 | Hu Z | 2013 |
| GCST002302 | IgE levels | 24324648 | Yatagai Y | 2013 |
| GCST005009 | Pneumonia | 28928442 | Tian C | 2017 |
| GCST001614 | Central corneal thickness | 22814818 | Hoehn R | 2012 |
| GCST001278 | Dengue shock syndrome | 22001756 | Khor CC | 2011 |
| GCST001979 | Circulating myeloperoxidase levels \(serum\) | 23620142 | Reiner AP | 2013 |
| GCST002425 | Puberty onset | 24770850 | Cousminer DL | 2014 |
| GCST000405 | Menarche \(age at onset\) | 19448623 | Ong KK | 2009 |
| GCST000400 | Menarche \(age at onset\) | 19448622 | Sulem P | 2009 |
| GCST003208 | Colorectal or endometrial cancer | 26621817 | Cheng TH | 2015 |
| GCST000915 | Primary sclerosing cholangitis | 21151127 | Melum E | 2010 |
| GCST002410 | Osteoarthritis \(hand, severe\) | 24728293 | Styrkarsdottir U | 2014 |
| GCST007848 | LDL cholesterol | 24507774 | Peloso GM | 2014 |
| GCST000321 | Psoriasis | 19169255 | Zhang XJ | 2009 |
| GCST001992 | Vitiligo \(non-segmental\) | 23678272 | Cheong KA | 2013 |
| GCST000645 | Glaucoma | 20363506 | Meguro A | 2010 |
| GCST003774 | Urinary albumin-to-creatinine ratio | 27650483 | Kramer HJ | 2016 |
| GCST001384 | Systemic lupus erythematosus | 22291604 | Okada Y | 2012 |
| GCST006306 | HDL cholesterol | 29404214 | Andaleon A | 2018 |
| GCST007926 | Medication use \(antihypertensives\) | 31015401 | Wu Y | 2019 |
| GCST000342 | Mean platelet volume | 19221038 | Soranzo N | 2009 |
| GCST006247 | Pediatric areal bone mineral density \(radius vs spine & hip discordant skeletal phenotype\) | 29240982 | Mitchell JA | 2017 |
| GCST000765 | Non-alcoholic fatty liver disease histology \(other\) | 20708005 | Chalasani N | 2010 |
| GCST007780 | Parkinson's disease \(age of onset\) | 30957308 | Blauwendraat C | 2019 |
| GCST004161 | Vitamin B12 levels | 28334792 | Nongmaithem SS | 2017 |
| GCST006058 | Total glycated albumin levels | 29844224 | Loomis SJ | 2018 |
| GCST002283 | Amyotrophic lateral sclerosis \(sporadic\) | 24256812 | Fogh I | 2013 |
| GCST004177 | Pediatric bone mineral density \(femoral neck\) | 28181694 | Chesi A | 2017 |
| GCST002575 | Body mass index \(change over time\) | 25133637 | Scannell Bryan M | 2014 |
| GCST004175 | Pediatric bone mineral content \(radius\) | 28181694 | Chesi A | 2017 |
| GCST007406 | Healthspan | 30729179 | Zenin A | 2019 |
| GCST002522 | Reading or mathematical ability | 25003214 | Davis OS | 2014 |
| GCST005211 | Nodular sclerosis Hodgkin lymphoma | 29196614 | Sud A | 2017 |
| GCST004071 | Cerebrospinal T-tau levels | 28247064 | Deming Y | 2017 |
| GCST003625 | diarrhoeal disease at age 1 with doctor diagnosis | 27559109 | Bustamante M | 2016 |
| GCST002886 | Prostate cancer aggressiveness | 25939597 | Berndt SI | 2015 |
| GCST003122 | Hemoglobin levels | 26366553 | Danjou F | 2015 |
| GCST000194 | Blond vs. brown hair color | 18488028 | Sulem P | 2008 |
| GCST003943 | Hepcidin levels | 27846281 | Galesloot TE | 2016 |
| GCST003675 | Obstructive sleep apnea trait \(average respiratory event duration\) | 26977737 | Cade BE | 2016 |
| GCST002528 | Colorectal cancer | 25023989 | Schmit SL | 2014 |
| GCST008264 | Psychological wellbeing index 12 \(lack of enjoying daily life\) | 31003110 | Kim S | 2019 |
| GCST005144 | Tacrolimus trough concentration in kidney transplant patients | 29160300 | Oetting WS | 2017 |
| GCST002406 | Plasma cystastin c levels in acute coronary syndrome | 24952865 | Akerblom A | 2014 |
| GCST000855 | Parkinson's disease | 21044948 | Spencer CC | 2010 |
| GCST002900 | Obesity in adult survivors of childhood cancer exposed to cranial radiation | 25963547 | Wilson CL | 2015 |
| GCST005185 | Fasting blood insulin | 22581228 | Manning AK | 2012 |
| GCST005276 | Dementia with Lewy bodies | 29263008 | Guerreiro R | 2018 |
| GCST000571 | Fasting blood insulin | 20081858 | Dupuis J | 2010 |
| GCST005179 | Homeostasis model assessment of insulin resistance | 20081858 | Dupuis J | 2010 |
| GCST003798 | Acute lymphoblastic leukemia in childhood \(B cell precursor\) | 27694927 | Vijayakrishnan J | 2016 |
| GCST002920 | Neuroticism | 25993607 | de Moor MH | 2015 |
| GCST005761 | Immunoglobulin M against phosphorylcholine \(IgM anti-PC\) levels | 29547969 | Chen X | 2018 |
| GCST005124 | Urinary magnesium-to-creatinine ratio | 29093028 | Corre T | 2017 |
| GCST005391 | Tooth agenesis \(maxillary lateral incisors\) | 29364747 | Jonsson L | 2018 |
| GCST006154 | Frontotemporal dementia | 29724592 | Pottier C | 2018 |
| GCST005008 | Scarlet fever | 28928442 | Tian C | 2017 |
| GCST006536 | Serum erythropoietin levels | 30271932 | Oskarsson GR | 2018 |
| GCST006747 | Oxygenated hemoglobin levels | 30188897 | Jeong C | 2018 |
| GCST005369 | Serum uric acid levels | 29408531 | Zhang D | 2018 |
| GCST002733 | Platelet count | 25705162 | Oh JH | 2014 |
| GCST000182 | Bone mineral density | 18455228 | Richards JB | 2008 |
| GCST006105 | Eye morphology | 29921221 | Cha S | 2018 |
| GCST001561 | Myopia \(pathological\) | 22685421 | Fan Q | 2012 |
| GCST000875 | Coronary heart disease | 21088011 | Erdmann J | 2010 |
| GCST002453 | Ulcerative colitis | 24837172 | Juyal G | 2014 |
| GCST001987 | Age-related macular degeneration \(extreme sampling\) | 23577725 | Naj AC | 2013 |
| GCST005365 | Serum C3d:C3 ratio \(systemic complement activation\) | 29398083 | Lores-Motta L | 2018 |
| GCST005207 | Midregional pro atrial natriuretic peptide levels | 29237677 | Salo PP | 2017 |
| GCST004170 | Monocyte-lymphocyte ratio | 28193307 | Lin BD | 2017 |
| GCST004482 | Peripheral arterial disease \(traffic-related air pollution interaction\) | 27082954 | Ward-Caviness CK | 2016 |
| GCST002155 | Osteoarthritis \(hip\) | 23989986 | Evangelou E | 2013 |
| GCST000070 | Rheumatoid arthritis | 17804836 | Plenge RM | 2007 |
| GCST000546 | Leprosy | 20018961 | Zhang FR | 2009 |
| GCST000377 | HDL cholesterol | 19359809 | Hiura Y | 2009 |
| GCST003363 | HDL cholesterol levels | 26763881 | Kurano M | 2016 |
| GCST001025 | Alzheimer's disease | 21460840 | Hollingworth P | 2011 |
| GCST000777 | Esophageal cancer and gastric cancer | 20729852 | Abnet CC | 2010 |
| GCST000963 | Uric acid levels | 21294900 | Charles BA | 2011 |
| GCST005209 | Hodgkin's lymphoma | 29196614 | Sud A | 2017 |
| GCST002475 | Myocardial infarction | 24916648 | Hirokawa M | 2014 |
| GCST001563 | Migraine | 22683712 | Freilinger T | 2012 |
| GCST000408 | Primary biliary cholangitis | 19458352 | Hirschfield GM | 2009 |
| GCST000574 | Pancreatic cancer | 20101243 | Petersen GM | 2010 |
| GCST005798 | Sperm motility | 29453196 | Sato Y | 2018 |
| GCST000148 | Recombination rate \(males\) | 18239089 | Kong A | 2008 |
| GCST004372 | Language performance in older adults \(adjusted for episodic memory\) | 28577822 | Deters KD | 2017 |
| GCST001550 | Type 2 diabetes | 22693455 | Perry JR | 2012 |
| GCST000168 | Colorectal cancer | 18372901 | Tenesa A | 2008 |
| GCST000001 | Age-related macular degeneration | 15761122 | Klein RJ | 2005 |
| GCST002237 | Hodgkin's lymphoma | 24149102 | Frampton M | 2013 |
| GCST004214 | Creatinine levels | 28270201 | Nagy R | 2017 |
| GCST000455 | Ovarian cancer | 19648919 | Song H | 2009 |
| GCST008112 | Proinsulin levels \(early-phase conversion\) | 23263489 | Huyghe JR | 2012 |
| GCST002158 | Acute lymphoblastic leukemia \(B-cell precursor\) | 23996088 | Migliorini G | 2013 |
| GCST002713 | Acute lymphoblastic leukemia \(adolescents and young adults\) | 25468567 | Perez-Andreu V | 2014 |
| GCST000067 | Glaucoma \(exfoliation\) | 17690259 | Thorleifsson G | 2007 |
| GCST003636 | lower facial morphology traits \(quantitative measurement\) | 27193062 | Adhikari K | 2016 |
| GCST002994 | Ear protrusion | 26105758 | Adhikari K | 2015 |
| GCST006093 | Thick vs thin eyebrows | 29895819 | Endo C | 2018 |
| GCST000580 | Platelet count | 20139978 | Kamatani Y | 2010 |
| GCST008168 | Platelet count | 31194788 | Read RW | 2019 |
| GCST003760 | Pre-treatment pain in head and neck squamous cell carcinoma | 27670397 | Reyes-Gibby CC | 2016 |
| GCST004202 | Systemic sclerosis | 28314753 | Terao C | 2017 |
| GCST000906 | Chronic lymphocytic leukemia | 21131588 | Slager SL | 2010 |
| GCST000058 | Restless legs syndrome | 17634447 | Stefansson H | 2007 |
| GCST002983 | Alzheimer's disease \(late onset\) | 26339675 | Tosto G | 2015 |
| GCST008153 | Lean body mass | 28552196 | Tachmazidou I | 2017 |
| GCST008170 | Thyroglobulin plasma levels | 30929638 | Matana A | 2019 |
| GCST000318 | Basal cell carcinoma | 19151717 | Rafnar T | 2009 |
| GCST003613 | Hypertension | 27480026 | Liu X | 2016 |
| GCST002933 | Magnesium levels | 26058915 | Tin A | 2015 |
| GCST002025 | Cystic fibrosis-related diabetes | 23670970 | Blackman SM | 2013 |
| GCST005946 | Cleft palate | 27018472 | Leslie EJ | 2016 |
| GCST001226 | Asthma | 21907864 | Ferreira MA | 2011 |
| GCST002649 | Nicotine glucouronidation | 25293881 | Patel YM | 2014 |
| GCST000463 | Acute lymphoblastic leukemia \(childhood\) | 19684604 | Papaemmanuil E | 2009 |
| GCST000694 | Phytosterol levels | 20529992 | Teupser D | 2010 |
| GCST002415 | Colorectal cancer \(diet interaction\) | 24743840 | Figueiredo JC | 2014 |
| GCST006425 | Gout in chronic kidney disease | 30181573 | Jing J | 2018 |
| GCST001846 | Bilirubin levels | 23371916 | Dai X | 2013 |
| GCST000386 | Bilirubin levels | 19414484 | Johnson AD | 2009 |
| GCST000213 | Response to statin therapy | 18650507 | Link E | 2008 |
| GCST001770 | Methotrexate clearance \(acute lymphoblastic leukemia\) | 23233662 | Ramsey LB | 2012 |
| GCST000793 | Glaucoma \(primary open-angle\) | 20835238 | Thorleifsson G | 2010 |
| GCST002012 | Venous thromboembolism | 23650146 | Tang W | 2013 |
| GCST004124 | Factor XI | 28053049 | Sennblad B | 2017 |
| GCST007946 | Psychological resilience \(self-assessed\) | 31081985 | Stein MB | 2019 |
| GCST000762 | Meningococcal disease | 20694013 | Davila S | 2010 |
| GCST001483 | Intracranial volume | 22504418 | Ikram MA | 2012 |
| GCST002371 | Parent of origin effect on language impairment \(paternal\) | 24571439 | Nudel R | 2014 |
| GCST007280 | Number of twin births | 30760885 | Mbarek H | 2019 |
| GCST000742 | Chronic kidney disease and serum creatinine levels | 20686651 | Gudbjartsson DF | 2010 |
| GCST007012 | Cerebrospinal fluid AB1-42 levels | 29274321 | Chung J | 2017 |
| GCST006998 | Cerebrospinal fluid p-tau levels in mild cognitive impairment | 29274321 | Chung J | 2017 |
| GCST003073 | Cerebral amyloid deposition \(PET imaging\) | 26252872 | Li QS | 2015 |
| GCST006997 | Cerebrospinal fluid t-tau levels in mild cognitive impairment | 29274321 | Chung J | 2017 |
| GCST007009 | Hippocampal volume | 29274321 | Chung J | 2017 |
| GCST007011 | Logical memory \(immediate recall\) | 29274321 | Chung J | 2017 |
| GCST002591 | Lewy body disease | 25188341 | Beecham GW | 2014 |
| GCST007008 | Cerebrospinal fluid p-tau levels | 29274321 | Chung J | 2017 |
| GCST003077 | Cerebral amyloid deposition positivity \(PET imaging\) | 26252872 | Li QS | 2015 |
| GCST007010 | Logical memory \(delayed recall\) | 29274321 | Chung J | 2017 |
| GCST006996 | Cerebrospinal AB1-42 levels in mild cognitive impairment | 29274321 | Chung J | 2017 |
| GCST007007 | Cerebrospinal fluid t-tau levels | 29274321 | Chung J | 2017 |
| GCST006699 | Parental longevity \(mother's age at death\) | 29227965 | Pilling LC | 2017 |
| GCST004127 | White blood cell count \(basophil\) | 28158719 | Jain D | 2017 |
| GCST000764 | Tuberculosis | 20694014 | Thye T | 2010 |
| GCST005112 | Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy | 29059430 | Morton LM | 2017 |
| GCST000565 | Angiotensin-converting enzyme activity | 20066004 | Chung CM | 2010 |
| GCST005000 | Cold sores | 28928442 | Tian C | 2017 |
| GCST000669 | Telomere length | 20421499 | Levy D | 2010 |
| GCST000151 | LDL cholesterol | 18262040 | Sandhu MS | 2008 |
| GCST002403 | Longevity \(85 years and older\) | 24688116 | Deelen J | 2014 |
| GCST004920 | LDL cholesterol levels | 17463246 | Saxena R | 2007 |
| GCST001040 | Endometrial cancer | 21499250 | Spurdle AB | 2011 |
| GCST002367 | Social communication problems | 24564958 | St Pourcain B | 2014 |
| GCST001703 | Apolipoprotein Levels | 23031429 | Surakka I | 2012 |
| GCST007116 | Cholesterol efflux capacity \(ABCA-1 dependent assay\) | 30369316 | Low-Kam C | 2018 |
| GCST004243 | LDL cholesterol levels | 28371326 | Zhu Y | 2017 |
| GCST005125 | Serum magnesium levels | 29093028 | Corre T | 2017 |
| GCST002987 | Stroke | 26089329 | Carty CL | 2015 |
| GCST000416 | Testicular cancer | 19483682 | Kanetsky PA | 2009 |
| GCST005231 | Major depressive disorder | 29317602 | Hall LS | 2018 |
| GCST004028 | Immunoglobulin light chain \(AL\) amyloidosis | 28025584 | da Silva Filho MI | 2016 |
| GCST000047 | Type 2 diabetes | 17554300 | Wellcome Trust Case Control Consortium | 2007 |
| GCST004661 | Uveal melanoma | 28781888 | Mobuchon L | 2017 |
| GCST004456 | Interferon gamma levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST006420 | Affective disorder and suicide attempts | 30116032 | Erlangsen A | 2018 |
| GCST008144 | Fasting plasma glucose | 31170924 | Kong S | 2019 |
| GCST001603 | Hepatocellular carcinoma | 22807686 | Li S | 2012 |
| GCST008118 | Suicide attempts in major depressive disorder | 31164008 | Mullins N | 2019 |
| GCST000582 | Mean corpuscular hemoglobin concentration | 20139978 | Kamatani Y | 2010 |
| GCST001594 | Bone mineral density | 22792070 | Medina-Gomez C | 2012 |
| GCST004367 | Anorexia nervosa | 28494655 | Duncan L | 2017 |
| GCST007343 | Epilepsy | 30531953 | International League Against Epilepsy Consortium on Complex Epilepsies | 2018 |
| GCST006246 | Childhood steroid-sensitive nephrotic syndrome | 30012571 | Jia X | 2018 |
| GCST000358 | Folate pathway vitamin levels | 19303062 | Tanaka T | 2009 |
| GCST002663 | Superior frontal gyrus grey matter volume | 25335168 | Hashimoto R | 2014 |
| GCST001062 | Glaucoma | 21532571 | Burdon KP | 2011 |
| GCST008257 | Diverticular disease | 28585551 | Sigurdsson S | 2017 |
| GCST008256 | Diverticulitis | 28585551 | Sigurdsson S | 2017 |
| GCST000984 | Idiopathic membranous nephropathy | 21323541 | Stanescu HC | 2011 |
| GCST001132 | Sudden cardiac arrest | 21738491 | Arking DE | 2011 |
| GCST007717 | Urinary sodium to potassium ratio | 30910378 | Zanetti D | 2019 |
| GCST000199 | Thyroid stimulating hormone levels | 18514160 | Arnaud-Lopez L | 2008 |
| GCST002813 | Alzheimer's disease in APOE e4+ carriers | 25778476 | Jun G | 2015 |
| GCST002810 | Tuberculosis | 25774636 | Curtis J | 2015 |
| GCST006387 | Thyroid nodules | 30099483 | Hwangbo Y | 2018 |
| GCST005109 | Progranulin levels | 29186428 | Tonjes A | 2017 |
| GCST002297 | Hepatitis B vaccine response | 24282030 | Pan L | 2013 |
| GCST001165 | Adiponectin levels | 21771975 | Chung CM | 2011 |
| GCST000709 | Breast cancer | 20585626 | Long J | 2010 |
| GCST006719 | BRCA1/2-negative high-risk breast cancer | 30323354 | Lee JY | 2018 |
| GCST001875 | Pubertal anthropometrics | 23449627 | Cousminer DL | 2013 |
| GCST002557 | Neutrophil count | 25096241 | Keller MF | 2014 |
| GCST001063 | Chronic myeloid leukemia | 21540461 | Kim DH | 2011 |
| GCST006419 | Suicide attempts | 30116032 | Erlangsen A | 2018 |
| GCST004005 | Hemoglobin levels | 28017375 | van Rooij FJA | 2016 |
| GCST000517 | Iron levels | 19880490 | Tanaka T | 2009 |
| GCST001652 | Crohn's disease | 22936669 | Julia A | 2012 |
| GCST000696 | End-stage renal disease \(non-diabetic\) | 20532800 | Bostrom MA | 2010 |
| GCST004171 | Macular telangiectasia type 2 | 28250457 | Scerri TS | 2017 |
| GCST005751 | Empathy quotient | 29527006 | Warrier V | 2018 |
| GCST008225 | Renal cell carcinoma | 31231134 | Laskar RS | 2019 |
| GCST006274 | Systolic blood pressure night-to-day ratio in hypertension | 29973135 | Rimpela JM | 2018 |
| GCST006040 | Atopy | 28927820 | Sugier PE | 2017 |
| GCST007004 | Hippocampal volume in normal cognition | 29274321 | Chung J | 2017 |
| GCST000228 | Vitamin B12 levels | 18776911 | Hazra A | 2008 |
| GCST005327 | Neuroticism | 29292387 | Turley P | 2018 |
| GCST004145 | Primary biliary cholangitis | 28062665 | Kawashima M | 2017 |
| GCST000113 | Colorectal cancer | 17934461 | Broderick P | 2007 |
| GCST000177 | YKL-40 levels | 18403759 | Ober C | 2008 |
| GCST001043 | Response to interferon beta therapy | 21502966 | Weber F | 2011 |
| GCST005626 | Extremely high intelligence | 29731509 | Zabaneh D | 2017 |
| GCST006878 | Dentate gyrus molecular layer volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST004716 | Heart rate variability traits \(RMSSD\) | 28610988 | Kerr KF | 2017 |
| GCST002182 | End-stage renal disease in Type 1 diabetics | 24029427 | Sandholm N | 2013 |
| GCST004948 | Breast cancer | 19330027 | Ahmed S | 2009 |
| GCST000545 | Fetal hemoglobin levels | 20018918 | Solovieff N | 2009 |
| GCST003242 | Plasma omega-3 polyunsaturated fatty acid levels \(alphalinolenic acid\) | 26584805 | Dorajoo R | 2015 |
| GCST001951 | Alzheimer's disease biomarkers | 23562540 | Cruchaga C | 2013 |
| GCST004070 | Cerebrospinal P-tau181p levels | 28247064 | Deming Y | 2017 |
| GCST001947 | Alzheimer's disease \(late onset\) | 23565137 | Miyashita A | 2013 |
| GCST005706 | Neutralising antibody response to interferon beta therapy in multiple sclerosis \(presence of antibodies\) | 29521573 | Buck D | 2018 |
| GCST001596 | Glaucoma | 22792221 | Takamoto M | 2012 |
| GCST007230 | Severe depressive disorders in coronary artery disease | 30563176 | Westermair AL | 2018 |
| GCST004199 | Osteoarthritis \(with total hip replacement\) | 28319091 | Styrkarsdottir U | 2017 |
| GCST006812 | Smoking status \(ever vs never smokers\) | 30271922 | Clifton EAD | 2018 |
| GCST004699 | Daytime sleepiness | 28604731 | Hammerschlag AR | 2017 |
| GCST007879 | Chronic kidney disease | 31015462 | Graham SE | 2019 |
| GCST003247 | Testicular germ cell tumor | 26503584 | Litchfield K | 2015 |
| GCST004536 | Hemoglobin | 28548082 | Southam L | 2017 |
| GCST004435 | Monokine induced by gamma interferon levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST002303 | Glycated hemoglobin levels | 24405752 | An P | 2013 |
| GCST000205 | Fasting plasma glucose | 18451265 | Bouatia-Naji N | 2008 |
| GCST006090 | Excessive sweating | 29895819 | Endo C | 2018 |
| GCST007022 | Type 2 diabetes nephropathy including microalbuminuria | 30566433 | Taira M | 2018 |
| GCST007588 | Attention deficit hyperactivity disorder or amygdala volume \(pleiotropy\) | 30818988 | Klein M | 2019 |
| GCST002921 | Multiple myeloma | 26007630 | Swaminathan B | 2015 |
| GCST002922 | Multiple myeloma and monoclonal gammopathy | 26007630 | Swaminathan B | 2015 |
| GCST004294 | Nicotine dependence | 28440896 | Yin X | 2017 |
| GCST004436 | Macrophage colony stimulating factor levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST006276 | Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy | 30066433 | Jabbari E | 2018 |
| GCST004167 | Colon cancer | 28295283 | Wang H | 2017 |
| GCST001825 | Beta-trace protein levels | 23328707 | Tin A | 2013 |
| GCST006618 | Uterine fibroid size \(maximum dimension\) | 30196971 | Bray MJ | 2018 |
| GCST003216 | LDL cholesterol | 26582766 | Lu X | 2015 |
| GCST007109 | Diarrhoea-associated Entamoeba histolytica infection | 30228239 | Wojcik GL | 2018 |
| GCST006129 | Pediatric areal bone mineral density \(spine vs radius & hip discordant skeletal phenotype\) | 29240982 | Mitchell JA | 2017 |
| GCST002089 | Intraocular pressure | 23836780 | Blue Mountains Eye Study \(BMES\) | 2013 |
| GCST005924 | Corticosteroid-induced adrenal suppression \(peak cortisol &lt; 500 nmol/L\) | 29551627 | Hawcutt DB | 2018 |
| GCST005927 | Corticosteroid-induced adrenal suppression \(peak cortisol &lt; 350 nmol/L\) | 29551627 | Hawcutt DB | 2018 |
| GCST004053 | Poor prognosis in Crohn's disease | 28067912 | Lee JC | 2017 |
| GCST000153 | Prostate cancer | 18264098 | Gudmundsson J | 2008 |
| GCST003683 | Intracranial, abdominal aortic or thoracic aortic aneurysm \(pleiotropy\) | 27418160 | van 't Hof FN | 2016 |
| GCST007389 | Suicidality | 30745170 | Strawbridge RJ | 2019 |
| GCST003483 | S-phenylmercapturic acid levels in smokers | 26959369 | Haiman CA | 2016 |
| GCST000136 | Height | 18193045 | Sanna S | 2008 |
| GCST002314 | Glomerular filtration rate | 24351856 | Nanayakkara S | 2013 |
| GCST007297 | Psychological distress | 30705256 | Koshimizu H | 2019 |
| GCST003660 | HDL cholesterol | 27036123 | van Leeuwen EM | 2016 |
| GCST002878 | Creutzfeldt-Jakob disease \(sporadic\) | 25918841 | Sanchez-Juan P | 2015 |
| GCST007948 | KANNO antigen negativity | 31020675 | Omae Y | 2019 |
| GCST004761 | Fasting blood glucose adjusted for BMI | 28548082 | Southam L | 2017 |
| GCST002819 | Adolescent idiopathic scoliosis | 25784220 | Sharma S | 2015 |
| GCST000790 | Fuchs's corneal dystrophy | 20825314 | Baratz KH | 2010 |
| GCST003181 | Staphylococcus aureus nasal carriage \(intermittent\) | 26569114 | Brown EL | 2015 |
| GCST004692 | Amyotrophic lateral sclerosis | 27455348 | van Rheenen W | 2016 |
| GCST003358 | Betaine levels in individuals undergoing cardiac evaluation | 26822151 | Hartiala JA | 2016 |
| GCST003961 | Hippocampal volume | 28098162 | Hibar DP | 2017 |
| GCST004311 | Facial morphology \(factor 7, width of cartilaginous portion of nose\) | 28441456 | Lee MK | 2017 |
| GCST002227 | Body mass index | 24064335 | Pei YF | 2013 |
| GCST005558 | Plantar fascial disorders | 29534260 | Kim SK | 2018 |
| GCST003980 | Sleep duration | 27992416 | Lane JM | 2016 |
| GCST005156 | Alloimmunization response to pregnancy \(HLA class I\) | 29168253 | Seielstad M | 2017 |
| GCST006869 | Nicotine withdrawal | 29532581 | Hallfors J | 2018 |
| GCST007243 | Intra-individual response time variability \(selective attention\) | 30287865 | Pinar A | 2018 |
| GCST002460 | Urinary bladder cancer | 24861552 | Rafnar T | 2014 |
| GCST005415 | Self-reported risk-taking behaviour | 29391395 | Strawbridge RJ | 2018 |
| GCST002531 | Cerebrospinal AB1-42 levels in Alzheimer's disease dementia | 25027320 | Ramirez A | 2014 |
| GCST001437 | Thyrotoxic hypokalemic periodic paralysis | 22399142 | Jongjaroenprasert W | 2012 |
| GCST002592 | Neuritic plaque | 25188341 | Beecham GW | 2014 |
| GCST003023 | Blond vs non-blond hair color | 26184321 | Lin BD | 2015 |
| GCST003847 | Caffeine metabolism \(plasma 1,7-dimethylxanthine \(paraxanthine\) level\) | 27702941 | Cornelis MC | 2016 |
| GCST002530 | Serum lipase activity | 25028398 | Weiss FU | 2014 |
| GCST000795 | Refractive error | 20835239 | Solouki AM | 2010 |
| GCST006079 | Accelerometer-based physical activity measurement \(fraction of time with accelerations &gt;425 milli-gravities\) | 29899525 | Klimentidis YC | 2018 |
| GCST000384 | Neuroblastoma \(high-risk\) | 19412175 | Capasso M | 2009 |
| GCST000448 | Follicular lymphoma | 19620980 | Skibola CF | 2009 |
| GCST000040 | Rheumatoid arthritis | 17554300 | Wellcome Trust Case Control Consortium | 2007 |
| GCST007689 | Low density lipoprotein cholesterol levels | 30911093 | Bandesh K | 2019 |
| GCST000283 | LDL cholesterol | 19060910 | Sabatti C | 2008 |
| GCST007688 | Total cholesterol levels | 30911093 | Bandesh K | 2019 |
| GCST000911 | Progranulin levels | 21087763 | Carrasquillo MM | 2010 |
| GCST002079 | Migraine - clinic-based | 23793025 | Anttila V | 2013 |
| GCST002214 | Serum alkaline phosphatase levels | 24094242 | Li J | 2013 |
| GCST000606 | E-selectin levels | 20147318 | Qi L | 2010 |
| GCST002193 | Abdominal aortic aneurysm | 24046328 | Bradley DT | 2013 |
| GCST004242 | HDL cholesterol | 28371326 | Zhu Y | 2017 |
| GCST004239 | Metabolic syndrome | 28371326 | Zhu Y | 2017 |
| GCST005248 | Delayed reward discounting | 29230059 | Sanchez-Roige S | 2017 |
| GCST006095 | Excessive hairiness | 29895819 | Endo C | 2018 |
| GCST004900 | Migraine without aura | 28952330 | Chen SP | 2017 |
| GCST000860 | Moyamoya disease | 21048783 | Kamada F | 2010 |
| GCST001871 | Renal transplant outcome | 23432519 | O'Brien RP | 2013 |
| GCST007221 | Type 2 diabetes | 30470734 | Hackinger S | 2018 |
| GCST003765 | Emotional dysregulation | 27643478 | Powers A | 2016 |
| GCST006308 | Triglycerides | 29404214 | Andaleon A | 2018 |
| GCST007991 | Large artery stroke | 28265093 | Malik R | 2017 |
| GCST007933 | Medication use \(immunosuppressants\) | 31015401 | Wu Y | 2019 |
| GCST000232 | Rheumatoid arthritis | 18794853 | Raychaudhuri S | 2008 |
| GCST003972 | Visceral adipose tissue/subcutaneous adipose tissue ratio | 27918534 | Chu AY | 2016 |
| GCST003973 | Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI | 27918534 | Chu AY | 2016 |
| GCST000295 | Bone mineral density \(spine\) | 19079262 | Styrkarsdottir U | 2008 |
| GCST006931 | Verbal memory | 29907492 | Nakahara S | 2018 |
| GCST005785 | Calcific aortic valve stenosis | 29511167 | Theriault S | 2018 |
| GCST004404 | Alcohol consumption \(drinkers vs non-drinkers\) | 28485404 | Jorgenson E | 2017 |
| GCST001260 | Coronary heart disease | 21971053 | Takeuchi F | 2011 |
| GCST006771 | Number of pregnancies | 30188897 | Jeong C | 2018 |
| GCST006765 | Number of live births | 30188897 | Jeong C | 2018 |
| GCST007683 | Triiodothyronine levels | 30843173 | Popovic M | 2019 |
| GCST007680 | Triiodothyronine levels and thyroxine levels | 30843173 | Popovic M | 2019 |
| GCST000431 | Height | 19570815 | Estrada K | 2009 |
| GCST008105 | Diverticular disease | 30661054 | Schafmayer C | 2019 |
| GCST008262 | Psychological wellbeing index 1 \(lack of subjective wellbeing and health\) | 31003110 | Kim S | 2019 |
| GCST004011 | RR interval \(tricyclic/tetracyclic antidepressant use interaction\) | 28039329 | Noordam R | 2016 |
| GCST001478 | Circulating cell-free DNA | 22511988 | Jylhava J | 2012 |
| GCST005775 | Hematocrit | 29615537 | Kulminski AM | 2018 |
| GCST004806 | Immunoglobulin light chain \(AL\) amyloidosis \(heart and kidney involvement\) | 28679651 | Meziane I | 2017 |
| GCST002102 | Thyroid cancer | 23894154 | Kohler A | 2013 |
| GCST006390 | Biliary atresia | 30102696 | Chen Y | 2018 |
| GCST001777 | LDL \(oxidized\) | 23247145 | Makela KM | 2012 |
| GCST002066 | B cell non-Hodgkin lymphoma | 23749188 | Tan DE | 2013 |
| GCST006063 | White matter integrity \(fractional anisotropy\) | 29752348 | Rutten-Jacobs LCA | 2018 |
| GCST006631 | Nicotine dependence and major depression \(severity of comorbidity\) | 30287806 | Zhou H | 2018 |
| GCST004097 | Response to platinum-based neoadjuvant chemotherapy in cervical cancer | 28120872 | Li X | 2017 |
| GCST002543 | Hearing function | 25060954 | Wolber LE | 2014 |
| GCST002700 | Cervical artery dissection | 25420145 | Debette S | 2014 |
| GCST001388 | Intracranial aneurysm | 22286173 | Low SK | 2012 |
| GCST003154 | Peripheral artery disease | 26488411 | Matsukura M | 2015 |
| GCST004299 | Atrial fibrillation | 28416818 | Christophersen IE | 2017 |
| GCST000123 | Urate levels | 17997608 | Li S | 2007 |
| GCST002593 | Dementia and core Alzheimer's disease neuropathologic changes | 25188341 | Beecham GW | 2014 |
| GCST002588 | Cerebral amyloid angiopathy | 25188341 | Beecham GW | 2014 |
| GCST008235 | Cognitive impairment | 31201950 | Lutz MW | 2019 |
| GCST002594 | Neurofibrillary tangles | 25188341 | Beecham GW | 2014 |
| GCST008209 | Interleukin-1-beta levels | 31217265 | Sliz E | 2019 |
| GCST000522 | Height | 19893584 | Kim JJ | 2009 |
| GCST000312 | Lp \(a\) levels | 19124843 | Ober C | 2009 |
| GCST005963 | Epstein Barr virus nuclear antigen 1 IgG levels | 29868224 | Sallah N | 2017 |
| GCST002138 | Waist-hip ratio | 23966867 | Liu CT | 2013 |
| GCST002607 | Response to thiopurine immunosuppressants in inflammatory bowel disease \(pancreatitis\) \(azathioprine and mercaptopurine\) | 25217962 | Heap GA | 2014 |
| GCST000188 | Neuroblastoma | 18463370 | Maris JM | 2008 |
| GCST003430 | Incident myocardial infarction | 26950853 | Dehghan A | 2016 |
| GCST001029 | Alcohol consumption | 21471458 | Schumann G | 2011 |
| GCST004017 | Neuroticism | 27918536 | Lo MT | 2016 |
| GCST000053 | Colorectal cancer | 17618284 | Tomlinson I | 2007 |
| GCST000948 | Colorectal cancer | 21242260 | Cui R | 2011 |
| GCST003615 | Susceptibility to persistent hepatitis B virus infection | 27244555 | Li Y | 2016 |
| GCST000727 | Abdominal aortic aneurysm | 20622881 | Gretarsdottir S | 2010 |
| GCST002981 | Longitudinal alcohol consumption | 26081443 | Adkins DE | 2015 |
| GCST002978 | Metastasis at diagnosis in osteosarcoma | 26084801 | Mirabello L | 2015 |
| GCST002952 | Pediatric bone mineral content \(radius\) | 26041818 | Chesi A | 2015 |
| GCST001067 | Testicular cancer | 21551455 | Kanetsky PA | 2011 |
| GCST002414 | Serum vitamin D-binding protein levels | 24740207 | Moy KA | 2014 |
| GCST002430 | Hippocampal sclerosis of aging | 24770881 | Nelson PT | 2014 |
| GCST001220 | Metabolite levels | 21931564 | Nicholson G | 2011 |
| GCST008141 | HDL cholesterol | 31170924 | Kong S | 2019 |
| GCST002967 | Mucinous ovarian carcinoma | 26075790 | Kelemen LE | 2015 |
| GCST006885 | Presubiculum volume | 30279459 | van der Meer D | 2018 |
| GCST002797 | Pulmonary artery enlargement in chronic obstructive pulmonary disease | 25101718 | Lee JH | 2015 |
| GCST001693 | Acute lymphoblastic leukemia \(childhood\) | 23007406 | Yang JJ | 2012 |
| GCST002183 | Relative hand skill in reading disability | 24068947 | Brandler WM | 2013 |
| GCST003965 | Subcutaneous adipose tissue | 27918534 | Chu AY | 2016 |
| GCST000446 | Atrial fibrillation | 19597491 | Gudbjartsson DF | 2009 |
| GCST001676 | Body mass index | 22982992 | Yang J | 2012 |
| GCST000061 | Asthma | 17611496 | Moffatt MF | 2007 |
| GCST001410 | Cardiac repolarization | 22342860 | Marjamaa A | 2012 |
| GCST002340 | Colorectal cancer | 24448986 | Zhang B | 2014 |
| GCST004168 | Colorectal cancer | 28295283 | Wang H | 2017 |
| GCST002698 | Serum VEGFR2 concentration | 25411163 | Maitland ML | 2014 |
| GCST003923 | DDT metabolite \(p,p'-DDE levels\) | 27839851 | Lind L | 2016 |
| GCST002919 | Colorectal cancer | 25990418 | Al-Tassan NA | 2015 |
| GCST004321 | Facial morphology \(factor 17, height of vermillion upper lip\) | 28441456 | Lee MK | 2017 |
| GCST005786 | Prostate cancer | 29356057 | Du Z | 2018 |
| GCST001554 | Sex hormone-binding globulin levels | 22675492 | Prescott J | 2012 |
| GCST005828 | Estradiol levels | 29325096 | Eriksson AL | 2018 |
| GCST003051 | Multiple myeloma \(survival\) | 26198393 | Ziv E | 2015 |
| GCST003321 | Small vessel stroke | 26732560 | Cheng YC | 2016 |
| GCST005938 | Maximum cranial length | 29698431 | Roosenboom J | 2018 |
| GCST003054 | Gait rhythm | 26219847 | Adams HH | 2015 |
| GCST008159 | Waist-to-hip ratio adjusted for BMI | 28552196 | Tachmazidou I | 2017 |
| GCST006486 | Periodontitis | 30218097 | Munz M | 2018 |
| GCST006260 | Childhood onset systemic lupus erythematosus | 29967481 | Joo YB | 2018 |
| GCST001093 | C-reactive protein | 21647738 | Wu Y | 2011 |
| GCST008312 | Sural nerve amplitude potential | 30992453 | Bjornsdottir G | 2019 |
| GCST006203 | Atazanavir levels | 29315502 | Tamraz B | 2018 |
| GCST008114 | Type 2 diabetes | 31049640 | Chen J | 2019 |
| GCST000858 | Systemic lupus erythematosus | 21044949 | Yang J | 2010 |
| GCST002515 | Pneumoconiosis in silica exposure | 24986923 | Chu M | 2014 |
| GCST002786 | Gene methylation in lung tissue | 25713168 | Leng S | 2015 |
| GCST004136 | Methadone dose in opioid dependence | 28115739 | Smith AH | 2017 |
| GCST000160 | Urate levels | 18327257 | Vitart V | 2008 |
| GCST001008 | Nonalcoholic fatty liver disease | 21423719 | Speliotes EK | 2011 |
| GCST001576 | Nonalcoholic fatty liver disease | 22719876 | Kawaguchi T | 2012 |
| GCST004779 | Uterine fibroids | 28836065 | Hellwege JN | 2017 |
| GCST000337 | Quantitative traits | 19197348 | Lowe JK | 2009 |
| GCST001645 | LDL cholesterol | 23067351 | Rasmussen-Torvik LJ | 2012 |
| GCST004966 | Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease | 28753643 | Yeo A | 2017 |
| GCST006393 | Serum creatinine levels | 29779033 | Hishida A | 2018 |
| GCST006392 | Estimated glomerular filtration rate | 29779033 | Hishida A | 2018 |
| GCST005220 | Insulin levels | 24699409 | Prokopenko I | 2014 |
| GCST006932 | Reasoning | 29907492 | Nakahara S | 2018 |
| GCST000593 | Multiple sclerosis | 20159113 | Jakkula E | 2010 |
| GCST000130 | Urate levels | 18179892 | Wallace C | 2008 |
| GCST000161 | Urate levels | 18327256 | Doring A | 2008 |
| GCST004431 | RANTES levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003261 | Ischemic stroke \(undetermined subtype\) | 26708676 | Pulit SL | 2015 |
| GCST002490 | Chronic hepatitis B infection | 24940741 | Chang SW | 2014 |
| GCST003977 | Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase | 28029757 | Merkel PA | 2016 |
| GCST002329 | Acne \(severe\) | 24399259 | He L | 2014 |
| GCST003378 | Response to lithium treatment in bipolar disorder | 26806518 | Hou L | 2016 |
| GCST006361 | Anti-Epstein-Barr virus nuclear antigen \(EBNA\) IgG levels | 30053915 | Scepanovic P | 2018 |
| GCST003085 | Warfarin maintenance dose | 26265036 | Parra EJ | 2015 |
| GCST007950 | Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals | 31092297 | Guan M | 2019 |
| GCST004425 | Tumor necrosis factor beta levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST004494 | Hand grip strength | 27325353 | Matteini AM | 2016 |
| GCST003927 | Dysmenorrheic pain | 27454463 | Jones AV | 2016 |
| GCST001733 | Schizophrenia | 23142968 | Betcheva ET | 2012 |
| GCST006130 | Pediatric areal bone mineral density \(concordant skeletal phenotype\) | 29240982 | Mitchell JA | 2017 |
| GCST003418 | Skin fluorescence in type 1 diabetes | 27207532 | Roshandel D | 2016 |
| GCST000249 | Basal cell carcinoma | 18849993 | Stacey SN | 2008 |
| GCST005808 | Plasma haptoglobin levels in type 2 diabetes | 29572449 | Gurung RL | 2018 |
| GCST005807 | Urinary haptoglobin levels in type 2 diabetes | 29572449 | Gurung RL | 2018 |
| GCST007110 | Physical activity \(walking duration\) | 30531941 | Doherty A | 2018 |
| GCST004530 | C-reactive protein levels | 28548082 | Southam L | 2017 |
| GCST003767 | Life satisfaction | 27089181 | Okbay A | 2016 |
| GCST001412 | Facial morphology | 22341974 | Paternoster L | 2012 |
| GCST001369 | Type 2 diabetes | 22238593 | Palmer ND | 2012 |
| GCST006108 | Facial morphology | 29921221 | Cha S | 2018 |
| GCST001775 | Hepatocellular carcinoma in hepatitis B infection | 23242368 | Jiang DK | 2012 |
| GCST002686 | Protein C levels | 25376901 | Munir MS | 2014 |
| GCST002511 | Response to radiotherapy in prostate cancer \(toxicity\) | 24974847 | Fachal L | 2014 |
| GCST004982 | Prostate cancer | 29117387 | Conti DV | 2017 |
| GCST005392 | Tooth agenesis \(maxillary second premolars\) | 29364747 | Jonsson L | 2018 |
| GCST007210 | Alloimmunization response to red blood cell transfusion in sickle cell anemia | 30578281 | Williams LM | 2018 |
| GCST002170 | Mesial temporal lobe epilepsy with hippocampal sclerosis | 24014518 | Kasperaviciute D | 2013 |
| GCST000432 | Alcohol dependence | 19581569 | Treutlein J | 2009 |
| GCST007054 | Weight | 30108283 | Granot-Hershkovitz E | 2018 |
| GCST001743 | Alzheimer's disease | 23150908 | Jonsson T | 2012 |
| GCST000665 | Type 2 diabetes | 20418489 | Qi L | 2010 |
| GCST002695 | Episodic memory | 25385369 | Ramanan VK | 2014 |
| GCST004821 | Monocyte chemoattractant protein-1 \(red blood cell fatty acid level interaction\) | 28820441 | Veenstra J | 2017 |
| GCST004040 | Response to paliperidone in schizophrenia \(positive Marder score\) | 27846195 | Li Q | 2016 |
| GCST006635 | Eudaimonic well-being | 30279531 | Baselmans BML | 2018 |
| GCST001346 | Response to gemcitabine in pancreatic cancer | 22142827 | Innocenti F | 2011 |
| GCST004485 | Survival in pancreatic cancer | 28470677 | Tang H | 2017 |
| GCST005755 | Cognitive empathy | 28584286 | Warrier V | 2017 |
| GCST002611 | Expressive vocabulary in infants | 25226531 | St Pourcain B | 2014 |
| GCST003558 | Major depressive disorder | 27519822 | Power RA | 2016 |
| GCST001461 | Type 2 diabetes | 22456796 | Imamura M | 2012 |
| GCST000532 | Beta thalassemia/hemoglobin E disease | 20183929 | Nuinoon M | 2009 |
| GCST005803 | Corneal astigmatism | 29422769 | Shah RL | 2018 |
| GCST002795 | Chronic obstructive pulmonary disease | 25101718 | Lee JH | 2015 |
| GCST001339 | Corneal astigmatism | 22144915 | Fan Q | 2011 |
| GCST003433 | Serum lycopene concentrations | 26861389 | D'Adamo CR | 2016 |
| GCST005096 | Iris color \(b\* coordinate\) | 29109912 | Rawofi L | 2017 |
| GCST005093 | Iris color \(a\* coordinate\) | 29109912 | Rawofi L | 2017 |
| GCST000234 | LDL cholesterol | 18802019 | Burkhardt R | 2008 |
| GCST002501 | Birdshot chorioretinopathy | 24957906 | Kuiper JJ | 2014 |
| GCST003581 | Response to radiotherapy in prostate cancer \(toxicity, decreased urine stream\) | 27515689 | Kerns SL | 2016 |
| GCST001393 | Glycated hemoglobin levels | 22290723 | Ryu J | 2012 |
| GCST003522 | Dermatomyositis | 27153935 | Zhang CE | 2016 |
| GCST000027 | Type 2 diabetes | 17460697 | Steinthorsdottir V | 2007 |
| GCST002693 | Enteric fever | 25383971 | Dunstan SJ | 2014 |
| GCST002718 | Type 2 diabetes | 25483131 | Ghassibe-Sabbagh M | 2014 |
| GCST004452 | Interleukin-5 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST003611 | Bone mineral density \(total hip\) | 27424934 | Choi HJ | 2016 |
| GCST006148 | Frontotemporal dementia with GRN mutation | 29724592 | Pottier C | 2018 |
| GCST004881 | Knee osteoarthritis | 28916551 | Liu Y | 2017 |
| GCST006894 | HATA volume | 30279459 | van der Meer D | 2018 |
| GCST002953 | Pediatric areal bone mineral density \(radius\) | 26041818 | Chesi A | 2015 |
| GCST003367 | circulating leptin levels | 26833098 | Kilpelainen TO | 2016 |
| GCST000973 | Hypertension | 21347282 | Lettre G | 2011 |
| GCST007137 | Warfarin-associated bleeding | 30357299 | De T | 2018 |
| GCST002668 | Mammographic density \(non-dense area\) | 25342443 | Lindstrom S | 2014 |
| GCST004807 | Immunoglobulin light chain \(AL\) amyloidosis \(liver involvement\) | 28679651 | Meziane I | 2017 |
| GCST005200 | Phenytoin-induced maculopapular exanthema | 29288229 | McCormack M | 2017 |
| GCST005237 | Mood instability | 29187730 | Ward J | 2017 |
| GCST000352 | Body mass \(lean\) | 19268274 | Liu XG | 2009 |
| GCST001250 | Basal cell carcinoma | 21946351 | Stacey SN | 2011 |
| GCST001830 | Osteoporosis | 23349225 | Hwang JY | 2013 |
| GCST001265 | Hypothyroidism | 21981779 | Denny JC | 2011 |
| GCST002402 | Serum IgA levels | 24676358 | Viktorin A | 2014 |
| GCST001441 | Glaucoma \(primary open-angle\) | 22428042 | Nakano M | 2012 |
| GCST007223 | Schizophrenia vs type 2 diabetes | 30470734 | Hackinger S | 2018 |
| GCST001759 | Type 2 diabetes | 23209189 | Tabassum R | 2012 |
| GCST000012 | Type 2 diabetes | 17293876 | Sladek R | 2007 |
| GCST005338 | Clinically amyopathic dermatomyositis | 29331962 | Kochi Y | 2018 |
| GCST001502 | Asthma \(childhood onset\) | 22560479 | Forno E | 2012 |
| GCST000374 | Atopic dermatitis | 19349984 | Esparza-Gordillo J | 2009 |
| GCST004527 | Subclinical trait of interstitial lung disease \(percentage of high attenuation areas on CT scan\) | 28521775 | Manichaikul A | 2017 |
| GCST004553 | White blood cell count | 28548082 | Southam L | 2017 |
| GCST006993 | Hippocampal volume in Alzheimer's disease dementia | 29274321 | Chung J | 2017 |
| GCST000639 | Urinary bladder cancer | 20348956 | Kiemeney LA | 2010 |
| GCST008155 | Waist-hip ratio | 28552196 | Tachmazidou I | 2017 |
| GCST004724 | Foot ulcer in diabetes and neuropathy | 28672053 | Meng W | 2017 |
| GCST006068 | Sub-foveal choroidal thickness | 29844195 | Hosoda Y | 2018 |
| GCST004255 | Body mass index | 28296344 | Chen G | 2017 |
| GCST007108 | Systolic blood pressure x sodium interaction \(1df test\) | 30242241 | Hachiya T | 2018 |
| GCST004844 | Gestational age at birth \(maternal effect\) | 28598419 | Hong X | 2017 |
| GCST000359 | Chronic obstructive pulmonary disease | 19300482 | Pillai SG | 2009 |
| GCST000172 | Lung cancer | 18385676 | Amos CI | 2008 |
| GCST000170 | Lung cancer | 18385738 | Hung RJ | 2008 |
| GCST000233 | Lung cancer | 18780872 | Liu P | 2008 |
| GCST002447 | Resting oxygen saturation in chronic osbtructive pulmonary disease \(pulse oxymetry\) | 24825563 | McDonald ML | 2014 |
| GCST006086 | Familial lung cancer | 29924316 | Byun J | 2018 |
| GCST007804 | Sleep \(number of episodes\) | 30952852 | Jones SE | 2019 |
| GCST001203 | Rheumatoid arthritis | 21844665 | Hu HJ | 2011 |
| GCST002572 | Congenital left-sided heart lesions | 25138779 | Mitchell LE | 2014 |
| GCST003422 | Squamous cell carcinoma | 26908436 | Siiskonen SJ | 2016 |
| GCST005936 | Supraventricular ectopy | 29618737 | Napier MD | 2018 |
| GCST000882 | Response to bleomycin \(chromatid breaks\) | 21106707 | Gu J | 2010 |
| GCST000557 | Chronic hepatitis C infection | 20060832 | Rauch A | 2010 |
| GCST000944 | Response to hepatitis C treatment | 21228123 | Ochi H | 2011 |
| GCST000485 | Response to hepatitis C treatment | 19749758 | Suppiah V | 2009 |
| GCST000486 | Response to hepatitis C treatment | 19749757 | Tanaka Y | 2009 |
| GCST003434 | Obsessive-compulsive symptoms | 26859814 | den Braber A | 2016 |
| GCST003626 | diarrhoeal disease at age 1 | 27559109 | Bustamante M | 2016 |
| GCST000801 | Breast cancer | 20852631 | Antoniou AC | 2010 |
| GCST002532 | High serum lipase activity | 25028398 | Weiss FU | 2014 |
| GCST002609 | Iron status biomarkers | 25224454 | Li J | 2014 |
| GCST004522 | Response to metformin in type 2 diabetes \(HbA1c reduction\) | 27500523 | Zhou K | 2016 |
| GCST001844 | Dietary macronutrient intake | 23372041 | Chu AY | 2013 |
| GCST001988 | Dietary macronutrient intake | 23636237 | Tanaka T | 2013 |
| GCST006219 | Executive function in ADHD | 29769613 | Sun X | 2018 |
| GCST003945 | Hepcidin/transferrin saturation ratio | 27846281 | Galesloot TE | 2016 |
| GCST000501 | Hemoglobin | 19820698 | Chambers JC | 2009 |
| GCST001365 | Anticoagulant levels | 22216198 | Athanasiadis G | 2011 |
| GCST003057 | Progression free survival in metastatic colorectal cancer \(chemotherapy interaction\) | 26222057 | Pander J | 2015 |
| GCST000451 | RR interval \(heart rate\) | 20031603 | Marroni F | 2009 |
| GCST001324 | Bilirubin levels | 22085899 | Chen G | 2011 |
| GCST001497 | Cholelithiasis-related traits in sickle cell anemia | 22558097 | Milton JN | 2012 |
| GCST005711 | Growth differentiation factor-15 levels | 29628937 | Jiang J | 2018 |
| GCST000441 | Cardiac structure and function | 19584346 | Vasan RS | 2009 |
| GCST007484 | Waist-to-hip ratio adjusted for BMI \(recessive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST007491 | Waist-to-hip ratio adjusted for BMI \(recessive genetic model\) | 30778226 | Justice AE | 2019 |
| GCST002827 | Urate levels \(BMI interaction\) | 25811787 | Huffman JE | 2015 |
| GCST000648 | Birth weight | 20372150 | Freathy RM | 2010 |
| GCST002644 | Birth length | 25281659 | van der Valk RJ | 2014 |
| GCST001849 | IgG glycosylation | 23382691 | Lauc G | 2013 |
| GCST000198 | Melanoma | 18488026 | Brown KM | 2008 |
| GCST005390 | Tooth agenesis \(mandibular second premolars\) | 29364747 | Jonsson L | 2018 |
| GCST002039 | Blood trace element \(Se levels\) | 23720494 | Evans DM | 2013 |
| GCST002792 | Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia | 25710658 | Diouf B | 2015 |
| GCST001675 | Barrett's esophagus | 22961001 | Su Z | 2012 |
| GCST004999 | Chickenpox | 28928442 | Tian C | 2017 |
| GCST005004 | Hepatitis B | 28928442 | Tian C | 2017 |
| GCST002516 | Frontotemporal dementia | 24943344 | Ferrari R | 2014 |
| GCST000716 | Multiple sclerosis | 20598377 | Nischwitz S | 2010 |
| GCST007111 | Vitiligo \(early onset\) | 30674883 | Jin Y | 2019 |
| GCST007112 | Vitiligo \(late onset\) | 30674883 | Jin Y | 2019 |
| GCST002758 | Oligoclonal band status in multiple sclerosis | 25616667 | Goris A | 2015 |
| GCST001805 | Leishmaniasis \(visceral\) | 23291585 | Fakiola M | 2013 |
| GCST005941 | Epstein Barr virus nuclear antigen 1 IgG seropositivity | 29868224 | Sallah N | 2017 |
| GCST005943 | Epstein-Barr virus immune response \(multivariate analysis\) | 29868224 | Sallah N | 2017 |
| GCST007247 | Latent autoimmune diabetes vs. type 1 diabetes | 30254083 | Cousminer DL | 2018 |
| GCST002300 | Rheumatoid arthritis | 23918589 | Negi S | 2013 |
| GCST002316 | Chronic hepatitis C infection | 24376798 | Miki D | 2013 |
| GCST002791 | Peanut allergy | 25710614 | Hong X | 2015 |
| GCST002802 | White wine liking | 25758996 | Pirastu N | 2015 |
| GCST000375 | Hepatitis B | 19349983 | Kamatani Y | 2009 |
| GCST002160 | Wegener's granulomatosis | 23740775 | Xie G | 2013 |
| GCST001672 | Esophageal cancer  \(alcohol interaction\) | 22960999 | Wu C | 2012 |
| GCST002807 | Classic bladder exstrophy | 25763902 | Draaken M | 2015 |
| GCST001505 | Multiple sclerosis | 22570697 | Matesanz F | 2012 |
| GCST001088 | Myopia \(pathological\) | 21640322 | Shi Y | 2011 |
| GCST002045 | Educational attainment | 23722424 | Rietveld CA | 2013 |
| GCST006049 | Central corneal thickness | 29847655 | Fan BJ | 2018 |
| GCST003523 | Coenzyme Q10 levels | 27149984 | Degenhardt F | 2016 |
| GCST004805 | Immunoglobulin light chain \(AL\) amyloidosis \(heart involvement\) | 28679651 | Meziane I | 2017 |
| GCST004811 | Immunoglobulin light chain \(AL\) amyloidosis \(serum Ig light chain only lambda/kappa based profile\) | 28679651 | Meziane I | 2017 |
| GCST004804 | Immunoglobulin light chain \(AL\) amyloidosis \(serum Ig light chain only lambda based profile\) | 28679651 | Meziane I | 2017 |
| GCST001581 | Coronary heart disease | 22745674 | Hager J | 2012 |
| GCST003610 | Bone mineral density \(spine\) | 27424934 | Choi HJ | 2016 |
| GCST006727 | Infant, child and juvenile death \(proportion of children died &lt;15 years\) | 30188897 | Jeong C | 2018 |
| GCST000794 | Refractive error | 20835236 | Hysi PG | 2010 |
| GCST000069 | F-cell distribution | 17767159 | Menzel S | 2007 |
| GCST006873 | Subiculum volume \(corrected for total hippocampal volume\) | 30279459 | van der Meer D | 2018 |
| GCST003873 | Colorectal cancer \(alcohol consumption interaction\) | 27723779 | Gong J | 2016 |
| GCST004503 | Waist circumference adjusted for BMI in smokers | 28443625 | Justice AE | 2017 |
| GCST000335 | Thyroid cancer | 19198613 | Gudmundsson J | 2009 |
| GCST004443 | Interleukin-13 levels | 27989323 | Ahola-Olli AV | 2016 |
| GCST001420 | Breast cancer | 22383897 | Long J | 2012 |
| GCST005407 | Glaucoma \(primary open-angle\) | 29449654 | Gharahkhani P | 2018 |
| GCST003424 | Arthritis \(juvenile idiopathic\) | 27005825 | Finkel TH | 2016 |
| GCST002880 | Recalcitrant atopic dermatitis | 25935106 | Kim KW | 2015 |
| GCST003014 | Postprandial triglyceride response to high fat diet meal | 26256467 | Wojczynski MK | 2015 |
| GCST001450 | Response to Vitamin E supplementation | 22437554 | Major JM | 2012 |
| GCST000231 | Urinary bladder cancer | 18794855 | Kiemeney LA | 2008 |
| GCST000329 | Essential tremor | 19182806 | Stefansson H | 2009 |
| GCST000640 | Thyroid cancer \(Papillary, radiation-related\) | 20350937 | Takahashi M | 2010 |
| GCST000680 | Multiple sclerosis | 20453840 | Sanna S | 2010 |
| GCST006107 | Upper eyelid morphology | 29921221 | Cha S | 2018 |
| GCST004247 | Alzheimer's disease \(APOE e4 interaction\) | 28183528 | Jun GR | 2017 |
| GCST004544 | Mean corpuscular volume | 28548082 | Southam L | 2017 |
| GCST004543 | Mean corpuscular hemoglobin concentration | 28548082 | Southam L | 2017 |
| GCST004546 | Red blood cell count | 28548082 | Southam L | 2017 |
| GCST000338 | Coronary heart disease | 19198612 | Erdmann J | 2009 |
| GCST008271 | Anti-adalimumab antibody production in response to treatment in Crohn's disease | 31043678 | Aterido A | 2019 |
| GCST000353 | Orofacial clefts | 19270707 | Birnbaum S | 2009 |
| GCST003539 | Mortality in heart failure | 27149122 | Smith JG | 2016 |
| GCST002988 | Ischemic stroke | 26089329 | Carty CL | 2015 |
| GCST000060 | Obesity-related traits | 17658951 | Scuteri A | 2007 |
| GCST000022 | Body mass index | 17434869 | Frayling TM | 2007 |
| GCST000426 | Obesity \(extreme\) | 19553259 | Cotsapas C | 2009 |
| GCST005577 | Change in glucose in response to thiazide diuretic treatment in hypertension | 29523524 | Singh S | 2018 |
| GCST000244 | Type 1 diabetes | 18840781 | Grant SF | 2008 |
| GCST004267 | Blood osmolality \(transformed sodium\) | 28360221 | Boger CA | 2017 |
| GCST005036 | Lean body mass | 28724990 | Zillikens MC | 2017 |

